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Summary
The work outlined in the following pages was devoted to 
studying the source of urinary dopamine (DA) as well as the position 
of DA within the natriuretic system. First, the availability of 
catecholamines (CA) in some peripheral tissues and plasma of 
normotensive and hypertensive rats was assessed. Following their 
estimation using high performance liquid chromatography with electro­
chemical detection (HPLC-EC), noradrenaline (NA), adrenaline 
(ADR), and dopamine (DA) were abundant in the rat heart, adrenals, 
kidneys, and to a much lesser extent in the plasma. In addition, 
the effect of species, sex, and mode of sacrifice were studied.
None of these factors affected the levels of CA in the kidney.
From this experiment, it was concluded that tissue concentration 
may not be the ideal parameter to study, especially when analysing 
the effect of the mode of sacrificing the experimental animals. 
Amine turnover may provide a more reliable measure.
The concentration of these CA were studied in plasma, heart, 
kidney and adrenals taken from normotensive and spontaneously 
hypertensive rats (SHR). With the exception of cardiac NA, and 
to a much lesser extent adrenal DA, no significant difference 
was seen. The reduction of cardiac NA was attributed to the in­
creased release of NA coupled with low turnover of the amine 
in SHR. Moreover, expressing the levels of these amines in relation 
to tissue protein content did not alter the significance already 
seen when CA were expressed in relation to the weight of the 
tissues used, indicating that oedema formation had not influenced 
the levels of CA observed in SHR.
In rats administered 3% solutions of either NaCl, CaCl^ 
or NaHCOg for a period of 3 days, the levels of CA in the kidney and
plasma and, to a lesser extent, in the adrenals were unchanged.
A greater effect of this treatment was observed on the concentration
in hearts loaded with CaCl^. This effect seems to be due to the
known effect of Ca on the cardiac muscle.
The results of all these experiments indicated that a continuous 
turnover takes place in the tissues studied, thus masking any alter­
ations due to salt loading or changes in species, sex, or mode of 
sacrifice. To expand and elaborate this idea, carbidopa (CD) was 
administered at a dose of 25 mg.kg  ̂i.p. to anaesthetized rats 
continuously infused with 0.9% saline at a rate of 13.33 ml.hr  ̂
for two hours. Urine samples were collected before, and half hourly 
after the injection of CD. Moreover, the time-course effect of 
CD on levels of DA was studied in anaesthetized non-perfused rats 
from which plasma and tissues were taken at half-hourly intervals 
following CD. It was found that urinary DA was reduced significantly 
while the most dramatic change was observed with the kidneys and 
plasma. On the other hand, DA in the heart and adrenals followed 
a similar pattern which was distinctly different from that of the 
kidney and plasma, indicating that the uptake of CD is different 
in different tissues. This was confirmed later with amonofluoromethyl- 
dopa (a MFMD), injected intraperitoneally at a dose of lOOmg.kg  ̂
and tissues were dissected free in a manner similar to that of 
CD. In these experiments, the kidney and adrenals showed a time- 
dependent decrease in DA levels which was much more marked in the 
kidney, indicating that aMFMD is taken up into the kidney resulting 
in a much more marked inhibition of DOPA decarboxylase and consequently
a lower level of DA. The results with both CD and aMFMD proved that 
a continuous turnover of DA takes place at different rates in 
different tissues. These experiments seem also to, indirectly, point 
at the importance of DA in the kidney because of the high uptake 
affinity of the renal tissues to DA.
The high levels of urinary DA estimated in the last experiments, 
taken with the low plasma levels of the amine stimulated the search 
for a possible source of urinary DA. The study involved the role 
of the adrenal gland and the sympathetic neurones and was carried 
out in adrenalectomized rats and in rats dosed with 6-OHDA.
Following the removal of the glands, DA concentration in urine coll­
ected following acute infusion of isotonic solutions was reduced 
significantly concomitant with a significant reduction in glomerular 
filtration rate (GFR). This latter reduction in renal function 
was restored when 1.2% hypertonic saline was infused but the urinary
DA levels ) was still reduced by 44.0%.This figure was
exc.
taken as being derived from the adrenal gland. On the other hand,
6-OHDA (50 mg.kg ^) given as a single dose and sacrificing rats
24 hours later, reduced by =20%.
exc.
The relationship between DA and Na^ was studied in rats infused 
with different concentrations of salts.The infusion of hypotonic 
solution resulted in a reduction in Na^ and DA excretion, while 
hypertonic saline did not affect DA, but Na^ excretion was greatly 
enhanced. The effect of hypotonic saline was attributed to an 
increased proximal tubular reabsorption of Na^ while that of 
hypertonic saline was probably due to a multiple action of suppressing 
aldosterone secretion and enhancing the release of a natriuretic 
substance.
Finally, a correlation was observed between urinary DA 
excretion and that of Na^, while no correlation was found between 
DA and Cl excretion, indicating the importance of Na^ and the 
possible participation of DA as a member of the natriuretic cascade.
Therefore, the main conclusions from this work are that the 
adrenal gland contributes about 44% to urinary DA while the 
sympathetic nervous system contributes no more than 20%. This huge 
amount of DA appearing in the urine seems to be related directly 
to urinary excretion of Na^ ion thus suggesting this endogenous 
DA to qualify as a natriuretic hormone within the natriuretic system,
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Chapter One. Introduction
1.
1 . 1 Aims of this Study
The work described in the following pages was directed towards 
studying some peripheral aspects of catecholamines (CA), with special 
emphasis on dopamine (DA) and its activity in the kidney. It will, 
therefore, describe the metabolic pathways of CA, their interaction 
with different receptors and the techniques used for their estimation, 
as well as the source of urinary DA. The relation of this urinary 
DA to the renin-angiotensin-aldosterone system and to prostaglandin- 
kinin system is also described.
The experimental section includes estimation of levels of CA 
in different tissues of normotensive rats and in rats with spontan­
eous hypertension; it will also discuss the relation between salt 
loading and tissue levels of these amines. The work was extended 
to include a study of the turnover of DA following inhibition of 
synthesis by different agents. Also, the source of urinary DA was 
studied as well as the effect of different- concentrations of salt 
intake on the urinary concentration of this amine.
2.
1J2. Introduction
Catecholamines (CA) are endogenously formed compounds that 
play a major role in regulating the activities of different organs. 
They may be synthesized inside an organ, but are mostly released 
from sympathetic neurones, where they modulate nerve-nerve, nerve- 
muscle transmission (Schwartz et al., 1982). In controlling cell 
metabolism, they couple with receptors in cell membranes, and this 
coupling produces either a change in the membrane; potential, or 
via changes in cyclic adenosine 3,5 monophosphate (cAMP), sparks 
a sequence of activation to the phosphorylase system in the cell 
with the net result of changes in cell metabolism (Bowman and Rand, 
1980; Schwartz et al., 1982).
The central role for CA is entirely beyond the scope of the 
work presented here. It is adequate, though to mention that 
noradrenaline (NA) and dopamine (DA) have been extensively studied 
in the brain and two comprehensive review articles were published.
One dealt with NA (Glowinski and Baldessarini, 1966 , while the other 
was entirely devoted to DA (Hernykiewicz, 1966).
13. Synthesis of CA
1.3.1 The major pathway in the synthesis of CA is shown as follows
CHz CH-NH;I Phenylalanine
COOH — ------:-------- >hydroxylase
Phenylalanine
CHgCHz-NHz
Dopamine
Dopamine
6-hydroxylase
,DOPA decarboxylasel
C H 2- C H - N H 2 
COOH
Tyrosine
lÿrosine
hydroxylase
CHg CH NH 
COOH
Dihydroxyphenylalanine (DOPA)
ÇH CM 2 NH2 phenethanolamine
OH    »
N-methyltransferase
HO
ÇH-CH2NH-CH3
OH
Noradrenaline Adrenaline
DOPA is a product of melanocytes (Agrup et al., 1980), where 
it is engaged in the synthesis of melanin (Bowman and Rand, 1980; 
32:12-14). It is also formed in the CNS and the adrenal glands 
and is converted to DA by the action of the enzyme DOPA decarboxylase 
(DD) (Ponder et al., 1976; Palfreyman et al., 1984). The enzymes 
responsible for the formation of NA and ADR are dopamine 6-hydroxy-
4.
lase (DBH) and phenethanolamine-N ,-methyltransferase (PNMT) 
respectively (Goldstein et al., 1972).
1.3.2 Minor Pathway
There is, however, a very minor pathway for synthesis of CA 
and this is shown in the following figure (for details, see Bowman 
and Rand (1980), 11.4
Tyrosine
AAAD
C H g C H a N H
Tyramine
CHCHj-NH 
lOH
Octopamine 
PNMT
CH-CH2-NH-CH3
OH Synephrine
TH
CFE
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---- >
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Î.4. Catabolism of Catecholamines
1.4.1 Introduction
In a stock.solution, a mixture of 100 pg.ml  ̂of different 
CAs made up in 0.05M HCIO^ was found to be stable for at least 
2 weeks when stored at 5°C (Felice et al., 1978). It was found, 
however, that the behaviour of CAs in vivo is entirely different 
from that in test tubes. Halushka and Hoffman (1968) have shown 
that within 2 minutes of intravenously injecting guinea pigs with 
1̂ H| -DA the amine underwent very rapid degradation. Moreover, 
injecting ^^C DA i.v. into cats, only 3.5% of the radioactivity 
was recovered as DA within 51 - 65 minutes (Stoecker and Hempel,
1976). Furthermore, 30 minutes after microinjecting  ̂H DOPA 
into the proximal tubules of rat, 14.6 ± 1.6% of the activity 
was excreted as  ̂H DA(Baines and Chan, 1980).
Binding studies revealed that 50% of DA injected into canine 
renal artery was bound to plasma protein, making available only 
50% for excretion by the kidney (Cuche et al., 1983).
Much of CA infused into cats and dogs is metabolized, however, 
this metabolism seems to vary markedly from one species to 
another (Stoecker and Hempel, 1976; Anden and Grabowska, 1983).
1.4.2 Major Pathways for the breakdown of CA are (a) catabolism via 
the action of the enzymes catechol-o-methyl transferase (COMT) 
and monoamine oxidase (MAO);(b) conjugation.
6.
1.4.2.1/1.4.2.2. In man the major pathway seems to be the formation 
of 0-methylated metabolites by the action of COMT and the oxidative 
deamination of CA by MAO to form an aldehyde intermediate followed 
by rapid oxidation or reduction of the aldehyde to form the corres­
ponding; acid or alcohol metabolite respectively (Bowman and Rand, 
1980).
1.4.2.3 Conjugation is the other Pathway for CA catabolism. The main 
conjugates in man and animals being sulphates and/or glucuronides 
with considerable variation from one species to another. Man tends 
to form sulfoconjugates predominantly (Elchisak and Hausner, 1984).
In urine, free DA was found to account for 0.6 mg.24hr while 
the conjugated DA was 2.5 mg.24hr ^(Lackovic and Neff, 1983). In 
another study, measurement of free and conjugated DA, indicated 
that 66.8% of urinary DA was conjugated (Elchisak and Hausner, 1984) 
which is comparable to the first study.
In the plasma, more than 90% of DA is conjugated (van Loon
and Sole, 1980). It was found that plasma free DA exists in concen-
-1 -1trations of 0.1 ng.ml while the conjugated DA was 1.0 ng.ml
(Lackovic and Neff, 1983). In other studies, however, the concen­
tration of DA was so low as to be undetectable as free amine 
(Kuchel, Buu and Unger, 1978). On the other hand, 20% of the total 
circulating NA and ADR is free, the rest i s conjugated (Kuchel, 
Buu, Unger and Genest, 1978).
Most of the conjugated DA in the plasma and urine is thought 
to exist as sulphate esters (Elchisak and Carlson, 1982).
7.
In post mortem human kidneys, 25% of DA was conjugated. The 
enzyme phenol sulfotransferase which is responsible for the 
sulphation of CA has more affinity for DA than NA + ADR (vein Loon, 
1983). Moreover, the products of sulphation,DA-3-O-sulphate and 
DA-4-O-sulfate ,can serve as substrates for DBH and can therefore 
be converted to NA (Qu et al., 1983). On the other hand, they can 
be acted on by COMT and form 3-0-Me-DA and 4-0-Me-DA respectively 
(Qu et al., 1983).
It is not known, however, to what extent plasma DA conjugates 
such as DA sulphate can provide a precursor pool for plasma free 
DA,but the enzyme aryl sulfate is indeed available (van Loon, 1983)
1 4.2.3.1 Site of Conjugation
The conjugation site of CA seems to be extraadrenal (Kuchel, 
Buuu, Hamet, Nowaczynski, Genest, 1979). In experiments involving 
measurement of CA in the adrenal venous outflow of 42 hypertensive 
patients (34 essential, 4 primary aldosteronism, 4 Phaeo- 
chromocytoma) and of 16 control patients, the total DA content 
was 6.0 ± 1 ng.ml ^, 83% out of which was conjugated. On the 
other hand, total NA + ADR content was 28.8 ± 8.0 ng.ml  ̂out of 
which only 1% was conjugated. The closer the sampling to the 
periphery, the more conjugated CA measured (Kuchel, Buu, Unger 
and Genest, 1978).
In the cat (Stoecker and Hempel, 1976) and the dog (Faucheux 
et al., 1977), the proportion of DA conjugated was higher than 
in man. Injecting DA into cat was accompanied by conjugated DOPAC
8.
and HVA as major metabolites while minor percentages were present 
in the form of DA and 3 methoxytyramine (Stoecker and Hempel, 1976).
In rat, however, whether DA is injected intraperitoneally (i.p.)
(Axelrod et al., 1958), or micro injected into the tubules (Craan 
and Baines, 1977), 50% of DA was conjugated with glucuronides, and 
there was considerable conversion of DA to methylated and acidic 
metabolites.
In another study. Radioactive CA was injected either into the 
tubules of the rat (which simulates delivery in the glomerular filtrate), 
or into the peritubular capillaries (which simulates the release 
into the peritubular space and may be analogous to CA released from 
the nerve terminals in the kidney) (Baines et al., 1979).
Chromatographic analysis of urine collected after tubular micro­
injection demonstrated that the majority of free DA and NA which 
enters the proximal tubules appears unchanged in the urine while 
this was not true for CA released into the peritubular capillaries, 
which were metabolized into their metabolites 3 MT and normetanephrine 
(NMN) respectively. No contradiction exists between this study 
(Baines et al., 1979) and the study mentioned before (Craan and 
Baines, 1977), because only ]0% of the DA injected into the proximal 
tubular lumen was taken up i.e. reabsorbed from the proximal tubule.
1.4.3 A minor pathway for DA catabolism was reported recently
(Thomas et al., 1983), namely the reaction of DA with aldehydes or 
a-keto acids lead to formation of tetrahydroisoquinolines. These 
compounds can appear in patients with Parkinsonism treated withL.
DOPA. Salsolinol and O-Me-Salsolind. have been found in the urine 
of alcoholics in higher concentration than in urine of normal subjects.
9.
The search for a role for DA in the natriuretic system and 
the measurement of free DA and indeed, CA in general, will have 
to be complemented by determination of conjugates as well since 
this conjugation process may affect the biological activity of the 
amines. The common step to determine the concentration of the 
conjugates is to release them by hydrolysing the sample containing 
them at 100°C for 120 minutes and then measurement of total CA.
The concentration of conjugates is given by the difference between 
the total and the free amine concentrations (Elchisak, 1983).
1.5 Implications of DA
1.5.1 Parkinsonism : DA has long been known to provide a remedy for 
Parkinsonism (Ponder et al., 1976), but since the precursor L.dOPA 
crosses the blood-brain barrier while DA itself doesn't (Guarini
and Zanoli, 1981) the former is given instead. This in turn is usually 
administered in combination with a DOPA decarboxylase inhibitor 
like carbidopa or benserazide. These inhibitors prevent the peri­
pheral decarboxylation of DOPA and therefore making available 
more DOPA to cross the blood-brain barrier.Consequently, the dose 
can be reduced and the undesirable side effects of DOPA can be 
significantly reduced (Ponder et al., 1976).
1.5.2 In congestive heart failure, DA is useful because it increases 
the cardiac output (CO) and improves the cardiac and renal function 
when given intravenously in reasonable doses (Wilk, Mizoguchi and 
Oylowski, 1978). Excessive doses,however, should be avoided
so as to avoid tachycardia and vasoconstriction (Goldberg, 1972).
10.
1.5.3 In hypotensive shock, or in shock after cardiovascular surgery 
(Goldberg, 1972; Wilk et al., 1978). DA does not seem only 
promising, but even unparalleled. Shock is a predisposing factor 
for acute renal failure and is usually associated with acute peri­
pheral circulatory failure due to derangement of circulatory control 
or loss of circulating fluid marked by hypotension and tackycardia. 
Since DA has an inotropic effect on the heart and selectively 
increases renal function, it may be valuable remedy in such cases 
(Goldfarb et al., 1981; Vane et al., 1982).
1.5.4 In patients with acute renal failure (Raftery eind Johnson,
1979) and in experimental renal failure produced by clamping the 
renal artery for different lengths of time (Goldfarb et al., 1981 ) 
or by glycerol induction (Lee, 1982), DA was found to alleviate 
the severity of the ischaemic renal failure and GFR was found to
be still elevated 24 hours after the DA therapy. Moreover, y glutamyl- 
DOPA seems to protect against the consequences of acute renal 
failure induced by glycerol (Wilk and his colleagues, 1978). It 
was concluded that DA, gnerated intrarenally can. produce vaso­
dilatation and oppose the vasoconstriction induced by glycerol.
DA is also.useful in situations characterized by oliguria 
probably by reversing the afferent glomerular arteriolar vaso­
constriction thought to be important in the pathogenesis of acute 
renal failure (Lee, 1982). Combined with frusemide, DA seems to 
be more potent in such cases (Raftery and Johnson, 1979).
1.5.5 In unstable kidney donors (defined as a patient, who despite 
adequate hydration, has transient hypotension associated with oliguria)
11.
It was suggested that such patients should be administered DA to
improve their renal function,Before the removal of the kidneys,
-1 -1DA was infused at 2 Wg.kg .min , jall patients n = 15 responded 
with a rise in mean blood pressure (M.B.P.) from 55 to 135: mm Hg 
and urine output from 6 ml.hr  ̂to 175 ml.hr  ̂ (Raftery and Johnson, 
1979).
DA has also been implicated in salt and H^O metabolism, possibly
by an effect on the renin-angiotensin-aldosteronesystem (Obika and
Schnider , 1982) and its effect on a receptors is well established
(Goldberg, 1972). This interaction should be monitored carefully
in cases of continuous infusion of the amine since it can lead
to undesirable, even dangerous, side effects. A pedal gangrene was
-1 -1reported in a 51 year old man receiving DA 10 ug*kg .min for
-1 -12 days. Also, a patient receiving no more than 1.5 yg.kg .min 
of the drug developed gangrene in the sixth day of the infusion 
(Raftery and Johnson, 1979).
1.6. Dopamine receptors
Specific DA receptors were reported in both the central as 
well as in the peripheral nervous system, and in both systems,, 
these receptors were classified into DA^ and DÂ - Since our work 
is almost concerned with the peripheral activity of DA. We will 
just lightly touch the central aspect of DA receptors before 
detailing the peripheral ones.
12.
1.6.1 Central Dopamine Receptors
The central role for DA has been extensively studied
(Hornykiewicz, 1966), and the central dopaminergic receptors have
been investigated and classified (Gower and Marriott, 1982), into
DA^receptors located in the caudate nucleus, olfactory tubercles, 
nucleus accumbens, cerebral cortex, retina and superior cervical 
ganglion (Nakajima,Naitoh and Kuruma, 1977). These receptors are 
linked to adenylate cyclase,stimulation, of which increases the 
levels of cAMP in the effector organ. On the other hand DA^ are 
not linked to adenylate-cyclase and are independent of guanine 
nucleotide regulation (Cavero et al., 1982a).
1.6.2 Peripheral DA receptors
1.6.2.1 Introduction
Specific pathways for DA were located which mediate an increase
in renal, coronary, and mesenteric blood flow (Augustin et al.,
1977), at doses lower than those required to stimulate 3-receptors
(Goldberg, 1972). DA 3 - 300 lag, applied intravenously to rats
caused a gradual increase in MAP which turned to a depressor effect
by pretreatment with phenoxy benzamine (PBA) 9 mmol.kg  ̂i.v. or
PBA + propranolol, while only a pressor response was seen after
-1sulpiride 0.7 ymol.kg was combined with PBA and propranolol 
(Chapman, Horn, Munday and Robertson, 1980). This observation implied 
that DA acts in the cardiovascular system of the rat by interacting 
with a, 3, and DA receptors. The study presented similar observations 
to the rat renal artery. Specific DA receptors had been found in
13.
molluscs (Simon and Schramm, 1983) and in infant (Vane et al., 1982) 
and mature mammals (Goldberg, 1972; Steinsland andHieble, 1978;
Lang and Woodman, 1982). These receptors seem to be available 
in almost all sites receiving sympathetic innervation (Lackovic 
and Neff, 1983).
1.6.2.2 Classification
DA receptors are classifiable into 2 types, DA^ is linked 
to adenylate cyclase and DA^ that are not (Schwartz et al.,
1982). DA receptors, their distribution and significance had 
been reviewed recently (Broddi.e, O.E., 1982; Cavero et al., 1982a; 
1982b; Stoof and Kebabian, 1984 ).
Cavero, Massingham and Lefevre-Borg (1982a) have suggested 
that the DA^ receptors are the ones which upon activation, 
produce responses preferentially blocked by bulbocapnine while 
DAg are those blocked preferentially by several benzamide 
derivatives and by haloperidol. Others relate the classification 
merely to the finding;that some of these receptors are linked 
to adenylate cyclase and are not easily stimulated by bromocriptine, 
these have been named DA^. The other type of receptors responds 
to bromocriptine and are not linked to adenylate cyclase 
(Broddie, 1982).
From an anatomical point of view, DA^ are those receptors 
located postjunctionally, particularly on the renal and mesenteric 
circulation, whereby they mediate relaxation. Typical DA^ receptrs 
are found prejunctionally on axonal varicosities and certain 
ganglion cell bodies, where their activation leads to a reduction
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in the release of NA (Broddie, 1982; Cavero et al, 1982a; 1982b).
1.6.2.3 Renal DA receptors and relation to cAMP
It is thought that renal dopaminergic receptors are of 
the DA^ type because they are not activated easily by bromocriptine 
and activation by DA leads to an increase in the.urinary excretion 
of cAMP.
Nakajima et al. (1977a),using the rat kidney particulate 
preparation, which is composed of tubules, glomeruli, and blood 
vessels, prepared by sieving the kidney homogenate using a 150 y 
sieve, found that DA 1 mM added to the kidney preparation 
accumulated cAMP within 15 minutes. Spiroperidol, a potent anti­
psychotic agent of butyrophenone series,completely blocked, 
the DA-elicited rise in cAMP without affecting the increase 
caused by isoproterenol, NA, vasopressin, or prostaglandins.
This rise in cAMP was not blocked by a, or 3 blockers. In other
experiments, Nakajima, Naitoh and Kuruma (1977b) found that
-4perfusing the kidneys in vitro with Krebs solution, DA 10 M
added to the perfusion medium produced a two-fold increase in
cAMP which declined only after the removal of DA. Spiroperidol 
-410 M did not change cAMP level, but it abolished the DA-induced 
rise in cAMP.
Recently, in the rabbit proximal convoluted tubules, Felder 
et al. (1984), found that receptors are linked to adenylate 
cyclase. Moreover, (+) sulpiride,which is stereo-selective DA^
3antagonist, had a greater affinity for the H haloperidol
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binding sites than the DA^ antagonist (-) sulpiride
lv.6.2.4 DA receptors and - ATPase
Specific DA antagonists have been synthesised out of which 
sulpiride is the most potent (Lee, 1982). DA receptors located 
pre- and postjunctionally appear to be different (Schwartz 
et al., 1982) and thus offer a promise of designing receptor 
selective agents (Goldberg et al., 1978; Berkowitz, 1983).
The binding characteristics of both DA and haloperidol 
in the kidney are different from those in the CNS. The relatively 
low affinity of DA and of haloperidol for each other's site 
is of interest and suggests that each ligand binds to a different 
site. In contrast to haloperidol binding, DA binding could be 
inhibited by omission of ATP or Na^, or by addition of or 
ouabain (Adam, 1980). Moreover, the dopamine binding requirement 
for Na^ or A TP and inhibition by high concentration are 
similar to those for the enzyme Na^-K^-ATPase. the possible 
relationship between the dopamine receptors and Na^-K^-ATPase 
is further supported by the finding that ouabain, a specific 
inhibitor of Na^-K^-ATPase, inhibits DA binding (Adam, 1980).
The study of dopaminergic receptors in the kidney is one 
way of elucidating the intrarenal role of dopamine. The effects 
of DA to produce natriuresis may take place via these specific 
receptors.
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1.6.3 Effect of DA on B receptors.
It has been reported that small dose of DA may stimulate 
3-receptors (Goldberg, 1972) resulting in increasing cardiac 
output without changing MAP, due to reduced peripheral vascular 
resistance (PVR). The effect of DA 10 ^ M to increase the re- 
absorptive capacity^ of the proximal tubular epithelium, was 
abolished by simultaneous injections of propranolol 10  ̂M; 
it was concluded that the tubular effects of DA are mediated 
by 3 receptors (Greven and Klein, 1979). On the other hand, 
the effect of DA on contracting the isolated hearts of rabbits, 
dogs and cats was attenuated but not blocked by cocaine. Thus 
DA was classified as a 'mixed amine' which exerts its cardiac 
actions by acting on 3-receptors and by releasing NA from 
sympathetic stores (Goldberg, 1972).
1.6.4 Effect on a receptors
High doses of DA stimulate a receptors (Guarini and Zanoli, 
1981; Lee, 1982; Gullner, 1983), and produce vasoconstriction 
(Kim et al., 1980). In ergo,toxin treated rats and yohimbine 
treated dogs (Goldberg, 1972), or in rats pretreated with the 
specific a-adrenergic blocking agent (HEAT) = 23-(4-hydroxy- 
phenyl)-ethylamino ethyl tetralone) (Augustin et al., 1974), 
the pressor effect of DA was antagonised or reversed by 
the a-blocking agents. This effect was extended to other 
experimental species and indeed to man (Lang and Woodman, 1982; 
Gullner, 1983). On the other hand, the depressor effect that 
prevails following a blockade is not antagonised by atropine.
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antihistamines or even 3-adrenoceptor blocking drugs (Goldberg, 
1972). It is this observation which prompted the idea of 
specific DA receptors.
1.7. Tissue Levels
1.7.1 Variation in catecholamine estimation
Different techniques have been developed to estimate CA 
in tissues and body fluids. The most commonly used ones so far 
being fluorimetric assays (Anton and Sayre, 1962; 1964); radio- 
enzymatic assay(Ball and Lee, 1977; Brown and Dollery, 1981); 
and High Performance Liquid Chromatographic (HPLC) techniques 
with either fluorescent (Honda, et al., 1983; Yamada and Aizawa, 
1983), ultraviolet (Knox and Jurand, 1976; Molnar and Harvath, 
1976), or electrochemical (Magnusson et al., 1980; Hegstrand 
and Eichelman, 1981; Davis and Molyneux, 1982 ; Ishikawa et 
al., 1982; Smeds, F. et al., 1982) detection.
The vast amount of data collected makes it a very difficult 
task to ascertain absolute CA content of a particular tissue 
or fluid, since the variation in the content using different 
techniques is enormous e.g.Anton and Sayre (1964) using fluori­
metric assay, reported that DA exists in the spinal cord of 
cats at concentration of 50 ng.g . Recently, Simon and Schramm 
(1983) reported it to be 750 ng.g  ̂using enzymatic assay. 
Consistent with this is the finding that fluorimetric assay 
of plasma CA of the same samples was inferior to HPLC or 
radioenzymatic methods of analysis (Hjendahl, 1984).
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Variation with the same technique is very high indeed.
Using HPLC-EC to analyse DA in human urine extract, Elchisak 
and Carlson (1982) reported concentrations of 48.4 ± 20 nmol.hr  ̂
while Elchisak and Hausner (1984), in six normal individuals 
found the concentrations to be 25.8 - 85.9 nmol.hr
Using the radioenzymatic technique for analysing urinary 
DA in man, the value was 44.8 ± 7.1 nmol.hr  ̂ (Ball et al.,
1978) while Brown and Dollery (1981) using the same technique, 
found it to be 68.7 ± 17.7 nmol.hr ^.
If we go one step further, the use of the same assay method, 
the same technique by the same researchers may yield different 
results from one time to another, e.g. Anton and Sayre (1962) 
found using their Al^O^-Trihydroxyindole procedure that brain 
NA in the rat was 0.15 yg.g while using the same technique 
in 1964, found NA to be 0.32 yg.g which is nearly 113% more. 
They ascribed this discrepancy as change in strain or diff­
erence of age of rats (Anton and Sayre, 1964).
1.7.2 Inter-Laboratory validation of techniques
Most results are usually validated on the basis of experiments 
showing good reproducibility and accurate recoveries of known 
amounts of added CA to samples, as well as comparing levels 
of CA obtained with that reported in the literature.
This approach was criticized by Hjendahl (1984) who emphasized 
the necessity of assessing results obtained with samples against
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analysing the same samples using another "well characterized 
and accepted technique". For this purpose, 4 human plasma samples 
were shipped on dry ice to 34 European Laboratories and were 
analysed using either HPLC or enzymatic assay methods. Poor 
agreement between results was shown when analysing plasma samples 
by HPLC in different laboratories.
The aim of this brief survey is neither to list the content 
of CA in tissues and body fluids of different species, nor, 
indeed tissues from the same species. These are listed elsewhere 
(Anton and Sayre, 1962; 1984; Buhler et al., 1978; Adam, 1980; 
Elchisak and Hausner, 1984). The aim is to illustrate the diffi­
culty in elaborating on a figure obtained using a particular 
technique.
1.8. Source of urinary DA
1.8.1 Introduction
DA is not only.a precursor for the production of NA, an
intermediate for the biosynthesis of NA and ADR, but also a
transmitter in the DAergic neurones (Stoecker and Hempel, 1976).
One of the arguments in favour of this idea is that the relative
rate of uptake of DA and NA is not the same in all tissues.
In experiments conducted by Halushka and Hoffman (1976) ,
14guinea pigs were injected with C DA. 1.5 - 2.0 minutes later,
the kidneys were found to contain 3 times as much DA as the
lungs; the liver, heart and plasma contained progressively
lower concentrations. In animals killed 5 minutes later, the 
kidneys contained 6 times as much radioactivity as the lungs
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despite its failure to take up comparable amounts of NA. These 
findings are consistent with the idea that DA may mediate some 
physiological functions in the kidney (Lackovic and Neff, 1983). 
The renal dopaminergic system may respond to DA arriving in 
the arterial blood (Baines et al., 1979; Adam, 1980), released 
from nerve endings in blood vessels and about renal tubules 
(Baines and Chan, 1980; Suzuki et al., 1984), or being synthesized 
intra-renally (Adams, 1980; Lee, 1982).
Rennick (1968) stated that "the major fraction of urinary 
free DA appears to reach tubular fluid by tubular transport, 
rather than by GFR"; this may imply intra - renal formation 
of DA. Lee (1982) and Schwartz (1982) reviewed data concerning 
DA in the kidney. It seemed that DA reaching the urine is 
formed either from plasma DA, or via release from neurones or 
by intra-renal conversion of plasma L-DOPA to urine free DA.
It is true however, that the integrity of these three pathways 
is necessary for the formation of total urine free DA, although 
the importance of each pathway is certainly-unequal.
1.8.2 Plasma as a source of urinary DA
Although plasma levels of DA were shown to double in 
response to low Na"̂  intake (Adam, 1980), it was reported that 
plasma DA concentration in the rat is 1 nM, while those required 
to produce physiological effect at known renal glomerular 
dopaminergic receptors is 10,000 nM (Lackovic and Neff, 1983).
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Oates et al. (1979) reported that urinary DA concentrations 
far exceeds that of plasma. Even if the Renal Blood Flow (RBF) 
is taken into account, the amount extractable from the plasma 
is smaller than urinary values (Faucheux et al., 1977; Adam,
1980). Ball and his colleagues (1978) demonstrated that, in
-1man, urinary DA concentrations amounts to 653 - 2285 nmol.24 hr 
while that of plasma is 0.74 ± 0.03 nmol/L. If the GFR is 
125 ml min  ̂ (Guyton, 1976 ) , then the simple filtration will 
yield 133 nmol.24 hrs . Even if the total clearance of DA 
from all the blood reaching the kidney(600 ml.min ^) is extracted, 
the urine free DA will be 640 nmol.24 hr . The other alternative 
is the intrarenal formation of DA. Evidence that seems to support 
the intrarenal origin of DA is the finding that DA excretion 
is increased in response to Na^ load, in the absence of changes 
in the plasma DA concentration (Weinberger et al., 1982).
Two main pathways can jointly illustrate the huge amounts 
of DA appearing in the urine,namely the neuronal release of 
DA and the extra neuronal elements for the formation of DA.
1.8.3 Neuronal Contribution for urinary DA
1.8.3.1 Introduction
The presence of DA-containing nerves was reviewed by 
Dinerstein et al. (1983) and Lackovic and Relja (1983), and 
has been complemented by finding dopaminergic receptors in almost 
all sympathetically innervated organs (Neff et al., 1983; Stoof 
and Kebabian, 1984). An exhaustive review concerning specificity 
of the functions of the renal nerves have been published (Di Bona,1982)
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Stimulation of the renal nerves resulted ina dilatory 
response which was blocked by sulpiride (DA antagonist) (Snyder, 
1983). If we take this result together with finding the enzymes 
responsible for formation and breakdown of DA in the kidney 
(Goldstein et al., 1972) the clear image will be that renal 
dopaminergic nerves are available and may be important in 
mediating some physiological functions in the kidney.
1.8.3.2 Renal dopaminergic neurones
With the advancement of techniques, it was noticed that 
sympathetic nerve terminals form a close contact with the basement 
membrane of the renal proximal and distal tubules (Barajas 
and Muller (1973). Moreover, using histofluorescence technique 
and pharmacological manipulation of the findings using 6-OHDA, 
reserpine or guanethidine, indicated the presence of dopaminergic 
autonomic axons in the canine cortical slice (Bell, Lang and 
Laska, 1978). Furthermore, applying the same technique 
to whole canine kidney slices, Dinestein et al. (1979), 
revealed that DA and NA containing nerves are present in the 
kidney with dopaminergic neuronal elements located at the 
glomerular vascular poles while the fluorescence in the arcuate 
arteries was derived from NA. When they examined slices 
prepared in such a way that the whole lobule could be observed, 
it was clear that fibre-tracts containing CA enter the kidney 
along the renal artery, pass along the interlobar, arcuate, 
interlobular arteries and finally proceed along the afferent 
arterioles to the vascular pole of the glomeruli.
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The finding of different NA and DA-containing poles within 
the kidney, taken together with finding heterogenous distribution 
of CA in the different renal areas (Fernandez-Pardal and Saavedra,
1982) support the idea of different roles for DA and NA.The 
urinary, excretion of these amines and presumably their major 
metabolites, should reflect intrarenal dopaminergic and norad­
renergic nerve activity, respectively (Weinberger et al., 1982).
Exogenous DA was found in return, to affect the renal sympa­
thetic nerve activity.Simon and Shramm (1983) found that 100 pmoles 
of DA superfused spinally into rats, increased the spontaneous 
renal sympathetic nerve activity by 80% while injecting 25 - 
200 pmoles of the amine intravenously produced no change in the 
renal nerve activity. They concluded that "DA is an important 
neurotransmitter of a spinal system modulating renal sympathetic 
nerve activity."
1.8.3.3 Renal DAergic nerves and Na"̂  balance
Renal nerves seem, therefore to be very important in the 
physiological regulation of the renal function (Morgunov and Baines, 
1981 ) are capable of directly influencing the renal tubular re­
absorption of Na^, and seem to be essential for complete adaptation 
to reduction in dietary Na^ intake (Morgunov and Bains, 1981 ).
In experiments with rats and dogs, electrical stimulation 
of renal nerves induced proximal H^O and Na^ reabsorption by 
25% without changes in renal hemodynamics (Gullner, 1983). This 
finding is consistent with the results of experiments carried 
out by Claude Bernard in 1859, who noticed that cutting the
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greater splanchnic nerve (i.e. preganglionic sympathetic nerve 
that originates from thoracic sympathetic trunk and descends 
down the diaphragm and ends in celiac ganglia and plexuses with a 
splanchnic ganglion commonly near the diaphragm) in anesthetized 
dogs, increased urinary volume while stimulating the interrupted 
nerve electrically reversed the effect(see Gullner, 1983).
Another study was conducted by Kim,and Collaborators (1980) 
who reported that denervation of rat kidney by. applying phenol 
to the renal artery increased Na^ excretion by 5 to 6 fold 
while unilateral denervation for 1-3 weeks resulted in marked 
ipsilateral increase in H^O and Na^ excretion (Herlitz et al.,
1983). All these responses took place in the absence of changes 
in RBF or GFR. The conclusion is that effects of renal nerves 
are mediated by direct effects on renal tubular epithelial cells 
rather than by an indirect effect on renal hemodynamics (Kim, 
et al., 1980).
Morgunov and Baines(1981) demonstrated that DA and NA are 
released from the renal nerves following stimulation by activating 
the baroreflexes and that Na^ excretion by the kidney appeared 
to be directly related to DA and inversely to NA excretion.
This relationship was demonstrated by Cuche et al. (1972) who 
found that human volunteers with Na^ restricted diet experienced 
reduction in urinary DA and Na"*̂ excretion while increases in 
NA and ADR excretion occcurred upon standing which is a known 
stimulus of the sympathetic nervous system (Gordon et al., 1967; 
Weinberger et al., 1982). This effect was explained by Carey 
and Van Loon (1982), by the possibility that reduction in
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dopaminergic activity may allow aldosterone secretion to rise 
during dietary Na^ deprivation. Moreover, Alexander eind his 
colleagues (1974), found that a change from low to high salt 
diet or saline infusion reduced NA and increased DA excretion.
1.8.3.4 ECFV as an inhibitory stimulus
The activity of the sympathetic nervous system is affected 
by various stimuli. Besides Na^ and the posture of the individual 
discussed above, the expansion of the extracellular volume (ECFV) is 
another inhibitory stimulus.
Faucheux et al. (1977), have demonstrated that rapid expansion 
of canine blood volume with 0.9% saline reduced the NA + ADR 
in the plasma from 0.26 + 0.04 to 0.12 + 0.02 pg.ml P < 0.05 
and in the urine by 61.0% P <0.05. On the other hand, the 
urinary excretion of DA was enhanced by 22.7% P < 0.05. more 
recently, this observation was extended to man. Weinberger,
Luft and Henry (1982), having infused 0.9% saline i.v. into 
normotensive and hypertensive subjects at a rate of 500 ml.hr 
for 4 hrs, reported suppression of the S.N.S. Volume depletion 
in these subjects , however, reversed the effect.
1.8.3.5 Neuronal contribution to urine free DA
The involvement of DA-containing neurones in the formation 
of urine free DA was illustrated by Baines and Chan, (1980),
3using a micro-puncture technique. In this experiment H DOPA 
was injected into proximal tubules of denervated and sham operated
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3kidneys of rats and it was found that H DA excretion was 
the same in both groups. On the other hand, denervation reduced 
the basal urine excretion of DA from 1.16 to 0.92 ng.min 
These authors concluded that only 20% of urinary free DA is 
neuronal in origin.
It is noted however, that even this 20% contribution is 
not maintained from one species to another. (Dinerstein et al., 
1983 ) ; reported the existence of huge amounts of DA in the goat 
kidney. (2168 — 278 ng.g  ̂compared to 291. — 43 ng. g  ̂NA). 
Denervation of the kidney leads to greater than 99% loss of 
renal NA without an appreciable reduction in DA.
1.8.4 Intra renal formation of DA
Since chronic denervation reduced urinary DA by only 20% 
and since chronic denervation did not prevent the formation
3of H DA from radiolabelled DOPA, then this dopamine must 
have occurred extraneuronally(Baines and Chan, 1980). Added to 
this is the demonstration that, following adrenalectomy, Na^ 
loading elicited marked urinary excretion of DA which may suggest 
an extra-adrenal source of urinary DA (Akpaffiong et al., 1980).
These observations taken together with finding DOPA decar­
boxylase in both denervated and innervated kidneys (Najatsu 
et al., 1969) and with demonstrating that DA has been secreted 
from peritubular space to luminal fluid (Baines et al., 1979), 
then the kidney will be most likely candidate for the non­
neuronal DA production.
27.
It is obvious that the plasma DOPA is, therefore, the 
target of DOPA decarboxylase found in the kidney whereby it 
is converted to urine free DA.
Evidence supporting this idea is overwhelming. Studies 
utilized either radioactive DOPA or the prodrug y-glutamyldopa 
as models or determined the arteriovenous difference in the 
concentration of the amine.
The kidney was found to contain the highest concentration 
of tissue Y-glutamyltranspeptidase, the enzyme that deconjugates 
the plasma prodrug to the urine free DA (Wilk et al., 1978). 
Moreover, following y-glutamyldopa,the kidney contained the 
highest concentration of DA, and if we take the DA kidney/DA 
heart ratio as an index of tissue specificity, the ratio 
was 25.8 following y-glutamyldopa while only 4.3 after corresponding 
dose of L.DOPA (Wilk et al., 1978).
In the experiments described previously (Baines and Chan,
1980), using a micropuncture technique, it was estimated that 
plasma DOPA is responsible for 30% of urine free DA. Moreover 
the plasma DOPA concentration in 8 normal people was 10.46 — 2.4
nmol.L and there was good correlation between plasma DOPA 
and urine free DA r = 0.84 P < 0.01 (Brown and Dollery, 1981 ).
In this experiment, following the administration of exogenous 
L.DOPA 250 mg, plasma DOPA and urinary.dopamine increased by 
similar proportions.
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A more direct approach was suggested by Brown and Allison, 
(1981) whereby blood samples were taken from the renal artery 
and vein of human: subjects undergoing a particular examination.
Measurement of plasma L.DOPA in both vessels, indicated 
a reduction in the renal vein by 34%. This was a direct conf­
irmation of results of Sole and Bendicot (1980) (see Van Loon
and Sole, 1980), who found a step-up in concentration of plasma
+ -1DA present in the renal artery, 50 — 4 pg.ml to renal vein 
+ -163 — 5 pg.ml P < 0.01. In support of these observations, •
Ball et al. (1982) reported that the canine kidney receives
-1 -1 92 ng DOPA.min out of which 54.0 ng.min appears in the
renal vein.Since urinary DOPA, in their experiments, was
barely detectable, the arteriovenous difference of DOPA i.e.
38 ng.min  ̂must be metabolized to DA.
By a stroke of genuis, Suzuki et al. (1984) designed a 
protocol using an isolated perfused rat kidney model and showed 
that following infusing DOPA through the renal artery, there 
was a reduction in DOPA concentration in the perfusate with 
a gradual, increase in urinary DA excretion. They noted that, 
when the concentration of DOPA in the perfusate was in the 
physiological range of plasma DOPA, the urinary DA was comparable 
to urinary DA concentration observed in normal rats (2.5 - 5.0 
X 10 M/L). This indicated that the main pathway for DOPA
elimination is via formation of metabolites. On the other 
hand, when DA was added to the perfusate, it underwent rapid 
degradation and was partly excreted in the urine. In the 
non-filtering kidney model, DA in the perfusate was still formed
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from administered DOPA. From this experiment, it was concluded 
that the process of glomerular filtration is of limited importance 
and that under normal circumstances, DA formed in the kidney 
is excreted preferentially in the urine rather than secreted 
into the circulation (Suzuki et al., 1984).
1.9. Hypertension
1.9.1 Introduction
After discussing the importance of CA in the last pages, 
it seems valuable to throw some light on the involvement of 
these amines in the manipulation of hypertension , which makes 
it necessary to lightly touch the involvement of the CNS, PNS, 
the kidneys and adrenals and also the response of B.P. to sodium 
intake.
The involvement of the central nervous system (CNS) in the 
pathogenesis of hypertension has been known for some time (for 
details see Hallback, M. (1975); AntonacciO M.J. (1977); Beyer 
and Peuler (1983), and the hypothalamus as a site for regulating 
B.P. was reviewed by Phillips (1980).
Hypertension is a complex integration of systems and thus 
no sole factor can be assigned to its production. The involvement 
of the sympathoadrenal system in the maintenance of high B.P. has 
been recently studied (Izzo, 1984),while the role of the adrenal 
gland in response to stress induced hypertension was reemphasized. 
The medulla seems to be more important in acute stress, while 
the cortex,, probably via the release of cortisones (Rabito et
30,
al., 1981; Gomez-Sanchez, 1982), appear to play a more prominent 
role in adaptation during the chronic exposure to stress 
(Rosecrans et al., 1966).
Hypertension is a disease of regulation found to be present 
in nearly 1/3 of sudden cardiac death victims (Anderson, 1984).
On the other hand, B.P. was demonstrated to have a distinct 
Cl Icadian rhythm with lowest levels during sleep (Sowers et 
al., 1982).
1.9.2 Sympathetic nervous system and the kidney in hypertension
The role of the sympathetic nervous system and the kidney 
in maintenance of blood pressure have been throughly studied, 
and their actions seem to be complementary (Gordon and colleagues, 
1967). A change from recumbent to upright posture leads to 
fluid pool in the lower extremities which stimulates the S.N.S.'s 
sequence of cardiovascular actions that eventually lead to 
raising B.P. and prevention of cerebral ischaemia. On the 
other hand, the kidney responds to the stimulus by increasing 
its renin secretion and this, in turn, leads to an increase 
in aldosterone production with a net result of more conservation 
of Na^ and expansion of the ECFV.
The role of the kidney in regulating B.P. has been reviewed 
(McDonald and Miller, 1980; Guyton et al., 1981). One of the 
interesting approaches was the cross-transplant of kidneys 
from normotensive into hypertensive rats and vice versa (Guyton 
et al., 1981). It was found that normotensive kidneys
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transplanted into hypertensive animals produced normotension, 
and the opposite was also true. Additional support for the 
role of the kidney was that, intrarenal injections of NA into 
rats at doses ineffective intravenously, produced an increase 
in B.P., which was thought to be related to an increase in 
the renal noradrenergic receptor-sensitivity, and was explained 
by triggering an additional intra-renally located pressor 
hormone such as renin-angiotensin-aldosterone system (Kleinjans 
et al., 1983). On the other hand, the-: pathogenesis of high 
blood pressure may involve not only the pressor mechanisms 
mentioned above, but may also involve deficiency in vasodilatory 
and antihypertensive mechanisms (Vane et al., 1982).
In man, hypertension may be idiopathic (Beyer and Peuler,
1983) or may occur secondary to a disease (Hirschman and Herfindal, 
1975). For experimental purposes, however, different animal 
models were adopted to elaborate on various: factors involved 
in the development and regulation of B.P.(Rosecrans et al.,
1966; Rabito et al., 1981; Morton and Wallace, 1982; Chatelain, 
1983; Neff et al., 1983).
1.9.3 B.P. and Na^
Although N intake is essential for the development 
and maintenance of human and experimental hypertension (Scoggins 
et al., 1978; Nowaczynski, Genest and Kuchel, 1979; Berthelot 
and Gairard, 1980; Schalekamp et al., 1981; DiPette et 
al., 1983), the evidence favouring a role for dietary Na^ 
was not seen with all experiments. Following a week of high
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salt intake by 8 normotensive and 8 hypertensive subjects, 
no effect on B.P. was found (Harvey and colleagues, 1984).
On the other hand, hypertension was directly related to urinary 
Na^ excretion (MacGregor and De Wardener, 1981.). Moreover 
Guyton et al. (1981) have shown that raising the blood'-pressure 
in man by 100 - 200 mm Hg increased the kidney output of 
Na^ by 7 fold, while reducing the B.P. to 50 mm Hg will reduce 
the urinary Na"*” output to zero. Furthermore, there was; a 
significant correlation between body Na^ and arterial B.P. 
in hypertensive patients (Beretta-Piccoli et al., 1982).
The mechanism of B.P. response to Na^ is not yet known.
One of the attractive hypotheses, however, is that retained 
Na^ enters the cells of the vascular smooth muscle and produces 
vasoconstriction directly or indirectly by increasing cellular 
Ca^^ (Beretta-Piccoli et al., 1982).
1.9.4 B.P. and CA
The relationship between circulating CA and B.P. has 
been extensively studied. However, it is very unfortunate 
that most of these studies dealt only with NA and ADR. In 
a study conducted by Sever, P.S. (1978), eight of the clinical 
studies on normotensive and hypertensive subjects were listed.
In only 4 studies, a clear-cut difference was seen while
in the rest no difference between the two groups was demonstrated.
The hypertensive subjects show a 23 - 46% increase in their
circulating CA when compared to the controls. In another
study in normotensive and subjects with borderline hypertension.
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no difference was found in the level of NA or adrenaline 
neither in the resting state nor in the level during activity 
(Henquet et al., 1978). From these studies, it seems that 
the severity of hypertension may play a role in the levels of 
CA in the plasma.
Patients with essential hypertension tend to have a reduction 
in their urinary free DA excretion (Schwartz, Imbs, Schmidt, 
and Rouot, 1982), however, in response to volume expansion, the 
level of DA in the urine rose from 9.22 ± 1.5 Mg.hr in normo- 
tensive subjects to 18.45 ± 5.4 Mg*hr in hypertensive ones 
(Weinberger et al., 1982). The apparent discrepancy between these 
two studies can be explained on the basis that the first study 
measured the basal level of DA in the urine of the normotensive 
and hypertensive subjects while in the second one, the measurement 
was under inhibited sympathetic system activity, which results, 
as has been shown before, in an enhancement of urinary DA 
excretion (Faucheux et al., 1977).
1.10 Natriuretic Cascade: relation to hypertension and role in
regulating electrolyte balance
This section will deal with those factors stimulation of 
which can trigger an increase in Na"*” excretion, the main factors 
under discussion will be, the natriuretic hormones, the kinin- 
ppostaglandin system and DA. I have called these factors "Cascade" 
because their action may be complemented by one another, and the 
stimulation of one "may" trigger an action of another. As far
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as I am aware, no one has attempted so far to link these factors 
to each other.
1.10.1 Natriuretic hormone
1.10.1.1. Introduction
One of the factors considered to relate to hypertension 
is the natriuretic hprmone. In the past few years an enormous 
amount of data has been published (for details see reviews by 
De Wardner and Clarkson, 1982; Haddy, 1982; Buckalew and 
Gruber, 1984 ).
Plasma from volume-expanded, but not control, animals, when 
injected into other animals (Buckalew and Gruber, 1984), caused 
a prolonged natriuresis which was maximal within 1 hr. If at the 
maximum of natriuresis, 2 ml of blood is taken and the resultant 
plasma is injected into another rat, the natriuresis is small, 
but significant (De Wardner and Clarkson, 1982).
1.10.1.2 Location of natriuretic hormones (NH)
The activity discussed above is not.confined to the plasma, 
but found in bovine hypothalamus (De Wardner and Clarkson, 1982), 
rat kidney(Favre and Gourjon, 1982), urine (Haddy, 1982) and atrium 
(Seymour et.al., 1985).This in no way means that factors ob­
tained from different species or, indeed, different places from 
the same animal, are the same. It merely means that they are 
all natriuretics.
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Two groups of rats were studied by Favre and Gourjon (1982). 
One group was made nephrotic by injecting puromycin (15.0 mg.ml ^) 
while the other served as control and received 1 ml saline 0.9%.
Eight days later both groups were prepared and loaded with saline
-1 -1 at 0.5 ml.min for 1 hr then maintained at 0.1 ml.min . Urine
was collected to measure GFR and RBF while the kidneys were
extracted and the natriuretic substance injected into other rats.
It was found that saline loading promoted natriuretic response
only in control rats. Moreover the natriuretic factor was found
only in renal tissue from control rats. It was concluded that the
absence of natriuretic response in nephrotic syndrome is linked
to a lack of production of the natriuretic factor (Favre and
Gourjon, 1982).
1.10.1.3 Nature of NH
Two substances were isolated from the sites mentioned 
above, one having a molecular weight of more than 30,000 and 
possessing a very weak natriuretic activity, while the other 
had a molecular weight of less than 1,000 but had a very potent 
natriuretic action. The former substance is thought to be the 
precursor of the latter (De Wardner and Clarkson, 1982). NH 
is a polar material the structure of which is not yet known.
It is resistant to heat, hydrolysis and proteolytic enzymes 
(Haddy, 1982). In one experiment reported by Buckalew and 
Gruber (1984), CA, steroids and angiotensin II were eliminated 
as possible candidates.
36,
1.10.1.4 Mechanism of action
It has been observed that natriuretic hormone is a digitalis­
like material that inhibiits Na^-K^-ATPase in numerous tissues 
including kidney (Haddy, 1982; Buckalew and Gruber, 1984).
In salt loaded dogs, antidigoxin antibodies were reported which 
inhibited Na^-K^-ATPase, however, the ability of NH to inhibit 
Na^-K^-ATPase is reported to be at least 3000 times greater 
than the plant glycosides (Haddy, 1982).
It was reported that the capacity of plasma to inhibit ouabain- 
sensitive Na^-K^-ATPase was approximately 25 times greater when 
the plasma was obtained from subjects on high Na^ diet than 
when the same subjects were on low Na^ diet (De Wardner and 
Clarkson, 1982). On the other hand, the inhibition of Na^-K^-ATPase 
stimulates glucose-6-phosphate dehydrogenase (G6PD) activity 
and this has been taken as a measure for the activity of the 
NH. It was found that plasma from salt loaded subjects stimulated 
G6PD activity 20 times more than plasma from subjects on low 
Na^ diet (De Wardner and Clarkson, 1982; Haddy, 1982). From 
this we can conclude that although the structure of NH is un­
known, its action is mainly by inhibiting Na^-K^-ATPase.
1.10.1.5 Interaction with Prostaglandins (PCs)
Other humoral factors such as PCs were suggested to be 
necessary for the action of NH. It has been demonstrated that 
the renal response to NHwas inhibited by indomethacin or naproxen.
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while response is restored after a subnatriuretic dose of FGÊ  
(Buckalew and Gruber, 1984). These authors concluded that the 
renal response to volume expansion is due to synergistic action 
between PGs and NH.
1.10.1.6 Involvement in high B.P.
The involvement of NH in the early phase of hypertension 
was studied by Haddy (1982); Siegers and Foenster (1982); Beyer 
£ind Peuler, (1983) and Buckalew and Gruber (1984), who suggested 
the scheme reproduced below, representing the action of NH in 
normotensive and hypertensive subjects.
Normotensive
Hypertensive f i S.N.S
Renal Na 
exc. Ih
ÎNa^ intake ÎEffective plasmalT ----> |n h j| 1 1 1 ' I— > Î B.P.
1 vol. 1 l
^vascular 
Î1 reactivity
Salt ingestion leads to NH release by expansion of the 
effective plasma volume . In non-hypertensive individuals, NH 
in conjunction with other natriuretic forces, causes an increase 
in renal Na^ excretion, returning effective plasma volume to 
normal.
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In hypertensive subjects, renal response to NH is blunted 
causing NH levels to become higher than in normotensive indivi­
duals. This pathologically elevated NH leads to an increase 
in B.P. either by activating the S.N.S. or by increasing the 
vascular reactivity or both (Buckalew and Gruber, 1984).
1.10.2 The atrial natriuretic factor
Extracts of the atria of rat heart were shown to stimulate 
fractional excretion of Na , K , Cl in anesthetized rat 
(Roberstein et al., 1983; Seymour et al., 1985). This endo­
genous natriuretic factor has been found in the monkey and human 
atrium as well, and the extract is generally known as the atrial 
natriuretic factor (ANF). This factor was not found in the 
ventricular fraction (Roberstein et al., 1983). ANF was characteiized 
as a peptide containing 73 amino acids, out of which a 26 
amino acid residue of the C-terminal was synthesized and infused 
into one kidney of rats while the other kidney was infused with 
saline. In the ANF infused kidney, urine volume, fractional 
excretion of Na^, K̂ , Ca^^, Cl , were all elevated in a dose 
related manner, but were not significantly affected in the 
contralateral kidney. The authors concluded that the ANF acts 
exclusively on the kidney (Seymour et al., 1985). Buckalew 
and Gruber (1984) reported that ANF is distinct from the NH.
1.10.3 The kinin-prostaglandin system
Prostaglandins are present in the kidney and are known to 
exert a natriuretic, diuretic, and vasodilating effect. PGE^
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and PGA ̂  also participate in the autoregulation of renal blood 
flow, while PGF^Q is hypertensive in man and most experimental 
animals (Petkov et al., 1981 ).
The involvement of the kinin-prostaglandin system in the 
maintenance of blood pressure has been reviewed by Abe (1981), 
who reported a reduction in urinary excretion of kallikrein 
and prostaglandins during high blood pressure which may mean 
that impairment of the renal kinin-PG production have some role 
in hypertension. Following coarctation of the aorta between 
the two renal arteries either for 3, 30, or 90 days, the 
concentration of PGF^^ in the kidney increased significantly 
within 3 days concomitant to raise in B.P. On the other hand,
PGEg was increased in only 50% of the animals (Petkov et al.,
1981). It was concluded that PGF^^ participates directly in 
the pathogenesis of hypertension, while PGE represent a unit 
of the antihypertensive cascade of the kidney. Abe (1981), 
suggested that kinin-PG system may contribute to the regulation 
of B.P. by counteracting the vasoconstrictor and the Na^-retaining 
action of the renin-angiotensin-aldosterone system.
Despite reporting that all kinins increase urinary Na^ 
excretion by Lee (1982), it was found that PGE^ increased RBF 
and Na^ excretion, PGF^^ did not change RBF but produced profound 
natriuresis, while PGD^ increased RBF without affecting Na^ 
excretion (Haylor and Lote, 1980). The participation of PGs 
in diuresis and natriuresis was studied in rats infused with 
0.9% saline at 5.8 ml.hr ^. Haylor and Lote (1980) found that
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-1 + indomethacin 10 mg.kg i.v. reduced urine output, urinary Na , and
urinary excretion without affecting RBF or GFR. It was concluded
that indomethacin blocked the PGs involved in the control of
the renal tubular function.
1.10.4 DA as natriuretic hormone
DA may have a phsysiological role in regulating plasma 
volume by regulating Na"̂  excretion. In pharmacological doses,
DA appears to be a potent natriuretic and renal vasodilating 
agent (Kuchel,Buu and Unger, 1978; Adam, 1980). This natriuretic 
effect of DA has multiple mechanisms. DA increases RBF and GFR 
and also induces redistribution of the intra renal blood flow 
while inhibiting Na^ tubular transport (see Lee, 1982).
An infusion of DA (4.7 yM.kg ^.hr ^) into rat i.v. did not
affect excretion, while Na^ excretion was increased (Greven
and Klein, 1977). Moreover, in H^O loaded and H^O restricted
-1 -1dogs, low doses of DA(1.6 yg.kg .min )injected into renal artery, 
produced diuresis and natriuresis, with natriuresis being more 
marked in the first model while diuresis in the second. It was 
thought that DA reduced the quantity of Na^ reabsorbed by the 
proximal tubule, while increasing the Na^ delivered to the distal 
parts of the nephron (Schwartz et al., 1982).
In man, consistent increments of Na^ excretion occurred 
when DA was infused i.v. at rates which did not affect blood 
pressure, i.e. 100 - 1000 yg. min  ̂ (Goldberg, 1972). On the 
other hand, DA produced a dose related increase in B.P. when
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-1 -1infused into rats at doses of 16, 32, 64 yg.kg .min and this 
response was attenuated in rats with Na^ restricted diet (Obika 
and De Schnider, 1982). These findings taken together with 
finding that carbidopa reduced not only DA excretion but also 
urinary Na^ excretion (Ball and Lee, 1977) and the finding of 
enzymes responsible for synthesis and breakdown of DA in the 
kidney (Goldstein et al., 1972), therefore suggested that DA 
can be freed within the kidney and can act locally to control 
Na^ reabsorption.
1.11 Renin-Angiotensin-Aldosterone System (R.A.A.)
1.11.1 Renin
1.11.1.1 Formation
Renin is an enzyme of molecular weight approximately 
40,000. It is synthesized and stored in the juxtaglomerular 
apparatus located along the afferent arterioles (McDonald, Linas 
and Shrier, 1980). Recently, a high molecular weight protein 
was identified in human plasma and renal extract.This extract 
has no intrinsic enzymatic activity and is thought to be a 
"pro-renin" or the inactive precursor of the biologically active 
renin (Sealey, Atlas and Laragh, 1982).
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1.11.2 Angiotensin (Ang.)
1.11.2.1 Formation of Angiotensin
Once in the plasma, renin acts on angiotensinogen to 
form the inactive decapeptide Ang I which is transformed to 
the active octapeptide Ang II by the action of angiotensin 
converting enzyme (A.G.E.) found abundantly in the lung. This 
Ang II is then, either taken up into tissues to exert an action 
and/or its life is terminated by the enzymes angiotensinases 
(McDonald et al., 1980).
1.11.2.2 Relation to B.P.
Ang II has many actions at least two of which are of 
profound physiological significance; (a) the vasoconstrictor 
activity (b) the production of aldosterone (McDonald et al.,
1980).
Ang II is the most potent pressor agent known, and is believed 
by some investigators to be important in the hour-to-hour regu­
lation of B.P. (Sowers, Stern, D'Nyby and Jasberg, 1982). For 
this particular reason, drugs that block the A.G.E. are used 
as medications for antihypertensive therapy (Goldstein et al., 
1972; Herxheimer, 1982; Tanaka et al., 1982) and to reduce Na^ 
retention in nephrotic patients (Petkov et al., 1981 ). Besides 
blocking the formation of Ang II, the action of these compounds 
is aggravated by increasing urine volume, urinary excretion 
of Na^ and preventing the breakdown of the vasodilator bradykinin 
(Tanaka et al., 1982).
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The renin-angiotensin (R.A.) system.has been thoroughly studied 
and reviewed over the years (McDonald, C.W. 1980), and its in­
volvement in hypertension hs been scrutinised by many authors 
(see Atlas and Case, 1981; Folkow, 1982; Frohlich, 1982).
Despite the fact that in certain experimental models of hyper­
tension, e.g. renovascular hypertension, plasma renin activity 
is increased,and in high renin chronically hypertensive rats, 
angiotensin blocking drugs produced a depressor effect (Freeman, 
Davis and Seymour, 1982), this does not seem to be the case 
in man. Frohlich (1982) found that only a sub-group of essentially 
hypertensive patients were primarily dependent on the R.A. system.
If, however, the R.A. system was not of prime importance 
in a group of individuals, no one can deny the importance of 
this system in the control of aldosterone production
1.11.3 Aldosterone
1.11.3.1 Formation
Aldosterone is produced exclusively by the cells of the 
zona glomerulosa of the adrenal cortex (Nowaczynski et al.,
197 9; Bowman and Rand, 1980; 19.31-33). In mammals, the most 
biologically significant endorgan affected by aldosterone is 
the kidney (Adam, 1980), where, the action is thought to be 
through the interaction of aldosterone with cytoplasmic receptors, 
followed by nuclear uptake of the hormone-receptor complex, 
where it induces the formation of "aldosterone-induced protein", 
which in turn either induces the cell membrane permease, or
44.
induces Na^-K^-ATPase, or enhances energy production (Adam, 
1980). Although the exact mechanism is not yet known, it is 
thought that Na^-K^-ATPase will be the final mediator of aldo­
sterone's action on sodium and potassium (Adam, 1980).
1.11.3.2 Effect on N^-K^-ATPase
Aldosterone has the ability to enhance Na^ and transport 
across epithelial membranes (McDonald et al., 1980). The admin- 
stration of aldosterone to rats produced an increase in and 
a reduction in urinary Na^ excretion (Adam, 1979).
Although it is not known yet whether aldosterone has any 
action in the proximal tubule (Adam, 1980), it is, however, 
believed that it exerts its action in the distal tubules and 
the collecting ducts partly by stimulating the Na^-K^-ATPase 
pumping system. Osore (1981), found that, the addition of 0.1 
mM aldosterone to the incubation medium, increased the Na^ level 
in rat renal slices by 53% within 10 minutes, while 60% of tissue 
was lost within 10 minutes . Moreover, aldosterone increased 
Na^ reabsorption in the distal tubule leading to increased 
osmolality of the extracellular fluid which in turn led to 
stimulation of ADH release. ADH then increased the permeability 
of the collecting duct to H^O with a net result that the osmolality 
of EOF returned to normal (McDonald, Linas and Schrier, 1980).
1.11.3.3 Factors affecting aldosterone concentration
In man ,plasma aldosterone is found in concentrations
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of 2 - 16 ng.dl  ̂ (Nowaczyonski et al., 1979) and these concentrations 
seem to follow a circadian pattern which correlates with changes 
in plasma renin activity (PRA) suggesting that the renin-angiotensin 
system is a determinant of the circadian rhythm of aldosterone 
(Sowers et al., 1982).
40 - 65% of aldosterone released from the adrenal cortex 
is bound to plasma protein, and this binding protects aldosterone 
from metabolism during its passage through the liver and the 
kidney and is one factor regulating its turnover and biological 
half-life (Nowaczyonski et al., 1979). Beside this, other factors 
are known to affect the plasma concentration of aldosterone out 
of which Ang II, K̂ , ACTH and Na^ are the most important (McDonald 
et al., 1980).
is a strong stimulus to aldosterone release (Campbell, 
et al., 1981; Pratt, 1982). In addition to direct adrenal action, 
contributes to control aldosterone secretion by potentiating 
the action of other aldosterone stimulating factors such as 
Na^ depletion (Carey and Van Loon, 1982; Pratt, 1982). Moreover, 
it was found that Ang II and ACTH must be available for to 
stimulate aldosterone secretion, hence Ang II blockade by captopril 
abolished the effect of on aldosterone secretion (Pratt,
1982).
Na^ depletion is another strong stimulant of aldosterone 
secretion (Gordon et al , 1967; Carey and Van Loon, 1982) and 
is accompanied not only by an increase in aldosterone production
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but also by an increase in the secretion of 18-hydroxycorticosterone 
and 11-deoxycorticosterone (Gordon et al., 1980). 18-hydroxycortico­
sterone is a major precursor of aldosterone and is the only 
glucocorticoid - other than aldosterone - that is synthesized 
predominantly in the adrenal zona glomerulosa (Sowers, Beck 
and Stern, 1983).
1.11.3.4 Interaction of aldosterone with DA
An interaction between dopaminergic mechanisms and steroids 
in general has been studied. The infusion of the DA-agonist 
bromocriptine(0.1 - 0.2 mg.kg  ̂i.v.)to dogs resulted in an 
increase in the plasma cortisol (hydrocortisone) level, which 
was paralleled by an increase in progesterone but not testosterone 
or oestradiol (Goiny et al., 1982). Consequent to the use of 
dopaminomimetics and dopamin.olytic agents in man, it is now 
firmly believed that aldosterone is under maximum tonic dopaminergic 
inhibition (Carey et al., 1979; Lackovic and Neff, 1983). More­
over, DA inhibited angiotensin-mediated aldosterone production 
(Adam, 1980), while bromocriptine, in man, was found to suppress 
plasma aldosterone response to frusemide (Edwards et al., 1975) 
and to Ang II (Sowers et al., 1982). On the other hand, meto- 
clopramide,a DA-antagonist, stimulated aldosterone secretion 
(Campbell et al., 1981; Grolub et al., 1982; Sowers et al.,
1982), regardless of changes in B.P., circulating electrolytes: 
or prolactin levels (Carey, Thorner and Ortt, 1979; Van Loon 
and Sole, 1980; Carey and Van Loon, 1982).
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DA was also found to inhibit selectively the production 
of aldosterone and 18-hydroxycorticosterone from the zona glomer­
ulosa of the monkey (Sowers, Beck and Eggena, 1984), while metoclo- 
pramide raised plasma levels of aldosterone in rat and monkey 
(Sowers, Sharp, Levin, Golub and Eggina, 1981), but failed to 
do so in the rabbit and dog (Sowers et al., 1981 ).
1.11.3.5 Relation to Na^ and B.P.
The observation that dopaminergic modulation of aldosterone 
secretion is altered in a state of salt retention and hypertension 
(Sowers, Stern, D'Nyby and Jasberg, 1982), led to speculation 
that altered dopaminergic effect on renin-angiotensin- aldosterone 
system may be involved in the development and maintenance of 
high B.P.
Gordon and his colleagues (1967) laid down a scheme presenting 
the relationship between the stimuH of aldosterone production 
and other factors affecting B.P. Both upright posture and Na^ 
depletion led to S.N.S. stimulation which in turn started a 
sequence of events leading to raised B.P. The kidney responds 
to the stimulus,increasing renin concentration leading to increased 
aldosterone production which,in turn, increased conservation 
of Na^, increased ECFV, and maintained B.P.
Chapter Two. Estimation of 
Catecholamines in rat tissues and fluids
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2.0 Introduction
Few investigations provided values for CA in the preparations used 
in this study, and because even these are variable , it was thought 
to be a good idea to tabulate them as shown in the scheme below.
A. Kidney
Figures for renal CA concentrations are tabulated in Scheme A.
As can be seen, a huge variation exists from one experiment to another. 
Note that in those studies where DA was estimated as 52.4 pmol.g ^, if
the molecular weight of DA (free base) is 153.1 then, this value will
-1 -1 be equal to 8.0 ng.g while 0.71 is equal to 108.7 ng.g . In another
group of experiments. Bell and Gillespie (1979), using HPLC-EC,
estimated DA in the rat renal cortex to be 7.01 — 0.8% of NA,however,
in Dahl sensitive and Dahl resistant rats, DA/NA in any group was
25.05% (Fernandez-Pardal and Saavedra, 1982 )
B. Heart
In the heart, the variation in DA is not as huge as was in the
kidney, the values shown below range from 10 - 30 ng.g  ̂while bigger
-1variation is seen with NA,with values ranging from 0.27 yg.g to
0.994 yg.g  ̂ (5.88 nmol.g ^). (Scheme B).
C. Adrenals
In the experiments carried out by Elchisak and Carlson,(1982),it 
was found that only 5.3% of total adrenal DA was conjugated.The 
figures for NA and ADR were 3.85 and 1.5% respectively (Scheme C). 
Moreover, considerable amounts for adrenal DA appear to exist in the 
adrenal cortex of rats, hence following adrenomedullectomy, NA and 
ADR were reduced by 98% while DA only by 50% (Van Loon and Sole,1980).
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D. Plasma
The estimation of CA in rat plasma constitutes a problem, 
because of the huge difference in levels depending on the sampling 
technique and other factors being studied thoroughly by Buhler
and colleagues (1978). In general, plasma DA ranged from 84 to
-1 -1 190 pg.ml ; NA from 461 to 509 pg.ml ; while adrenaline from
120 to 260 pg.ml ^
E. Urine
Basal urinary excretion of DA was estimated by Ackpaffiong 
et al., (1980) as 0.88 + 0.02 nmol.ml  ̂or 7.5 + 0.02 nmol.24 
hrs ^. However, most experiments utilize DA that is collected 
via a cannula implanted in the bladder or ureters during intra­
venous loading of animals with H^O or saline. In such experiments 
the rate of urine output and consequently DA concentration depends 
on the rate of saline or water infusion. Examples of such proce­
dure are the study of Greven and Klein (1977); Baines et al.,
(1979); Baines and Chan (1980). The latter researchers, upon
-1 -1infusing rats with saline at 0.39 ml.min for 1 hr then reducing 
the flow to 0.076 ml.min , found that DA excretion was nearly 
1.16 ng.min . Note that in the experiment of Ackpaffiong et al.
(1980) mentioned above, the equivalent of the 7.5 nmol.24 hrs  ̂
is 0.8 ng.min  ̂and it is nearly 69% of the value obtained in 
the experiment carried out by Baines and Chan, (1980).
2.2 Experimental
In principle, the basic HPLC method used for analysis of 
CA was a modification of that of Eriksson and Persson, (1982).
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This detailed section will deal with the method and is considered 
to be the main description and will not,therefore, be repeated 
in different chapters. It will be noticed, however, that slight . 
changes might have taken place from one experiment to another.
These changes will be pointed to in their respective sections. 
Moreover, the chemicals used vary from one section to another, . 
and only those used for the work concerning this chapter will 
be mentioned here, leaving any additions or omissions to their 
suitable places.
2.2.1 Chemicals
HPLC grade methanol, citric acid, NaOH, sodium acetate, sodium 
octane sulphonic acid were obtained from Fisons Chemical Labora­
tories (Loughborough, England); Tris buffer, adrenaline hydrogen 
tartarate and EDTA from BDH (Poole, England). DA-HCl,glutathione- 
reduced form (GSH) were purchased from Sigma Ltd. (USA), L.NA 
bitartarate from Koch-Light Laboratories, England, while DHBA 
from Aldrich Chemical Co. USA).
2.2.2 Chromatography
Spherisorb CDS 5y was used to pack a 25 cm column by the 
upward slurry packing technique (Dept.of Pharm. Chem., University 
of Bath). Packing material was obtained from Phase Separations 
(Deeside Ind. Est. U.K.).
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2.2.2.1. Instrumentation
The liquid chromatograph consisted of a constametric III 
pump (LDC - England), connected to an injection valve equipped 
with a lOOyl loop. An L C electrochemical detector (Model LC- 
4A, Bioanalytical System, USA), fitted with a glassy carbon working , 
electrode was used and recording was carried out using a JJ single 
channel recorder.
2.2.2.2 Chromatographic conditions
Fresh acetate-citrate buffer was prepared every week by 
adding sodium acetate 100 mM and citric acid 40 mM to double dis­
tilled, deionized water obtained from a Milli-Ro 15 water purification 
system (Millipore, France). The buffer was then adjusted to pH
5.2 by NaOH.
The mobile phase was acetate citrate buffer containing 5%
methanol and 0.5 mM sodium-l-octane sulphonic acid (SOSA) as an
ion pairing reagent. This was degassed thoroughly with helium
before being sucked through the system. The flow rate was main-
tained at 1.0 ml.min , and detector potential was operated at
+0.6 V vs a Ag/AgCl reference electrode (Bioanalytical Systems,
USA). For recording purposes, the chart of the recorder was run 
-1at 0.4 cm.min
2.2.3 Animal preparation
In this chapter, the content of catecholamines in the kidney.
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adrenals, heart, plasma and urine is presented. For this purpose, 
female Wistar rats (University of Bath strain) were anaesthetized 
with pentobarbitone sodium (Sagatal, 60 mg.kg  ̂i.p.) and left 
to stabilize for 0.5 hr. The abdomen of each rat was opened and 
blood drawn from the abdominal aorta at the point of bifurcation. 
Kidneys, adrenals and hearts were removed respectively and were 
dissected free of any connective tissues. The adrenals were blotted 
gently on a piece of filter paper and with the help of forceps 
most of the tissues were removed. All tissues were individually 
clamped using stainless steel tongs and dipped in liquid nitrogen, 
They were individually placed in small re-sealable bags and 
kept in a liquid nitrogen cupboard until analysis.
Blood collected from each rat was quickly centrifuged at 
3000 r.p.m. to separate plasma which was in turn frozen at -20°C 
till use. The urine values presented here were estimated after 
collecting urine from rats by infusing saline 0.9% through the 
jugular vein and collecting urine from the bladder over a period 
of 3 hours. The detail of this method will be mentioned later. 
Samples collected were kept at -20°C and were used to estimate 
dopamine.
2.2.4 Tissue preparation
Kidneys, hearts, and adrenals were individually crushed from 
the frozen state in a chilled stainless steel mortar using a 
chilled pestle, the powdered tissues were then poured into pre­
weighed tubes containing a known volume of 0.1 M perchloric acid
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(PCA) to which EDTA 2.7 mM was previously added. In the case
_ 7of kidney and heart, the PCA solution contained 10 M DHBA as 
an internal standard. After powdered tissues had thawed, tubes 
were re-weighed and the weight of tissue was determined. Allowance 
was made for 100 mg.ml in the case of kidney and heart and 
5 mg.ml  ̂in the case of adrenals.
The homogenates were then centrifuged for 10 minutes at 3000 
r.p.m. using an lEC Centra-7 centrifuge (lEC-USA) and the super­
natants separated and kept frozen till finally extracted.
2.2.5 . Extraction
The starting volume was variable from one tissue to another, 
for this purpose, starting volume for the kidney and heart homo­
genates was 1.0 ml containing 100 mg. For the adrenals, 0.2 ml 
containing 1.0 mg, while 0.5 ml of the plasma was used. For the 
urine, 1.0 ml samples were used, if possible, otherwise as small a 
sample as 40 yl can be used. Each sample was assayed in triplicate 
Samples were placed in 5 ml capacity pyrex conical tubes, and 
50 ]xl GSH, 50 yl EDTA 0.3 M, pH 7.0 added to each sample. At
this stage, 0.1 ml of 10 ^ M DHBA was added to the adrenals,
-7 -60.1 ml of 2 X 10 M added to the plasma and 0.1 ml of 3 x 10 M
added to the urine samples.
One of the three portions of each sample was spiked with 
a known amount of CA in order to calculate the endogenous content 
of these amines. For this, 0.1 ml of NA 10  ̂M, ADR 10"^M,
DA 2 X 10  ̂M was added to the kidney and heart samples; 0.1 ml
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—6 —7of NA, ADR 5 X 10 , DA 5 x 10 M added to the adrenal samples;
—70.1 ml of 2 X 10 NA, ADR, DA to the plasma samples while 0.1 
-6ml of 10 M DA was added to urine samples.
To all portions, 50 mg alumina (Al^O^) was added and while 
vortexing the tubes, 1.0 ml tris buffer (pH 8.6; IM) was added , .
and the tubes were immediately shaken for 10 minutes using a mechan­
ical shaker (Gallenkamp, England).
The alumina was allowed to settle and the supernatant was 
aspirated off. To wash the alumina, 2 x 1.0 ml portions EDTA 
(3 mM, pH 7.0) were added to the tubes and allowed to mix ten 
seconds after which the supernatant was aspirated off each time.
Finally, 0.15 ml of 0.2 M PCA was added to the tubes, the 
contents were mixed for 1.0 minute using a whirlimixer (Fisons, 
England), and then the tubes were centrifuged quickly using 
Herdens-Christ, GMBH, Germany), supernatants were then trans­
ferred to 1.0 ml capacity strastdt tubes and were kept at -20°C 
until used. At the time of assay, individual tubes were taken 
out, thawed at room temperature and 100 yl samples injected 
onto the HPLC-EC system.
2.2.6 Preparation of Alumina
The method used for activating Al^O^ is the same as detailed 
by Anton and Sayre, (1962). 100 g Al^O^ (BDH, Poole, England) 
was added to 500 ml 2N HCl in a 1000 ml beaker and heated to
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90 - 100°C for 45 minutes using a hot-plate and magnetic stirrer. 
The beaker was then taken off the heater and particles allowed 
to settled down for 1.5 minutes and then the supernatant was 
discarded. The alumina was then washed twice with 250 ml portions 
of 2 N HCl at 70°C for 10 min., discarding the supernatant each 
time. In a final wash, A1 0 was stirred with 500 ml HCl at 50°C ̂V < , > ) > > > ‘ ‘ > ' ‘ '
for 10 minutes. After decanting the supernatant, the residue was 
washed with distilled vmter until pH 3.4 was reached. Finally,
Al^Og was transferred to an evaporating dish, heated at 120°C 
for 1 hr Eind at 200°C for 2 hrs and was then transferred to an 
amber glass bottle and stored in a desiccator at room temperature.
2.2.7 Linearity of the method
Over the period involving measuring the three catecholamines 
in various tissues and fluids, several linear regression analyses 
were carried out. For the kidney, for instance, samples were 
spiked with 4 conc. of standard solutions containing NA, from 
30 - 340 ng (n=13), DA from 0.19 - 19 ng (n=15) and ADR from 
0.03 - 6.66 ng (n=3) and the correlations were 0.984 P < 0.02;
0.977 P < 0.01; 0.974 P < 0.01 respectively. For the heart 
and plasma, similar concentrations were involved with a similar 
outcome.
For the adrenals, linearity was established by spiking samples 
with 4 standard concentrations ranging from 31.9 - 640 ng for 
NA; 33.3 - 667 ng for ADR and 1.0 - 19 ng for DA, and the 
correlation coefficients were 0.999 P <0.01; 0.999, P <0.01; 
0.997, P < 0.01 respectively.
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2.2.8 Calculation
The general method of calculation, unless otherwise stated, 
depends on spiking samples with a known concentration of catechol­
amine and using the peak height ratio of catecholamine/internal 
standard (CA/IS) to calculate the unknown concentration using . 
the following formula:
xng(standard) x ^  (sample) _ ̂ lb luuu mg
^ ^ ^  (standard) wt.used
and if measuring xg.ml  ̂plasma the formula is the same with
, . lOOOmg . 1 . 0  mlreplacing . . --  with — — —-----:---wt.tissue starting volume
2.2.9 Recovery of CA from Al^O^
The method involved preparing a mixture of NA, ADR, and DA, 
adding 0.15 ml of the mixture (without IS) to 50 mg Al^O^, and 
extracting CA side by side with the samples extracted on that 
particular day . Catecholamines were then eluted with 0.15 ml 
PCA as usual. In two tubes, containing 50 yl (IS), 100 yl of the 
eluate was added to one of them, while to the other, 100 yl of 
the original standard mixture. The final volume in each of the 
tubes was 150 yl and the internal standard did not go through 
the extraction so as to give consistent results in both.
100 yl of both the tubes were injected and the extracted DA was 
divided by the standard mix as follows
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PHR (extracted DA) 
PHR (non-extracted) X 100
This procedure was done with most experiments to ensure reproducibility 
The procedure is set out diagrammatically below:
A mixture of standard 
NA, ADR, and DA in PCA
0.150.15
Tubes
1
0.15
ml
EDTA 2.7 mM 
+
Glutathione
+
50 mg Al^Og 
+
Tris buffer.
Shake for 10 min 
Wash with EDA 3.0 mM 
twice eliminate the 
supernatant 
Add 0.15 ml PCA 0.2 M 
shake for 1.0 min 
remove supernatant 
Take 0.1 ml
0.1 ml 0.1 ml 
+ 0.05ml 0.05
0.1 ml DA extract 
0.05 DHBA
mix tubes well and inject 100 yl 
lots onto HPLC
PHR PHR
Take mean (A)
PHR
No
extraction
0.1ml 0.1ml 0.1ml DA std,
0.05ml 0.05 0.05 DHBA
mix tubes well and inject 
100 yl lots onto HPLC
PHR PHR PHR1
Take mean (B)
% recovery = (A)(B) X 100
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This method was applied to the work in general, and for the 
work presented in Chapters 2, 3, 4, 5 the recoveries were DA
69.3 ± 1.88% n = 28; NA 62.84 ± 1.57% n = 28; ADR 64.6 ± 1.75% 
n = 21. For the work presented in Chapters 6 and 7 the recovery 
of DA was 66.61 ± 1.1 n = 9 and for those in Chapters 8, and 
9 was 66.3 ± 1.9 n =  8.
2.2.10 Statistics
Statistical significance of differences between the means 
was assessed by using Student's t-test. Probabilities of identity 
of less than 0.05 were taken as denoting a significant difference.
2.3 Results
The HPLC-EC involved in the estimation of CA in this study 
proved to be of immense value. It is reliable, easy to handle, 
and cut down the cost and time of analysis once the machines are 
maintained and used properly. With the system adopted using 
acetate-citrate buffer at pH 5.2 with 5% methanol in the case 
of kidneys, adrenals, heart, plasma; or 10% in the case of 
analysing urinary DA, it was possible to analyse about 40 samples 
per day. It should be noted that variation does occur, usually 
from day to day and from one animal to another, however, all the 
values obtained were grouped together which resulted in low error 
values.
The results obtained are listed in Tables 1 - 5 .
Table 2.1 The contents of CA in the rat kidney
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DA(ng.g NA(yg.g ADR(ng.g
No. of rats(n) 54 
Mean - S.E.M. 58.34 i 3.7
14
0.421 ± 0.03
13
28.61 ± 2.95
Table 2.2 CA concentrations in the rat heart
DA(ng.g NA(yg.g ADR(ng.g
No of rats (n) 16 
Mean ± S.E.M. 36.85 ± 4.2
16
1.24 ± 0.056
8
82.06 ± 9.08
Table 2.3 Concentration of CA in rat adrenal gland
DA(yg.g“ )̂ NA(yg.g ADR (yg.g
No of rats(n) 13 
Mean ± S.E.M. 9.22 ± 0.97
14
130.4 ± 12.5
14
494.88 ± 65.2
Table 2.4 The concentration of CA in rat plasma
DA(ng.ml ^) NA(ng.ml ^) ADR (ng.ml ^)
No. of rats(n) 9 
Mean ± S.E.M. 6.5 ± 0.91
9
3.7 ± 0.5
4
2.4 ± 0.23
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Table 2.5 Urinary DA concentrations
DA (ng.%hr DA(ng.3hrs
No of rats (n) 22 19
Mean ± S.E.M. 52.71 ± 6.9 306.72 ±44.1
Urine was collected every 0.5 hr and DA was estimated as ng.0.5 hr ^. 
One can easily convert this value to calculate the concentration 
of DA as ng.ml  ̂by dividing individual values by its urine 
output. This is shown in Fig.2.1. Although variable, the 
quantity of DA/0.5 hr  ̂was much more consistent than the concentration, 
ml  ̂which showed an initial rise and then a decline in DA concen­
tration (b). The explanation is that urine volume followed the 
opposite pattern with time, so at the beginning urine volume was 
very low {- 0.25 ml/0.5 hr and increased to = 7.0 ml at the
end of the collection period. The correlation of time with urine 
volume is seen in Fig. 2.2. It is this product of urine volume and 
the DA concentration that produced more consistent figures calcu­
lated as ng/0.5 hr ^.
_1Although more consistent, the quantity as ng.0.5 hr was not 
fully satisfactory for the work involving adrenalectomy and it was 
thought to be more accurate to measure the amine as ng.3.0 hr 
so that variation taking place in the concentrated urine in the 
beginning of the collection period will be reduced dramatically 
with the diluted urine lots. The values of DA estimated for a total 
period of 3.0 hrs are found in Table 2.5.
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Fig. 2.1(a)
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Fig. 2.1(a). The relation between time of urine collection and urinary 
DA/0.5 hr~^ in anaesthetised rat. Number of experiments 
are shown at each point and results calculated as 
mean ± S.E.M.
Fig. 2.1(b) Correlation between the time of urine collection and 
urinary DA excretion, calculated as ng.ml"! urine.
Results are expressed as mean ± S.E.M. No. of 
experiments are shown.
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Fig. 2.2. The correlation between the time of urine 
collection and urine output in rats^ 
infused with saline at 13.33 ml.hr for 4 hrs 
Results expressed as mean ± S.E.M. and no. 
of observations are shown at each point.
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2.4 Discussion
2.4.1 Stability of catecholamines
During the course of this study, tissue samples were always kept 
in liquid nitrogen, while plaëmà Samples were frozen at -20°C until 
analysis. Oh the other hand, the standard CA solutions were pre­
pared as 10 ^ M solutions in 0.1 M perchloric acid. They were then 
divided into 1 ml portions and were kept in ampoules at -20°C.
At a later stage, DA and DHBA, prepared as 10 ^ and 3 x 10 ^ resp­
ectively, were kept under the same conditions at -20°C. When used 
over 2 months, the peak height ratio of DA/DHBA was constant 
(0.6692 + 0.016) indicating that the compounds were stable over 
this period of time. Felice et al. (1978), used a stock solution 
of CA to estimate the concentration of endogenous CA in the brain 
of the rat. The stock solution was prepared as 100 yg.ml  ̂in 
0.05 M HCIO^ and stored at 5°C for a period of 2 weeks after which 
a fresh solution was prepared. Satisfactory and reproducible results 
were reported. Moreover, Hegstrand and Eichelman (1981), using 
brain tissues that were frozen at -80°C until assayed,observed 
no difference in NA or DA levels upon storage for one month. 
Furthermore, Elchisak and Carlsson (1982) stored rat kidneys, 
adrenals, and brain tissue homogenates for several months at 
-75°C without any significant changes in CA levels.
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2.4.2 Recovery of catecholamines
The use of alumina (Al^Ogjyields cleaner samples* Magnusson 
et al. (1980) and Van Valkenberg et al. (1982),injecting unrefined 
brain samples onto the HPLC, found that the top of the column became 
very dirty and the packing material had , therefore, to be scraped 
off the top of the column, which, in the long run, resulted in a 
rotten column with a very low resolving affinity and low theore­
tical plate count. In our studies, the recoveries were estimated, 
as can be seen in Chapter 2 from standard CA extracted onto Al^O^ 
in the absence of the samples and were compared to the same 
standards injected directly onto the column. Freed and Asmus 
(1979) have estimated the recovery of NA, DHBA, DA, DOPAC, CD,
L-DOPA in the same way and then applied this recovery to the 
respective CA in the samples. In this experiment, recoveries of NA, 
DA and DHBA were 64.0, 65.0 and 60.0% respectively, which is in 
agreement with our recovery of approximately 63.0 and 67.0% res­
pectively for NA and DA. On the other hand, Oates et al. (1979) 
found the recovery of urinary DA to be 63 + 5.8% while that of 
plasma DA was 64 + 4.7%. These recoveries, however, were calculated 
from added DA to urinary and plasma samples. This seems to be a 
more precise method than the one used in our study because Wagner 
et al. (1979) found that the recoveries of DA, NA and ADR on 
Al^Og in the presence of tissues were slightly lower than in 
their absence. It is, therefore, recommended for future work, to 
involve another group of spiked tissue samples into the recovery 
studies to see if any difference exists.
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2.4.3 Calculations
The calculation of tissue, plasma and urinary, CA was similar 
to that used by Felice et al. (1978) and Eriksson and Persson (1982), 
utilizing an added concentration of standard CA to some samples. 
Althpugh.it is. possible to.calculate .endogenous eimine concentrations 
from a standard curve plotted by spiking samples with increasing 
doses of the standards, it was much more precise to run spiked 
samples along with extraction procedure on every working day to 
control any daily variations in the extraction or machinery or 
indeed the standards themselves.
2.4.4 Tissue levels
Anton and Sayre (1964), analysing the concentrations of cate­
cholamines (CA) in various tissues of different animals found NA 
and DA in the canine kidney to be 0.32 and 0.03 yg.g tissue 
respectively. Analysing the same tissue. Bell et al. (1978) found 
the values of the two amines to be 1.095 £ind 0.19 yg.g . Moreover, 
in the kidney and the heart of guinea pigs, DA was estimated to 
be 3.9 + 0.85 and 15.4 + 2.71 ng.g  ̂respectively (Agrup et al.,
1980) while these values were 40.0 and 60.0 ng.g  ̂when estimated 
by Anton and Sayre (1964). A similar pattern found in the rat 
kidney as well, where 8.0 ng.g  ̂was found by Elchisak and 
Carlson (1982), while Yamada and Aizawa (1983), using a micro- 
HPLC technique with fluorescence detection, found it to be 
670 ng.g . Whatever the reason for this huge variation in values 
among researchers, it certainly allowed a wide range of manoeuvre 
in explaining results.
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In the results shown in Tables 2.1 - 2.5, the values obtained 
were, with the exception of plasma CA, within the rsinges obtained 
by other workers. For DA in the kidneys, our results were more than 
the 30 ng.g obtained by Anton and Sayre (1964) and less than the
108.7 ng.g  ̂reported by Lackovic sind Relja (1983). ADR was in 
agreement with that of Anton and Sayre (1964), while NA was similar 
to that of Yamada and Aizawa (1983). It is not known, however, that 
any one else has obtained a value for DA in the rat kidney as high 
as 670 ng.g reported by Yamada and Aizawa.
In the heart, the values obtained for DA were similar to those 
of Anton and Sayre (1964) and Martin et al. (1983). NA was comparable 
to the 5.88 nmol.g  ̂obtained by Fuller et al. (1982). These 
authors, however, did not specify whether they have used the NA 
base or one of its salts in their calculations. If the authors 
used the base then our results are just above theirs, if they used 
the HCl form then the two results are identical while if they 
calculated theirs as bitartarate, their values will be very high 
indeed . For cardiac ADR, only one report was available to us from
the study of Anton and Sayre (1964). The value obtained was
-1 -1 approx. 50 ng.g which was lower than the 82.02 ng.g obtained
in this study.
The adrenal ADR and NA content was similar to the values ob­
tained by Anton and Sayre (1964). The values obtained by Rosecraan 
(1966) and Elchisak and Carlson (1982) were difficult to compare, 
since they estimated the CA content per adrenal without stating 
the weight of tissue used. Although comparing the result of one 
of them with the other yields similar values for NA, it reveals
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huge differences in the ADR content of the gland.
Plasma CA in our study was very much higher than those obtained 
in most reports. In man the basal plasma ADR, NA and DA were 
estimated to be 64.5, 203, and 98.0 pg.ml  ̂respectively (Buhler 
et al., 1978). The values for the same CA were reported by Honda
et al. (1983) to be 900, 2600, and 2600 pg.ml  ̂respectively.
These authors related these high values to the state of excitation 
of the healthy volunteers from whom the blood samples were taken.
In rat, Buhler et al. (1978) estimated the basal levels of ADR,
NA and DA to be 175, 509 and 84.0 ’̂g.ml respectively. The same 
authors, however, found that gentle handling of rats for 5 minutes 
increased the levels of the three amines by 1000, 300 and 100% 
respectively. On the other hand, they found that restraining rats 
for 5 minutes increased the levels of the three amines by 2000,
600 and 300% respectively, and if rats were killed at the climax
of stress, the levels of the amines were 24.5 ng.ml  ̂for ADR, 15.9
-1 -1 ng.ml for NA, and 1.43 ng.ml for DA. Furthermore, using the
GLC-mass spectt., Lackovic et al. (1982) found plasma DA levels
of their experimental rats to be 2.9 ng.ml ^. Thus it appears
that the high values obtained here may be a consequence of handling
the rats or a consequence of stress due to anesthesia, surgery,
or sampling technique where all the blood was drawn within a
minute from the abdominal aorta in some experiments and from the
right carotid artery in others. Whatever changes in the extraction
procedure or the design of the experiments, the CA values were
always high.
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As stated in the introduction of this chapter, the values 
for urinary DA excretion were obtained at a later stage of the work 
but were listed along with the CA values of other tissues and plasma 
for the sake of completing the picture. These values , therefore 
do not represent the basal urinary DA excretion. At one stage,
DA was determined 0.5 hourly and at another stage every 3 hours, . ,
values are listed in Table 2.5. As can be seen, urinary DA excretion 
was 306.7 +44.1 ng.3hr  ̂which, assuming uniform excretion, amounts 
to 1.7 ng.min . This value is a little higher than that of 1.2 
ng.min  ̂obtained by Baines and Chan (1980). The difference can 
be accounted for by the difference in the perfusion technique used
by these workers. They infused rats with saline at a rate of 0.39
-1 -1 -1 ml.min for 1 hr ie. 23.4 mlhr then reduced it to 4.6 ml.hr
for the rest of the experiment, while in our study, a continuous
constant infusion of 13.3 ml.hr was employed for 3 hrs.
As seen in Fig. 2.1(a,b) and Fig. 2.2, it is much better to 
express the quaintity as ng/unit time rather than concentration/ml 
because, infusing solutions into rats, urine volume increases for 
the first 1.5 hr then becomes fairly constant with corresponding 
reduction of DA concentration, however, when the quantity is 
estimated the volume negates the reduction in DA and the estimations 
become more consistent (Fig. 2.1a). The alternative is to consider 
the first 2 hours as an equilibration period after which urine 
collections start.
Chapter Three. Influence of species, 
sex and mode of sacrifice on 
catecholamine levels in the rat kidney
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3.1 Introduction
Although the application of experimental tools to animals of 
different strains or even different species may yield comparable 
results, it seems that a great degree of inter- and intra-species 
differences exist. In rats of the Fawn Hooded strain, measuring 
plasma DA under the same experimental conditions produced a huge 
variation ranging from 48 to 225 pg.ml  ̂ (Buhler, Prada, Waefely 
and Picotti, 1978). On the other hand, in the isolated perfused 
rat kidney from normal Wistar strain and 10 - 12 week age 
matching Wistar kyoto, the application of renal perfusion pressure 
of 80 - 160 mm Hg resulted in the same Na^ excretion rate ex­
pressed as ymoles Na^.min  ̂ (Favre and Gourjon, 1982).
The mode of sacrifice of animals or mode of plasma sampling 
may be held responsible for some of the variation. Thus plasma 
samples collected either from freely moving or from decapitated
rat show an increased plasma adrenaline from 175 to 3014 pg.ml ,
-1 -1 NA from 209 to 1012 pg.ml and DA from 84 to 234 pg.ml in the
plasma of decapitated rats (Buhler et al., 1978), moreover,
Lackovic and Neff (1983) reported, using rat mesenteric arteries,
veins and hearts, that the percentage fall in tissue DA content is
more from decapitated animals than those anaesthetized first.
Furthermore, different modes of killing presented significant
differences in the NA content of the guinea pig heart. The values
were ( yg.g ^dry wt.) : 8.5 ± 0.32 after stunning; 9.9 ± 0.56
after a chloralose(80 yg.kg ^) i.p. with halothane; 10.73 ± 0.51
following 40 mg.kg  ̂i.p. pentobarbitone Na^ and 11.29 ± 0.68 after
cervical dislocation (Griffiths et al., 1983). The authors
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interpreted these results on the basis that high levels of sympathetic 
stimulation were associated with different modes of sacrifice.
Moreover, the choice of anaesthetic agent may be crucial.
In experiments on cats and dogs, to determine the controlling 
stimuli for the release of NA aind ADR from the adrenal gland, 
the choice of the anaesthetic agent was a major problem, because 
in cats under pentobarbitone, it was possible to obtain balanced 
adrenal responses to chemoreceptors and baroreceptors from a 
low resting level, while cats under chloralose have high resting 
output with a high ratio of NA/ADR On the other hand, there 
was a balanced response in dogs under chloralose while under 
pentobarbitone, the chemoreceptor response was strongly inhibited 
in relation to baroreceptors (Critchley, Ellis and Unger, 1980). 
Furthermore, Sowers and colleagues (1981) suggested that ketamine 
which was used to anaesthetize monkeys, played a role in the 
response of aldosterone to metoclopramide.
3.2 Experimental
To study the effect of species, sex and mode of sacrifice 
on the content of catecholamine, it was decided to use only the 
kidneys because this experiment was meant to be a preliminary 
one and secondly because the kidney constitutes the core of the 
work presented here.
For this purpose, 4 groups of rats were studied. The first 
group (n=4) was female Wistar rats meant to be compared with
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the second group (n=4) of female New Zealand normotensive rat 
and with the third (n=4) of male Wistar rats and with the fourth 
(n=4) female Wistar rats to be killed by a blow on the head.
At the time of sacrifice, all the groups were anesthetized 
with pentobarbitone 60 mg.kg  ̂i.p. except the last one. The 
kidneys were removed and placed in small individual resealable 
bags in liquid nitrogen. The fourth group was dealt with in the 
same way, except that rats were killed by a blow on the back 
of the head. Kidneys were kept at -70°C until the time of analysis.
3.2.1 Extraction
This was performed exactly as described before and 100 yl 
of the final eluate was injected onto the HPLC system.
3.3 Results
Fig. 3.1 represents all the results involved in this study.
The effect of species is depicted in panel (A) whereby DA concen­
tration in the kidneys of New Zealand normotensives seems to be 
less than that of Wistar rat (P < 0.01). No significant difference 
is seen with NA or ADR.
In panel (B), the values for female and male rats are plotted, 
as seen, no significant change in DA and ADR concentration, however, 
NA levels were significantly (P < 0.05) lower in male compared 
to female Wistar rats.
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Fig. 3.1 The effect of (A) species (B) sex and (C) mode of 
sacrifice on DA, NA, ADR in the rat kidney.
(female Wistar rat tissues of which were taken during
anaesthesia; _______female New Zealand normotensive
Male Wistar normotensive 
Female Wistar killed by a
dealt with as above; 
dealt with as above; 
blow on the head.
Each result is the mean ± S.E.M. of 4 experiments each 
group,with exception of female New Zealand rats where 
n = 10 -if-P < 0.05; < 0.01
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The mode of sacrifice of the experimental animal may be
very important, especially for ADR. As seen in panel (C) there
-1was an increase of ADR from 22.35 to 44.72 ng.g tissue 
in the rats killed by a blow on the head. The values were very 
variable, ranging from 21.5 to 55.24 ng.g  ̂which rendered the 
standard error involved very high and therefore the difference 
not significant (DF = 6, t = 2.329;tabulated,t = 2.447 for 0.05 
levels of probability).
3.4 Discussion
The effect of species, sex and mode of sacrificing the exper- 
mental animals on the content of CA in the rat kidney is shown 
in Fig. 3.1. As can be seen, there was no major change with the 
exception of a significantly (P < 0.01) lower content of DA in 
the New Zealand rat (Panel A) and low content (P < 0.05) of NA 
in the male rat of the same strain as the female (Panel B). On 
the other hand, there was a 100% increase in the level of ADR 
in the rats killed by a blow on the head, however, because of 
the large errors involved, this was not significantly different 
for the control (Panel C).
It is well known that strains of one species and members 
of different species vary in their tissue content of catecholamine 
(Anton and Sayre, 1964; Buhler et al., 1978; Fuller et al.,
1982). There are no published reports, however, aimed at differ­
entiating between male and female members of one strain. Most 
researchers tend to use male rather than female rats because
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they do not have changeable levels of hormones as do the females 
because of the oestrous cycle. Others, especially those concerned 
with obesity and antiobesity drugs, tend to use the males because 
they grow much faster than the females. We used the female, however, 
simply because they are available and most people do not like 
to use them.! Although the oestrous cycle was not controlled 
in our study, in all experiments, control and experimental rats 
were taken from the same batch. It is, however, very much recom­
mended to control this factor in future work.
The mode of sacrificing experimental animals is probably 
the most important factor of all. The negative result obtained 
here in no way negates its importance because firstly, the use 
of two different modes of sacrificing animals may generate two 
different metabolic sequences leading to drastic changes in the 
levels of amine biosynthesis (Buhler et al., 1978). Furthermore, 
in the experiment of Griffiths et al. (1983) cardiac NA in the
guinea pig was 8.5 ± 0.32 yg.g after stunning, 9.9 ± 0.6
-1 -1 yg.g after a chloralose; 10.7 ±0.5 yg.g after pentobarbitone
sodium, and 11.3 ± 0.7 yg.g after cervical dislocation.Secondly, 
the shock involved in killing an animal by a blow on the back 
of his head is probably much greater than that involved in anaes­
thetizing the animal and dissecting free tissues while unconscious, 
and this certainly will lead to several fold increase in amine 
content, especially in the plasma (Buhler et al., 1978).
Buhler et al. (1978) found that stressing rats for 5.0 minutes 
and killing them while under stress, promptly increased the plasma
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-1 -1 levels of ADR from 250 pg.ml to 24,500 pg.ml . Levels of NA
and DA were still very high but to a lesser extent. From their 
study and my results, we can conclude that either the changes 
in CA concentrations in the plasma are not reflected to the 
same extent in the kidney, or, on the other hand, that there 
is comparable increase in the metabolism of the catecholamines 
in the kidney leading to constant levels of the amines. The first 
possibility means that the kidney is not involved to a great 
extent with circulating levels of the amines, while the other 
possibility means that it is a major source of circulating 
catecholamines. Certainly, the kidney is not the main source 
of NA since that comes mainly from the sympathetic nerve endings 
while ADR comes mainly from the adrenal gland. There is contro­
versy, however, as to the participation of the kidney in the 
circulating concentrations of DA (Van Loon and Sole, 1980).
This experiment was intended to be a preliminary one, and 
was therefore, not extended to other tissues and plasma. However, 
it would be of interest to study the turnover of NA, ADR and 
DA in the plasma and different tissues under different modes 
of sacrifice.
Chapter Four. The levels of 
Catecholamines in normotensive and 
hypertensive rats
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4.1 Introduction
Not many experiments seem to have been carried out aiming to 
directly compare CA levels in normotensive and hypertensive 
rats.
In the plasma of Wistar normotensive and matching SHR, there
was no difference in the levels of NA, ADR or DA (Buhler
-1 -1et al., 1978) with DA being 84 + 14 pg.ml vs. 8 4 + 9  pg.ml
respectively. In another study, adrenal dopamine was not diff­
erent in both groups, while NA was higher in SHR than 13 week 
old matching normotensives, moreover, ADR show similar tendency 
as NA although to a lesser extent (Nakada et al., 1982). Further­
more, in normal rats, and SHR, groups matched in age, DA was 
not different while NA content of the celiac ganglion was 
higher in hypertensive rats at 4, 6 but not 20 weeks of age 
(Neff et al., 1983).
4.2 Experimental
The analytical system and preparation of rats was similar 
to that previously discussed. Two batches of female New Zealand 
normotensive and hypertensive animals were chosen. The kidneys, 
hearts, adrenals, and plasma were extracted as before and 
injected onto the chromatographic system.
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4.2.1 Protein estimation
To find out if the concentrations of CA might have been 
affected by development of oedema in hypertensive animals, 
they were also estimated as xg.mg protein. The procedure 
is simple and based mainly on the method of Lowry et al. (1951). 
It involved digesting a few milligrams of tissue homogenate 
(precipitated residue) in IN NaOH.This was carried out by heating 
at 100°C for 10 minutes. Allowance was made for 1.33 mg tissue 
(kidney, heart, adrenal) per 1.0 ml of NaOH and 0.4 ml of 
the sample was used for estimation of protein as follows:
a) Reagents : 
Solutions A. 5% (w/v) CuSO^.SH^O
B. 10% (w/v) NaK tartarate
C. 2% (w/v) Na^CO^ in 0.1 M NaOH
D. 1 vol. Folin-Ciocaltea reagents
+ 2 vol. distilled water
E. 1 ml A + 1 ml B + 8 ml H 0
2
F. 1 ml E + 50 ml C
Note: solutions D, E, F were prepared immediately 
before use.
b)
set up:
Incubations :
Incubations containing the following solutions were
0.4 ml sample (diluted as appropriate, the protein 
concentration must be less than 400 yg.ml” )̂
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4.0 ml solution F.
0.4 ml solution D.
Incubations were mixed well and allowed to stand for 30 minutes 
at room temperature in the dark. Absorbance was read at 650 
nm against a reagent blank using a Cecil 595 digital UV 
spectrophotometer, and protein concentrations were then calcu­
lated from a calibration curve prepared using purified bovine 
serum albumin as standard.
c) Calibration:
a) Bovine serum albumin (BSA; Sigma Ltd.) was 
made up as 400 yg.ml in saline;
b) dilutions 400, 200, 100, 50 and 25 yg.ml  ̂
were made in saline;
c) Duplicate assays were set up as described 
above.
Note: The absorbance at 650 nm of the 400 yg.ml BSA 
standard should be approximately 0.5 .
d) Calculation:
1) From the calibration curve, the concentration
of protein g.ml in each sample was calculated 
and used as a basis to calculate the concentration 
as mg protein.g  ̂tissue.
2) From the previous CA estimation as ng.g  ̂
tissue, it can be easily calculated how much 
ng.CA.mg protein.
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4.3 Results
Fig. 4.1 represents a calibration curve relating the 
concentration of bovine serum albumin (B.S.A.), and the absorb­
ance at 650 nm. This calibration curve is the mean ± S.E.M. of 3 
estimations and was used as a basis for calculating protein 
content of different tissues.
The use of 0.4 ml of sample homogenate residue containing 
1.33 mg tissues per 1.0 ml of 1 N NaOH proved to be appropriate 
to give the desired dilution for the assay.
Figures 4.2, 4.3 and 4.4 illustrate the content of DA, NA 
and ADR in the kidney, heart and adrenal glands respectively.
In the three figures. Panel (a) represents DA; Panel (b) NA
and Panel (C) represents ADR. The three CA were measured both
-1 -1 as xg.g tissues and as xg.mg protein. The tissue precipi­
tate left after centrifuging the homogenate was used to 
estimate the protein concentration, and was related to its 
own homogenate supernatant used to estimate CA as xg.g  ̂tissue.
Fig. 4.2 shows no difference in DA, NA or ADR in kidneys 
from normotensive and hypertensive New Zealand female rats 
(n=10 each), when measured by HPLC-EC using both ways.
The contents of cardiac CA is illustrated in Fig. 4.3 
(n=10 each group). Significant reduction( P < 0.GDI)was found 
in cardiac NA from hypertensive rats. This reduction was seen
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Fig. 4.1. A calibration curve for protein estimation 
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at 650 nm (Y). The values of each 
point is the mean + S.E. of 3 experiments
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Fig. 4.2 The contents of (a) DA (b) NA (c) ADR in kidneys
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and age-matching New Zealand spontaneously hypertensive 
rats ̂ 5 , n=10 estimated both as pg.g” tissue
and as xg.mg~^ protein. Results are expressed as 
mean ± S.E.M.
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Fig. 4.5 DA(a), NA (b) and ADR (c) estimated in the plasma 
of normotensive and hypertensive New Zealand 
female rats. Results are expressed as mean + S.E.m 
n = 5.
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clearly when NA was estimated as ng.mg  ̂protein as well (P < 0.01) 
No difference in DA or ADR was found in this tissue.
Fig. 4.4 are values obtained from 10 adrenals taken from 
normotensive and 10 adrenals from hypertensive rats. DA was sig­
nificantly higher in the hypertensive rats when estimated 
as ug.g  ̂tissue (P < 0.05), and this significance became 
much more pronounced when values estimated as ng.mg protein 
(P < 0.02). No significant changes were seen with NA. On the 
other hand, although ADR levels were not significantly diff- 
erent when estimated as pg.g tissue, the values were rendered 
highly significant when expressed as yg.mg  ̂protein (P < 0.01),
The plasma CA were estimated only as ng.ml  ̂and values 
showed no difference in normotensive and hypertensive rats. 
(Fig. 4.5 (a), (b), and (c)).
4.4 Discussion
The relationship between circulating CA and B.P. has been 
an issue of constant debate and a field of marked controversy. 
Sever (1978) reviewed the data concerning the levels of 
circulating catecholamines in relation to arterial blood 
pressure in man. Recently, Ely et al. (1985) have shown that 
when spontaneously hypertensive rats (SHR) and normotensive 
control of Wistar Kyoto strain (WKY) were fed either low 
(0.5 mmol.100 g  ̂food) or high (50 mmol.100 g  ̂food) Na^ 
for 5 weeks, the B.P. of the WKY was not affected at all
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while SHR maintained on low Na^ diet responded by a reduction 
(P < 0.05) in their B.P. Moreover, SHR retained less Na^ when maintained 
on low Na^ diet but excreted much more when kept on high Na^ containing 
food. In another recent study, Meldrum et al. (1985) have shown 
that when SHR and WKY were maintained on a low Na^ diet for 7 - 9  
days, the release of NA from peripheral and central areas was not 
different. We aimed in our work at finding out the plasma and tissue 
levels of CA in SHR of the New Zealand strain and in age matching 
New Zealand normotensive control (NZN). As can be seen in Figures
4.2 and 4.5, no difference was found in the renal and plasma NA,
ADR or DA. The result obtained with the plasma samples is consistent 
with that of Buhler et al. (1978) although their levels were very 
much less than those reported here.
The levels of cardiac NA were lower in the SHR(Fig. 4.3.)This 
is a very interesting observation in the light of the well established 
increase in the sympathetic activity to the heart of SHR (Pfeffer
et al., 1974) combined with finding that NA turnover is lower in the
SHR than that of the normotensive ones (Louis et al., 1969).
The observation of an increased level of DA in the adrenal gland 
is shown in Fig.4.4. Nakada et al. (1982) found that NA and ADR 
were higher in SHR compared to 13 week age matching (WKY), while 
the adrenal DA was not different in both groups i.e. their observ­
ations are quite the opposite to ours. The discrepancy arises -
probably - from two points. Firstly, in the abstract of the work
of Nakada et al. (1982), not much information as to the methodology 
involved was revealed - besides using HPLC. Secondly, they 
have used the Japanese version of the SHR and WKY while.
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in our study, the New Zealand version of the hypertensive and normo­
tensive rats were used. Although, change in methodology might have 
participated in the different outcome, an inter strain difference 
is much more likely.
It has been well documented that oedema formation may take place 
in hypertensive subjects especially as a consequence of congestive 
heart failure (Herfindal sind Hirschman, 1975). Although no report 
was available to us concerning oedema formation in SHR, to rule out 
this possibility, the protein concentrations of tissues studied were 
determined and the values were expressed not only in relation to the 
weight of tissue involved, but also to its protein concentration which 
is not likely to change with oedema formation. The method involved 
is discussed in the methodology section and its linearity is seen 
in Fig. 4.1.
As can be seen in Fig. 4.2, 4.3, 4.4, expressing the CA in relation 
to protein concentration did not alter the overall picture indicating 
that no oedema formation was involved. Note that ADR concentration 
in the adrenal gland (Fig. 4.4c) was significantly increased (P 
0.01) when expressed as yg.mg  ̂protein while was not different when 
expressed as yg.g tissue. No clue as to this odd observation is 
known.
All available reports so far, indicated that researchers always 
express their results in relation to the weight of the tissue involved 
with the exception of Fernandez-Pardal and Saavedra (1982), 
who estimated CA content of different rat kidney regions as pg.mg  ̂
protein. The dominance of the first way of expression indicates
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that, in rats, oedema formation, under normal circumstances is either 
not a problem or has not been considered as such.
Chapter Five. Effect of salt 
loading on catecholamine levels
91.
5.1 Introduction
Ackpaffiong, Redfern and Woodward (1980) reported that upon 
loading of rats with 3% of either NaCl, KOI, NH^Cl, CaCl^ or 
NaHCOg, an increase in the total 24 hour DA excretion was evident 
while the concentration as nmol.ml was increased with all but 
NaHCOg. These findings were accompanied by stability of the 
plasma DA concentrations over the period of salt treatment. The 
first impression is that continuous DA turnover is taking place 
within the kidney. A previous study by Ball et al. (1978) quoted 
unpublished results showing an increase in kidney tissue DA with 
NaCl, KCl or NH^Cl but not with NaHCO^. These changes were similar 
to urinary changes following salt loading and they concluded 
that urinary changes ran in parallel with tissue values.
5.2 Methods
4 batches of female Wistar rats were used. The first group
(n=10) served as a control and was orally dosed with water, 20
-1 -1ml kg .day . The second, third and fourth groups were orally 
administered 2 0ml.kg ^.day ^, 3% NaHCO^, 3% CaCl^; and 3% NaCl 
respectively, the number of rats involved were 5, 5 and 10 
respectively. The administration was continued for a total period 
of 3 days after which rats were anaesthetized as usual, left 
to stabilize for 0.5 hr, and then blood, kidneys, adrenals 
and hearts were dissected out. The blood was dealt with as 
detailed before, while kidneys, hearts and adrenals were im­
mersed in liquid nitrogen and were stored there in small resealable 
bags until analysis. The extraction and assay procedures were 
the same as discussed.
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5.3 Results
Fig. 5.1 - 5.4 illustrate the effects of salt treatment 
20 mis.kg ^.day  ̂P.O on (a) DA, (b) NA, (c) ADR in the rat 
kidney, heart, adrenals and plasma respectively.
In Fig. 5.1, no effect for such treatment on CA in the 
kidney was noticed. On the contrary, cardiac NA showed a signi­
ficant increase when rats were treated with CaCl^ (P < 0.01). 
Moreover, when treated with CaCl^ and NaHCO^, the cardiac ADR 
content fell significantly (P < 0.01) from 82.06 ng.g  ̂in the 
control to 47.8 and 52.97 ng.g  ̂respectively (Fig. 5.2).
Fig. 5.3 presents the effects of salt treatment on the adrenal 
gland. No effect was seen in the content of DA or ADR, however 
when rats were dosed with NaCl the level of the NA in the 
adrenals increased from 223.95 to 356.1 yg.g  ̂ (P < 0.05).
Salt treatment seemed not to affect the plasma levels of 
CA (Fig. 5.4). Although there was some tendency for the three 
CA to increase in rats dosed with NaHCO^, this increase was 
not significant.
5.4 Discussion
The results of the present study clearly demonstrated that
upon the oral administration of 3% solution of either NaCl,
-1 -1CaClg, or NaHCOg to rats at a dose of 20 ml.kg .day for 3 days.
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Fig. 5.1. The effect of salt treatment on kidney DA(a), NA(b) and 
ADR (c)
control dosed orally with H^O. 20 ml.kg .day for 
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Fig, 5.4 The effects of salt treatment on DA (a), NA (b)
and ADR (c) in rat plasma. Rats were dosed orally 
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CaCl^i NaCl, the dose was 20 ml.kg day . Results 
are mean ± S.E.M. of 4 experiments (control) 
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No significant difference detected.
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no alteration in the CA levels of the plasma and the kidney 
was visible. Fig. 5.1, 5.4. Similar observations were seen 
with the adrenal gland with the exception of a significant 
increase in NA levels (P < 0.05) following NaCl (Fig. 5.3).
These observations led to two possibilities. Firstly, the con­
centration administered might not be enough to elicit a change 
in the tissue levels of the amines. Secondly, a continuous 
turnover might have been taking place. Ackpaffiong et al. (1980), 
using the same concentration and the same route of administration 
as used here, reported a significant increase in urinary DA 
excretion. If we bear in mind that this increased DA 
must be generated somewhere, with the plasma and the kidney 
as the most likely sources, it seems that the idea of increased 
continuous turnover is feasible. Recently, Racz et al. (1985) 
reported that after the administration of fusaric acid, an 
inhibitor of DBH, at a dose of 100 mg.kg i.p., there was 
a 70% reduction in NA and ADR in the adrenal gland accompanied 
by 300% increase in DA levels within 2.0 hours. Similar, but 
smaller changes took place in the rat kidney and heart tissue.
Ball et al. (1978) administered NaCl, KCl, NaHCO^, and
NH^Cl to Wistar rats via the pelleted food for a total period
of 3 days, during which they monitored and
exc. exc.
. They found that was increased with
exc. exc.
NaCl, KCl and NH^Cl, but was reduced with equimolar doses of
NaHCOg. Moreover, quoting unpublished results wherein they 
estimated kidney tissue content of DA following salt admini­
stration, the results were an increase in renal levels of DA
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with NaCl, KCl and NH^Cl but not with NaHCOg. The conclusions
of their experiments were that it was probably the chloride
ion and not the sodium ion that was important in relation to
DA , and this DA is not a consequence of volume exc. exc.
expansion secondary to Na^ ion. These two points will be 
discussed later in Chapter 9, but the outcome of the experiment 
of Ball et al. (1978) with its unpublished annex strengthened 
the idea of continuous turnover of CA following salt adminis­
tration, otherwise we might have expected an increase in
combined with a decrease in the tissue level of the
exc.
amine. Moreover, finding the enzymes responsible for synthesis 
and catabolism of CA in the plasma, adrenal (Goldstein et al., 
1972), and kidney (Najatsu, 1973) points in the same direction.
The effect of salt treatment on cardiac content of the 
amine is very complicated in the light of the fact that de­
polarization, repolarization and hyperpolarization of the 
cardiac muscle is dependent on the availability of ions especially 
K̂ , Nâ , Ca^^. Guyton (1976) reported that stimulation of the 
cardiac sympathetic nerves releases NA at the nerve endings and 
this NA is believed to increase the permeability of the fibre 
membrane to Na^ and Ca^^. The increased permeability of S.A. 
node fibres to Na^ ions will result in an increased heart 
rate while the A.V. node will reduce the conduction time from 
the atria to the ventricles. On the other hand, increased 
permeability to Ca^^ is at least partially responsible for the 
increase in contractile strength of the cardiac muscle. One 
might argue that the simultaneous increase in NA with reduction
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in ADR following CaCl^ administration, denotes an effect of Ca^^ 
on the enzyme PNMT. As far as I am aware, some enzymes depend 
on certain ions for theÂr catalytic reaction, therefore DBH 
reacts with ions during the enzymatic hydroxylation
reaction (Goldstein et al, 1972) but no report outlined so 
far an ionic requirement for PNMT.
Chapter Six. Dopamine response to 
volume expansion following 
DOPA decarboxyleise inhibition
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6.1 Introduction
6.1.1 Turnover
Measurement of turnover of a substance gives a better idea 
than the mere steady state tissue content (Lackovic and Neff, 
1983). DA turnover has been estimated in a number of ways. Some 
of which include the rate of metabolism of radiolabelled precursor 
or the measurement of the rate of change in DA concentration 
following inhibition of synthesis or of inactivation (Wagner et 
al., 1979; Cheng and Wooten, 1982).
Inhibitors of the enzyme DOPA decarboxylase are expected 
to reduce DA concentration and DA excretion as well; this 
effect was confirmed by Ball and Lee,(1977); and a review con­
cerning Carbidopa and bengarazide was published by Ponder and 
colleagues,(1976 ).
The work listed in the following chapter was aimed towards 
estimating the turnover of DA following the induction of DOPA 
decarboxylase inhibition by carbidopa (L-a-hydrazino-3,4, 
dihydroxy-L-a methyl cinnamic acid).
6.2 Experimental
6.2.1 Reagents
Besides those chemicals already specified, the following 
were involved in the present study;
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L-DOPA, ADR hydrogen tartarate (BDH, England, Adr.). oMeDOPA, 
DOPAC, Epinine (Sigma), L-NA bitartarate (Koch-Light Lab. 
England), aMeNA HCl (K & K, England), CD was generously 
donated by MSB (England), sulphuric acid, trisodium citrate.
6.2.2 Abbreviations used
L-DOPA
aMeDOPA
DOPAC
EPI
aMeNA
DHBA
CHgOH
SOSA
3.4 dihyroxyphenylalanine
dl 3 methyl 3(3,4) dihydroxyphenyl alanine
3.4 dihydroxyphenyl acetic acid 
Epinine (N-methyl dopamine) 
a-methyl noradrenaline
3.4 dihydroxybenzylamine 
methanol
sodium octane sulphonic acid.
6.2.3 Mobile phases
The different mobile phases used for this study were
1. Acetate citrate buffer + 5% CH^OH + 0.5 mM SOSA (pH 5.2)
2. Acetate citrate buffer + 5% CH^OH + 1.25 mM SOSA (pH 2.2,
4.4, 1.8).
3. Acetate citrate buffer (pH 1.8) without CH^OH or SOSA.
4. Sodium hydrogen orthophosphate buffer + 8% CH^OH + 1.25 mM
SOSA (pH 3.2).
5. Double distilled deionized H^O containing 0.15% H^SO^ (conc.)
6. 7% acetonitrile in H^O containing 0.15% conc. H^SO^.
7. 5% acetic acid in H^O + 5% CH^OH + 1.25 mM SOSA.
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6.2.4 Chromatographic conditions
The NaH^PO^ buffer composed of 100 mM NaH^PO^, 20 mM citric
acid and the pH was adjusted tO 3.2 with NaOH.
All mobile phases were degassed well with helium then put 
through the system at rates of 0.6 or 1.0 ml.min , in both 
cases, when mentioned, the flow rate was increased to 1.5 -
2.0 ml.min following the appearance of the DA peak. Detector 
potential was operated at +0.6 or 0.7 V vs. Ag/AgCl reference 
electrode.
6.2.5 Standards
A 10  ̂mixture of NA, ADR, aMeNA, L.DOPA, aMeDOPA, DA, 
DOPAC, DHBA, CD and EPI was prepared and was injected fre­
quently to find out the best separating technique for a parti­
cular mobile phase.
6.2.6 Animal preparation
Animals used were female Wistar rats (200 - 250 g), 
anaesthetized with pentobarbitone(60 mg.kg  ̂i.p.) and left 
to stabilize for 0.5 hr., then were mounted on an operating 
table (C.F. Palmer Ltd., London, England), maintained at 37°C 
An incision was made through the skin and the trachea was 
cannulated using a 6FG cannula (Portex Ltd., England) having 
an opening diameter (O/D) of 2.1 mm. Another 3FG (0.2 mm O.D)
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cannula was inserted through the right carotid artery and was 
connected to a pressure transducer (Bell and Howell, Ltd., 
England) connected to a physiograph MK III-S recorder (Narco 
Biosystems, England), for measurement of B.P. and heart rate.
A third cannula (0.75 mm 0/D) was inserted into the left 
jugular vein and was connected to an automatic slow infusion 
pump (Scientific Res. Indust. Ltd., Elgnad) equippped with 
3 X 50 ml syringes to infuse normal saline or other infusion 
fluid. Moreover, an abdominal incision was made to expose 
the bladder, the urethra was tied very tightly and a 3FG 
(0.2 mm 0/D) cannula was pushed through the bladder for 
urine collection which was achieved using a LKB 2112 Redi Pac 
fraction collector.
6.2.7 Choice of perfusion rate
The pump used offers a rate of infusion ranging from 
0.067 - 66.67 ml.hr , however, since collecting periods
desired were 0.5 hourly, two infusion rates were studied,
-1 -16.67 ml.hr and 13.33 ml.hr . It was found that infusing
13.3 ml.hr produced a reasonable output that was consistent
after 2 hrs.
6.2.8 Sample collection
Saline was infused via the jugular vein at a rate of 13.33 
ml.hr and urine was collected 0.5 hourly into a 10 ml 
graduated tube containing sufficient concentrated HCIO^ (PCA) 
to push the pH down to = 2.0. Two hours after perfusion, CD
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(suspended in N. saline) was injected i.p. at a concentration 
of 25 mg.kg and the perfusion continued for another 2.0 
hours. In a second group, rats served as control, and were 
infused in similar ways but 2.0 hours after the infusion,
N. saline was injected instead of CD. A third group served as 
sham op. control, rats cannulated similarly, but no infusion 
took place.
At the end of 4.0 hours infusion period, blood was collected 
via the carotid artery in tubes containing 3.2% (w/v) trisodium 
citrate, plasma was separated by spinning at 3000 r.p.m. for 
20 min. using l.E.C. Centra-7 (Intern. Equip.Co.) centrifuge, 
both plasma and urine were stored immediately at -20°C.
Kidneys, hearts, and adrenals were dissected out as mentioned 
before, blotted on a tissue paper, and frozen immediately in 
liquid nitrogen.
6.2.9 Extraction procedure
The principal extraction procedure was exactly as described 
before. There are, however, some differences concerning the 
work described in this chapter.
(a) Only DA was studied here and therefore, 0.3 ml of 10  ̂
standard were used to spike some samples to calculate the
endogenous content of the amine.
(b) The final eluate was 0.3 ml instead of 0.15 ml so that 
more injections were available if needed.
(c) The starting volumes were 0.5 - 1.5 ml for plasma; 40 pi
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to 2.5 ml for urine, 0.5 - 3.0 ml for tissue supernatant.
-6To the urine samples, 0.1 ml of 10 M DHBA and to plasma
_7samples, 0.1 ml of 2 x 10 M were added.
(d) In some experiments where plasma was measured, epinine 
was used as an internal standard, and for this purpose, 10 pi 
EPI was added to 90 pi plasma extract.
6.2.10 Measurement of blood pressure
Mean arterial blood pressure was calculated using the 
following formula:
mean arterial _ 3 x diastolic B.P. + 2 x systolic B.P. 
pressure 5
6.3 Results
6.3.1 Choice of perfusion rate
5 female Wistar rats were perfused with N. saline at
-1 -113.33 ml.hr while 3 rats were tested at 6.67 mls.hr for a
total period of 6 hours. As can be seen in Fig. 6.1, almost
constant urine output was obtained at both rates 2 - 6  hours
after the saline infusion. With the lower rate,however, the
output was minute when urine was collected Vz hourly. On the
other hand, reasonable output was obtained at the higher
perfusion rate. It was consequently decided to use the higher
rate for the rest of the experiments. Moreover, it was thought
reasonable to cut the time of the experiments to 4 hours and
to consider the first 2 hrs as an equilibrium period after
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Fig. 6.1 The effect of perfusion rate on urine output. 
Rats were infused with saline, either at
13.33 ml.hr^ (•) n = 5 or at(#)
6.67 ml.hr n = 3. Each point represents 
the mean of respective experiments. The 
error bars represent the S.E. mean.
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which carbidopa (CD, 25 mg.kg  ̂in saline) or saline was 
injected.
6.3.2 Effect of perfusion rate on B.P.
Figure 6.2 illustrates the effect of perfusion rate on 
B.P.. The B.P. was measured 0.5 hrly in sham-operated controls 
(open circles), in rats perfused with 6.67 ml.hr  ̂ (closed 
squares) and in rats infused with higher rate (13.33 ml.hr  ̂
closed circles). Although the perfusion with saline 0.9% at 
the higher rate tended to raise the B.P., this increase was 
not significant. As can be seen, the low perfusion rate had 
no effect on B.P. over the period of 4 hours.
6.3.3 Effect of CD on urine volume
There was no significant difference in urine output following
the injection of CD. Fig. 6.3 shows the urinary volume before 
(circles) and and after (triangles) CD, collected every 0.5 
hr. Since the CD was injected at 120 minutes of infusion, 
those results obtained before this point were added together.
6.3.4 Effect of CD on B.P.
CD failed to elicit any change in the B.P. of the rats
(Fig. 6.4).
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Fig. 6.2. Effect of perfusion rate on B.P. in rat
administered with 0.9% saline at 13.33 ml.hr 
(•), 6.67 ml.hr"! (■) compared to B.P. 
from sham operated control ( O ) where no 
infusion took place. Each point is the 
mean + S.E.M. of 5 experiments for sham 
op. and high perfusion rate and of 3 
experiments for lower perfusion rate.
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Fig. 6.3. Effect of CD on urine volume.
-1Rats n=4 were dosed with CD ( A ) 25 mg.kg
2.0 hrs after the infusion and urine collected 
for 2.0 more hours. Control rats (•) were 
injected with 0.9% saline instead. n=5.
Each experiment is the mean + S.E.M.
Results before 2.0 hrs were grouped together.
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Fig. 6.4 Effect of CD on B.P.
B.P. was estimated % hrly in sham operated 
rats not perfused or dosed (O ) and compared 
to this were rats dosed with CÇ (A ) n=4
or saline (#) at 13.33 ml.hr 
No significance was found.
n=5. each.
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6.3.5 Effect of CD on plasma and urinary electrolytes
Fig. 6.5(A) illustrates the effect of CDon plasma Na^. 
Plasma was collected from sham-operated controls, from control 
perfused rats and from perfused rats given CD. As can be seen, 
there was no effect of CD on plasma Na^ or K*. No 0.5 hourly 
estimation was made since the blood was drawn from the carotid 
artery after the 4.0 hrs infusion period had ended. Panel (B) 
represents the effect of CD on urinary Na^ and . CD was 
injected i.p. 120 minutes after the beginning of the saline 
infusion (0.0 time).
No effect of carbidopa on urinary Na^ or was found.
Fig. 6.5(B).
6.3.6 Effect of CD on plasma, urine and tissue levels of DA
When analysing plasma, urine and tissue levels of DA, 
after CD it was soon obvious that the drug produced extensive 
changes leading to alteration of chromatographic pattern of 
all desired peaks. Figures 6.6 A-D show the chromatographic 
analysis of (A) plasma, (B) kidney, (C) urine, (D) adrenals 
prior to the introduction of CD. This was achieved using a 
mobile phase containing acetate citrate buffer (pH 5.2) and 
5% methanol + 0.5 mM SOSA. Using this mobile phase following 
CD proved impossible. A huge response appeared, probably 
a combination of L-DOPA, CD and their metabolites that persisted 
for nearly 0.5 hr and masked any desired response. It was 
necessary, therefore, to develop a method by which all those
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Fig. 6.5(A). The effect of CD on plasma Na and K 
was taken from sham op. control 
from control perfused 
treated rats —
Plasma
and from CD 
Plasma Na concentration
was estimated by flame photometer. Results are 
mean + S.E.M. of 5 experiments for sham and perfused 
and 4 for CD.
Fig. 6.5(B) The effect of CD ( ̂  ) n = 4 on urinary Na and 
K'*' excretion. CD was introduced at (0.0 time) 
and perfusion continued for 2.0 hrs. Controls 
n = 5 ( • ) were injected with saline i.p. 
Results mean + S.E.M.
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Fig. 6.6 Chromatographs of (A) Plasma ; (B) kidneys;
(C) urine; (D) adrenals of rats. The method 
of separation composed of mobile phase 
of acetate citrate buffer pH 5.2 + 5% CH^OH 
+ 0.5 mM SOSA; Stationary phase was 
Spherisorb ODS 25 cm columm. The potential 
was 0.6 V vs. Ag.AgCl reference electrode. 
The flow rate was 1.0 ml.min“ .̂
114,
interfering peaks are delayed while bringing forward DA and 
the internal standard. It is known that methanol concentration, 
the pH and the ionic strength of the mobile phase are factors 
affecting the chromatographic separation. Manipulation of those 
factors was therefore attempted.
6.3.7 Development of method
6.3.7.1 Effect of methanol
A mixture of 10 standard CA was injected using mobile 
phase^pH 2.2)at different concentrations of methanol. Fig.
6.7 shows the effect of reducing the methanol to 5% (A).
4% (B) and 3% (C). No effect of this reduction is noted. In 
other experiments unrelated to this chapter, it was necessary 
to reduce the methanol from 27.5 to 5% to obtain the desired 
change . It therefore, apppeared that the reduction in methanol 
concentration had a minimal effect.
6.3.7.2 Effect of pH
Fig. 6.8 illustrates the chromatographic separation of 
standard CA using a mobile phase consisting of acetate-citrate 
buffer containing 5% methanol and 1.25 mM SOSA, at various 
pH ranges. (A) 1.8 ;(B) 2.2; (C) 4.4. Using the mobile phase
at pH 4.4 resulted in a clear separation of DA and DHBA from 
the rest of the compounds. However, when applied to samples, 
it was impossible to obtain a clear separation since those 
peaks for DA and DHBA were masked by the large ones before.
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When the pH was pushed further down to 1.8 (A), it was clear
that DA and the internal standard were separable from the rest.
When this mobile phase was applied to the kidney and to 
the urine samples, a more than acceptable separation resulted that was 
devoid of any interference (Fig. 6.9 and 6.10 respectively).
Fig. 6.9 is a chromatographic presentation of kidney extracts 
obtained from the sham operated kidneys (A), kidneys perfused with 
N. saline (B) and CD introduced into the animal and kidneys extracted 
2 hrs later (C). As can be seen, using the mobile phase at pH 1.8 
+ 1.25 mM SOSA led to separation of the CAs in the kidney extracts.
Fig. 6.10 shows the application of this mobile phase to urine 
samples. Fig. 6.10(A) is a urine sample from control rat while (B) 
is from a CD-treated rat. It should be noted that the separation of 
DHBA and DA took place on xlO nA thereafter the sensitivity was 
switched down to 500 nA to accommodate the rest of the compounds ; 
the size of these interfering peaks gives a clue to the extent these 
compounds interfered with the response of DA and DHBA.
6.3.7.3 Linearity of the method
A regression analysis was applied to the method outlined 
above and linear plots were obtained for both the kidnevs 
and urine.
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Fig. 6.9 Chromatograms of (A) kidneys extracted from sham op.
animals, (B) control perfused rats, (C) CD treated 
rats.
Samples were run on a Spherisorb ODS column 25 cm 
using a mobile phase of acetate citrate buffer pH 1.8 
+ 5% CHgOH + 1.25 mM SOSA.
Potential + 0.7
Flow rate 0.6 ml.min-1
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Fig. 6.10. A chromatograph of (A) urine from control rats 
(B) urine from CD-treated rats.
Urine was collected via the bladder by infusing 
saline 0.9% at a rate of 13.33 ml.hr” through 
the jugular vein. The system of chromatography 
was the same as for Fig. 6.9.
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In Fig. 6.11, DA 1 - 20 ng were added to kidney extracts 
and a calibration was constï'Ucted between the DA added and 
the peak height ratio of DA/DHBA.
6.3.7.4 Calculation
After establishing linearity of the method, some urine 
and kidney samples were spiked with a known concentration of 
DA and that was used to calculate the concentration of unknown 
DA in the samples. The recovery of DA on Al^Og in 9 recovery 
studies conducted was 66.6 + 1.1.
(a) Kidney
Kidneys were taken out of the animal at the end of the 
experiments i.e.4.0 hrs after the beginning of saline infusion 
and 2.0 hrs after CD injection.The renal DA values obtained 
are tabulated in Table 6.1, and no significant change is seen.
Table 6.1 DA in the kidney
Samples DA (ng.g n
Sham op. control 53.1 - 7.03 5
Control perfused 51.995 ± 4.5 5
CD treated 52.12 ± 7.84 5
(b) Urinary DA
Fig. 6.12 is a histographic illustration of changes in
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Fig. 6.11 Relationship of DA concentrations used to 
spike kidney samples vs. peak height ratio 
of DA/DHBA using a mobile phase of acetate 
citrate buffer pH 1.8 + 1.25 mM SOSA + 5% CH^OH 
flowing at 0.6 ml.min” .̂ Detection was carried 
out using electrochemical detector at 
+ 0.7 V.
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urinary DA in 4 rats following CD compared to urinary DA from a 
perfused control rat. The upper panel represents the DA taken 
as ng. 0.5 hr  ̂while the lower is DA concentration (ng.ml ^)
In the histogram, the values for each rat are plotted and the 
numbers 0.5 - 2.0 are the hours after the introduction of CD 
(or saline in the case of the control). The curve in both 
panels is the mean + S.E.M. of urinary DA 0.5 - 2.0 hrs after 
the introduction of CD (triangles) compared to the control 
values obtained from the four individual rats (circles).
Note that CD has the tendency to reduce urinary DA whether
-1 -1 DA is taken as ng.0.5 hr or as ng. ml and this was signi­
ficant despite the variation at 1.5 hrs (P < 0.001 and P < 0.05 
respectively.)
It was very unfortunate not to be able to estimate plasma 
DA and since it was not possible to estimate the DA turnover 
in the tissues studied, it was thought to be a reasonable idea 
to determine the effect of CD in plasma and tissues without 
infusing saline. The experiments were therefore repeated as 
follows :
10 female rats were taken, 8 of them injected with CD
(25 mg.kg ^. i.p.) while the other two served as control and
were injected with saline (i.p.). The volume of injection 
-1was 30 mg.ml . 2 rats were used after 0.5 hr, the blood 
was drawn, kidneys, hearts and adrenals were dissected out 
and kept in liquid nitrogen. Another 2 rats were used in the 
same way after 1.0 hr of CD injection, 2 more rats following
123.
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Fig. 6.12. Effect of CD on urinary DA in individual rats 
(histogram) and on the mean of 4 rats together 
(curve)
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Linear regression P < 0.05 P < 0.001
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1.5 hrs while the last pair were tested after 2.0 hrs. All 
tissues were analysed as before using Mobile Phase at pH 1.8.
All the kidneys were analysed at one time to eliminate variation. 
The same treatment was applied to plasma and other tissues.
Fig. 6.13 illustrates the time-course of the effect of 
CD in the different tissues involved. A time-dependent course 
reduction was seen with the plasma and kidney while in the 
heart and adrenals,the concentration of DA fell in the first
0.5 hr (significant in the case of the adrenals (P < 0.05)) 
but returned to normal after 1.0 hr and continued to rise 
in both tissues. Two hrs after CD it was significantly elevated 
(P < 0.02) in the adrenal, but failed to reach a statistically
significant level in the case of the heart. The use of 2 
animals for each point is a shortcome of the experimental 
design, however, this was repeated later using another DOPA 
decarboxylase inhibitor, aMFMD.
6.4 Discussion
6.4.1 Chromatcgraphic analysis
The use of electrochemical detection for the separation 
of various compounds proved to be very effective and demands 
are increasing for its use in the analysis of catecholamines 
and indolamines. Many methods were developed in an attempt 
to simplify or shorten the separation time or removing inter­
fering compounds. Later, the introduction of soap chromato­
graphy or ion-pairing reagent to the separation procedure proved
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to be of immense value.The addition of small amounts of short chain 
sulphonic acid detergents have resulted in drastic changes to chromato­
graphic separations, this effect was studied in detail by 
Thomas et al. (1983). In a part of the study listed in this 
chapter, the increase of ion-pairing reagent from 0.5 to 
1.25 mM considerably increased the separation time of the 
catecholamines studied.
6.4.2 Chromatographic conditions
The use of acetate-citrate buffer containing mobile phase 
was reported to have resulted in satisfactory separation for 
NA, ADR, and DA (Eriksson and Persson, 1982). In our experiment 
it was possible to resolve all four needed catechols once samples 
were taken from control animals (Fig. 6.6). Moreover, the use 
of Spherisorb ODS 5y as a support proved to be adequate under 
the conditions outlined above. In fact, during the course of 
developing the method, Hypersil ODS was used and proved to 
have reasonable resolving affinity as well.
The flow rate used were either 0.6 or 1.0 ml.min which 
allowed all the desired peaks to be resolved. For the study, 
two potentials were used, +0.6 V which have been used by Magnusson 
et al. (1980) and by Eriksson and Persson (1982); the other 
one is +0.7 V applied by Nissinen and Taskinen (1982) as well.
It was found, however, that a range of +0.5 to +0.9 V are 
applicable and are appropriate for the separation of catechol­
amines (Pleece et al., 1982).
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6.4.3 Internal standards
The use of an internal standard has an advantage regarding 
precision and reduction of analysis time over the use of an 
external standard. DHBA, as an internal standard, has been 
extensively used. It closely resembles NA, ADR, and DA in 
structure and is resolved at reasonable retention times.
Other exogenous materials can be used as replacement for DHBA. 
These include aMeDOPA (Wagner et al., 1979) and epinine 
(Magnusson et al., 1980). As can be seen in Fig. 6.8, epinine 
(EPI) is retained longer than DHBA at pH 1.8 and was, 
therefore, resolved after L-DOPA, which after CD, becomes so 
much concentrated that it tends to mask the peak of epinine.
One other problem regarding the use of EPI as an internal 
standard is that it can be formed endogenously as an intermediate 
compound in the metabolism of DA to ADR involving the enzyme 
phenethanolamine-N-methyl transferase (PNMT), which is found 
mainly in the adrenal gland (Bowman and Rand, 1980). In the 
rat, it is localized in the cytoplasm of the adrenal gland 
medullary cells (Goldsetein et al., 1972), and this point must 
be kept in mind once using epinine as an internal standard 
especially in samples from the adrenal extracts.
6.4.4 Effect of pH
Although the concentration of methanol (CH^OH) has an 
effect on the separation of compounds, it did not seem to be 
the decisive determinant of chromatographic patterns in our
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experiments, probably because the range over which it was varied 
was very minimal (Fig. 6.7).
It was found that the retention of the acidic metabolites 
of DA is strongly affected by changing the pH (Molnar and 
Harvath, 1976; Van Valkenburg et al., 1982). The lower the 
pH, the more the resolution i.e. the more the retention time. 
This was explained by the fact that ion-pair formation in­
creases as the protonation of the carboxylic group increases,
i.e. as the pH decreases (Wagner et al., 1979). This held 
true in our experiments, the resolution of DOPAC, L-DOPA, CD, 
was excessively increased by lowering the pH (Fig. 6.8). In 
general, the retention values decreased with increasing 
the dissociation of the solutes.For the amines, the retarddtion 
values increase as the pH increases, however, with DA, DHBA 
and EPI,this increase in the retardation with pH is seen if 
the pH is raised above 5.3 (Molnar and Horvath, 1976). Below 
this pH, the amines are fully proionated. Wagner et al.,(1979), 
applied a pH range of 2.4 - 3.5 to separate their CA and 
reported eventually no changes in the retention values of DA, 
DHBA, NA,ADR, EPI, since these amines are fully protonated 
at this pH range.
It should be noted that unless absolutely necessary, the 
pH should never be pushed down below 1.5 using these silica 
columns, especially when using an ion-pairing reagent, because 
both these two factors may attack the packing material of the 
column and, thereafter, distort the image of the chromatogram.
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Although the long-term exposure of bonded silica columns to 
ion-pairing agents may significantly reduce the life of the 
column (Davis and Moleyneux, 1982), the ultimate problem lies 
with the low pH because Nissinen and Taskinen (1982) used 
the same concentration of the sodium octane sulphonic acid 
used in our study while Molnar and Harvath (1976) used much 
higher concentrations. Moreover, after this study the packing 
material had to be scraped out and the column repacked.
The study listed in this chapter describes an attempt
to solve the problem of estimating DA in the plasma and tissue
of rats in the presence of high concentrations of carbidopa.
It is highly recommended, for future work, to start with as
-1low a dose as 0.5 mg.kg and increase the dose by a factor 
of two hoping to obtain clear dose response curves with minimal 
if any, interference from endogenous compounds or metabolites.
6.4.5 The choice of the infusion rate
In experiemnts similar to these described here, the rate 
of infusion varies significantly from one published paper to 
another, and each researcher, uses what he thinks gives realistic 
results. Although changing the infusion rate may affect the 
dynamics of the kidney, the rate chosen in our study seems 
to be justified on the basis that it was kept constant through­
out the experiment, it did not promote oedema formation and 
it was within the range used by other investigators. Baines 
et al. (1979) in rats of 300 - 570 g weight, infused 
isotonic saline at a rate of 4.2 to 6.0 ml.hr and this rate
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permitted urinary samples to be collected every 20 - 30 minutes.
Moreover, Baines and Chan (1980) infused saline through the
-1jugular vein with 23.4 ml.hr for one hour then reduced it 
to 4.56 ml.hr for two more hours, while Morgunov and Baines
(1981) produced volume expansion by infusing rats with 45.5
-1 -1 ml.hr for 40 minutes then reducing the rate to 11.4 ml.hr
for 2 more hrs. In another experiment, Favre and Gourjon
(1982) infused rats with 30 ml 0.9% saline over a period of
1.0 hr . Moreover, Robertsein et al. (1983), using a Ringer
-1solution, infused into rats at a rate of 1.2 ml.hr while
urine was collected every 20 minutes. On the other hand, NaCl
-1was infused to rats at a rate of 23.0 ml.hr preceded by
6.0 ml over 5.0 minutes (Wilcox et al.,1984). These ranges 
infused to rats were as variable as the rates used in other 
experimental animals, which show a range of 1.2 to 30.0 ml.hr
it implies that our choice of 13.33 ml.hr was not radical. This 
infusion rate was very well tolerated and the outcome was much more practical 
than using the lower rate of 6.7 ml.hr  ̂ (Fig. 6.1). The point 
of practicality stems from the ability to use the urine for many 
observations without the need to repeat the experiments again.
I think it will be much better if, in the future, investigators 
try a wider range of rates for every experiment. Although time 
consuming, it will be very practical and may yield very 
interesting and scientifically useful observations.
6.4.6 Effect of carbidopa (CD)
Two interesting articles constitute the core of this dis­
cussion, both of them reported investigations carried out on
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human volunteers. The first one is that of Ball and Lee (1977), 
carried out to investigate the effect of interfering with DA 
synthesis on Na"*" excretion.lt was carried out in six volunteers 
each given 50 mg carbidopa twice daily under no dietary 
restriction. The second report was carried out aiming at quanti­
fying CD, L-DOPA and DA in the plasma of human volunteers following
an oral dose of 100 mg L-DOPA and 25 mg CD (Nissinen and
Taskinen, 1982). The first report analysed DA using the trihydroxy-
indole-fluorimetric method while the other used HPCL-EC for 
their analyses. Both groups extracted their catechol compounds 
onto Al^Og. The first experiment may be considered chronic, 
while the second is an acute one measuring the catechols 60 
min. after a single dose of L-DOPA and CD. The point of interest 
stems from the desire to analyse tissue and fluid content of 
DA in relation to electrolytes as in the first article, but 
acutely and usingHPLC-EC as in the second.
Ball and Lee (1977), and Nissinen and Taskinen (1982) 
used 2 X 50 and 25 mg CD/day respectively. If we consider , 
just for the sake of argument, that uniform distribution of 
the drug takes place in a person weighing 70 kg. then the 
dose given will amount to 1.5 and 0.36 mg.kg respectively.
From this point of view, the rat in my experiments received 
25 mg.kg . This of course, in no way means that distribution 
of CD is the same in rat and man, it does not also mean that 
the metabolism is identical. There are some similarities 
however, Vickers et al. (1975) found that the major metabolic 
pathway of CD results from the loss of the hydrazino group
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with 3-hydroxy -a-( methylphenyl) propionic acid being 
excreted in the urine of man, monkey and rat.In the report 
of Nissinen and Taskinen (1982) there was no interference 
of L-DOPA or one of its metabolites with CD. This is probably 
owing to the low dose comparatively given. In our experiments 
it was clear from the first moment that the conventionally-used 
mobile phase would not work. This was the first move towards 
the development of method seen in this chapter.
CD did not affect urine volume or U^+ after a dose
exc.
of 50 mg b.d. (Ball and Lee, 1977), this was similar to our
observation seen in Fig. 6.3 and Fig. 6.5b. Moreover, these
authors reported that CD reduced by 15% (P < 0.05)
exc.
within 24 hrs and this returned towards normal in the second
and third day despite continuous administration of the drug
and this pattern was paralleled by . In the acute
exc.
experiment conducted here showed a very unstable
exc.
response to CD with reduction in the first hour. It is definitely
the variation from one rat to another that produced this
inconsistency (Fig. 6.5b). The same explanation can be extended
to the lack of significance in in response to CD treat-
exc.
ment. Fig. 6.12 demonstrates the tendency of CD to reduce 
and this tendency reaches the significance level
exc.
1.0 hr after CD whether it is expressed as a quantity/0.5 hr 
or a concentration/ml. It is the variation from one animal to 
another than rendered the responses non-significant.
Ball and Lee (1977) relying on their experiments and on 
the literature, reported that enzymes for the breakdown and
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synthesis of DA are available in the kidney, and that since DA is 
found in a much higher concentration in the urine than in the plasma, 
then CD acts on the kidney and this organ i.e. the kidney seems to 
be the main source of urinary DA. These authors, however, did not 
estimate the contribution of different sites to the formation of 
urinary DA. This problem will be tackled later when the source of 
urinary DA is discussed in Chapter 8, but as can be seen from Fig.
6.13, the effect of CD is mainly on the kidney and the plasma. Although 
kidneys which had been taken out at the end of the perfusion period 
did not show any reduction in DA content (Table 6.1), when the time 
courses of DA in the plasma and tissues of non-perfused rats were 
analysed, it was clear that CD was concentrated in the kidney and 
plasma (Fig. 6.13). The review of Finder et al. (1976) includes 
a quotation that CD is accumulated in the kidney and liver.
The similarity of effects of CD on adrenal and cardiac 
DA denote that either CD is not taken up into these tissues in 
enough concentration, or these tissues may not have high concen­
tration of DOPA decarboxylase.
Both assumptions are consistent with the view of Finder 
et al. (1976) who reported that CD is concentrated in the 
kidney, lung and liver (which contain high decarboxylase 
activity) while lesser amounts were found in the heart and 
other peripheral tissues.
Chapter Seven. Turnover of dopamine 
following DOPA decarboxylase inhibition by
aMFMD
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7.1 Introduction
For experimental purposes, aMFMD has successfully been 
used in rats (100 mg.kg  ̂i.p.) and mice (250 mg.kg  ̂i.p.) 
and was found to produce a rapid (within an hour) and complete 
inhibition of brain DOPA decarboxylase (Wagner et al., 1979).
It produced similar effects in mouse heart and kidney (Wagner 
et al., 1979), without having the neuronal degenerative effect 
of 6-OHDA or reserpine-like action, and without inhibiting 
other CA (Palfreyman et al., 1984).
7.2 Experimental
7.2.1 Chromatography
A chromatographic method was developed in order to 
separate DA and the internal standard. The method utilised 
a mobile phase of acetate-citrate buffer pH 5.2 + 10% CH^OH 
+ 0.5 mM SOSA. The stationary phase was Hypersil ODS 5y 
(Shandon Southern Products Ltd., Cheshire, England) packed 
into a 20 cm column. It was decided in this experiment to 
use epinine as an internal standard instead of DHBA, as the 
peak for DHBA was close to the front and any undesirable extension 
of L-DOPA peak may easily mask DHBA. These chromatographic 
conditions were constructed utilizing a standard mixture of 
8 CA including aMFMD and epinine(EPI).
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7.2.2 Calibration
Three female rats weighing from 240 - 250 g were anaesthetized
-1 \with pentobarbitone'̂ 60 mg.kg i.p.) and were left as usual
for 0.5 hr. The kidneys were taken and kept in liquid nitrogen.
At the time of analysis, the six kidneys were crushed
together and were homogenized as before in PCA containing EDTA 
—62.7 mM and 10 M epinine as an internal standard. The homo- 
genate was spun down and supernatant was divided into 20 portions.
The first 4 portions served as a control.To the other 4x4 portions,0.15ml 
of either 5 x 10 2 x 10 10 %r 2 x 10 ^ M DA were added.
Extraction was carried out and samples were eluted with 0.15 ml 
of 0.2 M HCIO^. Finally 100 yl were injected onto the system.
7.2.3 Animal experiments
20 Female rats weighing 200 - 255 g were used. Rats were 
anaesthetized and left for % hr, then aMFMD (Merrell, France) 
(lOO mg.kg ^ was injected intraperitoneally at a concentration 
of 30 mg.ml saline and kidneys and adrenals were collected 
at 0.0, X, %, IX and 2% hrs of the injection of aMFMD. They 
were assayed as before.
7.2.4 Calculations
Once linearity of the method was established, some kidney
— 7 *“6and adrenal samples were spiked with 0.15 ml of 2 x 10 and 10 M 
DA respectively which was then used as a basis for calculating 
the endogenous amine concentration.
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7.3 Results
Fig. 7.1 shows the chromatograph of a mixture of 8 standard 
CA used for the development of the method. As can be seen, the 
retention of epinine is much longer than DHBA, which make it 
less liable to be affected by interfering peaks like L-DOPA 
or aMFMD, if any. Luckily enough, those intereferences were 
minimal, and the method proved to be linear over the concentrations 
studied (1 - 40 ng). Fig. 7.2 shows the regression analysis.
The starting weight of kidney tissues was 170 mg which contained
2.0 ng while 5 mg of the adrenals containing 12 ng DA.
Fig.7.3 represents the effect of aMFMD 100 mg.kg on renal
and adrenal DA concentration. As can be seen, within the first 
15 min. considerable reduction in tissue DA took place which 
continued to decrease over the 2% hrs of the experiments.
For the kidney, it was significant (P < 0.02) after % hr and 
the significance increased to P < 0.001 at lYz and 2% hrs. For 
the adrenal values the reduction was significant only at 
IX hr and was on the verge of significance otherwise. The high 
standard error encountered in the case of adrenal glands might 
have rendered the response non-significant.
7.4 Discussion
This chapter should indeed be a continuation of the work 
on CD presented in the previous chapter. The only reason it 
has been separated is the low values obtained. The time gap
137
2+3
2 0 0 n A
20 0 15 .0  1 0 .0  5 . 0  0 . 0
R e te n t io n  Time (min. )
Fig. 7.1 A Chromatograph for the separation of 8 CA by the method adopted 
in this chapter. The stationary phase was Hypersil ODS 5y packed 
into a 20 cm column. The mobile phase was acetate-citrate 
buffer pH 5.2 + CH^OH 10% + 0.5 mM SOSA. Pot. +0.6 V, and 
flow rate 1.0 ml.min"^.
Peak identity; 1. L-DOPA; 2 + 3  DOPAC + aMFMD; 4. NA;
5. ADR; 6. DHBA; 7. DA; 8. EPI
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Fig. 7.2. Calibration curve for the linearity of the method 
relating DA added to kidney samples and the 
peak height ratio of DA/EPI.
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Fig. 7.3. Time course of aMFMD. The drug was given at 
0.0 time and kidneys and adrenals were taken 
at % hr, % hr, hr, 2% hrs.
0.0 hr; 
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Results are mean ± S.E.M. of 4 experiments each 
time * Linear regression. P < 0.02
< 0.001
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between ending the experiments using CD and commencing the ones
on aMFMD was only 7 days. All groups of animals in both designs
were experimented on at nearly the same time of the day.The only
variables being changed from the last experiment were the
chromatographic conditions. In the experiments involving CD,
the mobile phase was acetate-citrate buffer, pH 1.8 + 5% CH^OH
and 1.25 mM SOSA. In the work with aMFMD, it was changed
to acetate-citrate buffer pH 5.2 + 10% CH^OH + 0.5 mM SOSA.
It is worth mentioning however, that this latter mobile phase was
similar to the one routinely used throughout the course
of the study. Moreover, the stationary phase was changed to
Hypersil ODS 5y packed onto a 20 cm column. It is not known
if these changes might have contributed to changing the apparent
tissue levels of DA. Furthermore, the internal standard was
changed to epinine which, I think, should not have any effect
as long as the same concentration was added to the samples
and to the spiked samples from which the calculations were
carried out. Fuller et al. (1982) measuring DA in the heart
of rats before and after D6H inhibition, found DA in the
-1control heart to be 0.13 + 0.01 nmoles.g . In another place 
in the same article, the value of the control was estimated 
as 0.04 + 0.008 nmoles.g , while later it was estimated as 
0.08 + 0.008 nmoles.g . All these values were estimated 
under the same conditions using HPLC-EC.
Quoting the authors "variation in DA concentration occur 
among different lots of rats even from the same strain and 
supplier". Whatever the reason may be, all samples were 
analysed at one time to reduce day-to-day variation. Fig. 7.1
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depicts a trace for the separation of standard catecholamines 
using the method stated above. Note that because the dose of 
otMFMD is high (100 mg.kg ^), and because of the experience 
with interference from endogenous metabolites when using CD, 
it was decided to use epinine as an internal standard so that 
if the response to DHBA was masked, then EPI would be retained 
well away, thus permitting accurate calculations. The use of 
this internal standard along with the mobile phase stated under 
the conditions discussed in the method section proved to be 
accurate and a linear correlation was found between DA and 
the peak height ratio of DA/EPI (Fig. 7.2).
It is very interesting to note (Fig. 7.3), that both in 
the kidney and the adrenal gland, DA experienced similar patterns 
of disappearance which was linear for the first 1% hr (r = 
-0.951; P < 0.05 for the kidney; r = -0.991 P < 0.01 for the 
adrenals) after which the DA concentrations goes up in both 
tissues. It is interesting to note, also,that the effect of 
a MFMD on renal DA was much more pronounced than on adrenal 
DA, similar to the changes observed with CD (Fig. 6.13) which 
may indicate that like CD, aMFMD is taken up more efficiently 
into the kidney thus affecting renal DOPA decarboxylase more 
than in the adrenals.
The use of aMFMD seem to be - in the doses studied - super­
ior to CD since only slight interference occurred with the 
use of 100 mg.kg of aMFMD which was very easy to overcome 
with a reliable system.
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In my system with aMFMD, the maximum time lapse before 
sacrificing the rats was 2% hours. It would be interesting 
to use lower concentrations and longer periods of time. Recently 
working on the pineal gland. Smith and colleagues (personal 
communications, 1984) used 10 mg.kg  ̂ aMFMD, and upon sacrificing 
the animals after four and seven hours, no interference of 
aMFMD with the chromatogram was seen.
In my study, the low values for DA concentration were 
noticed in all systems, whether renal or adrenal while the 
plasma DA was below the limit of detection. As stated above, 
no clue as to what happened is known but one experimental 
habit was stuck to during the course of the work summed up 
in this thesis, and that is to dose, sacrifice, extract and 
analyse control and treated samples at the same time if possible, 
and at the time of the HPLC work. Samples of the two groups 
were injected in random. It was hoped, in this way, to control 
variation which may take place, so that whatever changes in 
experimental conditions take place, it will be expected to 
affect both control and treated samples to a similar extent.
This work with aMFMD was intended to verify the effect 
of CD on plasma and tissue levels of DA. As described in the 
text, plasma DA was undetectable while that of the kidney and 
the adrenals is shown in Fig. 7.3.
From the results, the idea of continuous turnover of the 
amine is reemphasized; it seems,however, that this turnover 
is different with different drugs and in different tissues.
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it was,therefore, more efficient when using aMFMD than CD, 
and in the kidney than the adrenals. Moreover, the similar 
pattern of disappearance of renal and adrenal DA which varied 
in magnitude, following the administration o»f aMFMD suggests 
that the rate of uptake of the drug into different tissues 
is not the same. Furthermore, finding that both CD a.ud aMFMD 
are efficient inhibitors in the kidney, coupled with reporting 
the enzymes responsible for synthesis and breakdown of the 
amine in the renal tissues, supported the suggestion that 
the kidney is an active site for the production of urinary 
DA.
Lee (1982) outlined three main theories by which urinary 
DA may be formed: 1) the deconjugation theory; 2) the neuronal
source of DA; 3) the formation of DA from L-DOPA in the kidney. 
Although favoured the third theory, he strengthened the first 
one relying on experiments carried out using the prodrug y- 
glutamyldopa and the presence of the enzyme y-glutamyltrans- 
peptidase in the kidney. No doubt exists, however, that plasma 
DOPA is one major source of urinary DA (Baines and Chan, 1980; 
Suzuki et al., 1984). The results obtained here with CD and 
aMFMD, although strengthened the importance of the kidney as 
a source of urinary DA, they stemmed the interest in completing 
the picture by looking for other candidates which may contribute 
to the formation of urinary DA. It was, therefore, decided 
to study the participation of the adrenal gland and the 
sympathetic nerveswhich will be fully discussed in Chapter 8.
Chapter Eight. Source of urineæy dopamine, 
the involvement of adrenals and 
dopaminergic nerves in urinary dopamine formation
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8.1 Introduction
The contribution of different sites to urinary DA was discussed
before, however, no one study aimed to find out the contribution 
of all sites. Moreover, the contribution of the adrenal gland - if 
any - was not studied. It was therefore decided to trace the involv­
ement of the adrenals on the one hand and the dopaminergic nerves, 
on the other by finding out how much urine DA is reduced once the 
adrenals are eliminated and the nerves are degenerated by 6-OHDA.
Adrenalectomy
In the rat, adrenalectomy produces profound haemodynamic 
changes within 1 hr of operation. In experiments carried out by 
Peart and Pessina (1975), rats were infused with saline at 0.5 ml.min 
for urine collection periods of 20 minutes each. Adrenalectomy was 
associated with reduction in GRF, RBF and redistribution of blood 
without changes in B.P. The long term effect of adrenalectomy, however, 
seans to be different. Gardener and Bennett (1983) reported that a week 
following bilateral adrenalectomy in rats, a clear resting hypo­
tension was seen (^^ vs. ), which returned to normal levels
within 3 weeks.On the other hand, development of hypertension, in 
male Wistar rats, was demonstrated after unilateral adrenalectomy 
with contra-lateral adrenal enucleation and substitution of 1% NaCl 
for drinking water. This adrenal regeneration hypertension was 
associated with regeneration of functional adrenocortical tissues may 
have resulted from abnormally high levels of endogenous mineralo- 
corticoids other than aldosterone (Milmer, Bennett and Gardner,
1984).
Bilateral adrenalectomy was associated with an increase in 
CA excretion that lasted for at least 2 weeks (Imms and Jones,
-1
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1966; 1967). Replacement therapy (50 yg or 1 mg b.d. corticosterone) 
reduced CA excretion to normal levels. In order to elaborate on 
the importance of the endogenous steroids, adrenomedullectomy of 
a group of rats was carried out; the consequence was that CA 
excretion lay within normal levels. Results showed that the absence 
of circulating corticosteroids are behind the increase in CA excretion,
Following either 24 or 72 hours of bilateral adrenalectomy, 
rats were decapitated and levels of plasma DA were determined 
(Buhler et al., 1978). Despite the disappearance of ADR, 
detectable amounts of DA were found, indicating that plasma DA 
is partially of adrenal origin. Moreover, although DA is known to 
be synthesized in the adrenal medullae, and the enzymes required 
for its synthesis and catabolism are found in the gland (Tepperman, 
1973), adrenomedullectomy reduced the DA content of the glands only 
by 50% compared to 98% reduction in NA + ADR (Van Loon, 1983), 
implying the importance of the adrenal cortex as well.
Adrenalectomy was shown to abolish the aldosterone-induced 
effects on urinary electrolytes (Siegi and Ryffel, 1982). Consistent 
with this is the finding that adrenal demedullation abolished the 
hypotensive effect of bromocriptine(0.3 mg.kg  ̂i.v.)in dogs made 
neuronally hypertensive by bilaterally sectioning the carotid sinus 
nerves and both vagosympathetic trunks(Montastruc and Montastruc,
1983). These results show that the integrity of the adrenal gland 
is essential for the anti-hypertensive effect of bromocriptine and 
indeed important for the normal function of the adrenals.
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8.2 Method
8.2.1 Adrenalectomy
Female rats were used for the work outlined here. After anaes­
thesia,2 - 3 cm bilateral dorsal incisions were made over adrenals. 
Two pairs of curved forceps were then inserted carefully and were 
used to pull the adrenals free. All efforts were taken not to 
injure the kidney. Following the adrenal removal, the skin was 
put together and then stapled. Rats were then mounted individually 
on an operation table and left jugular, right carotid artery and 
bladder were camuXatedas described before. Sham operated animals 
served as control, whereby the procedure was repeated without the 
removal of the glands.
8.2.2 Infusion fluids
The initial experiments were designed to infuse saline 0.9% 
into the animal. By doing this and collecting urine every 0.5 hr, 
the first problem appeared. It was soon realized that variation 
is huge from one rat to another.Fig. 8.1 depicted results obtained
with 2 rats on 2 consecutive days. The histogram represents
-1 -1 DA as ng.0.5 hr while the curves show DA as ng.ml . Although
_1within the same day, the expression of DA as ng.0.5 hr is more 
consistent than as ng.ml ^, huge variation may still be a 
problem. It was therefore decided to collect urine for a period 
of 3 hours which certainly would reduce the error. Secondly, the 
measurement of GFR following saline infusion led to the observation
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that GFR was reduced significantly in adrenalectomized animals.
In the search for a solution that would not reduce GFR, the following 
were tried: (a) saline 0.9% (b) saline 1.2% (c) mannitol 5.07%(w/v), 
(d) Krebs solution of the following composition (gL ^): NaCl, 6.9; 
NaHCOg, 2.1; glucose, 2.09 and MgSO^ (14.7% , 2.1 mls);KH2P0^
(16.2%, 1.0 ml); KOI (25%, 1.42 ml) and CaCl^ (28.0%, 1.0 ml). All 
the solutions were infused at 13.33 ml.hr for a total period of 
3 hours.
8.2.3 GFR
Glomerular filtration rate was measured utilizing the estimation 
of creatinifttin plasma and urine using a Pye Unicam PU 8610 UV/VIS 
kinetic spectrophotometer (Philips, England). Urine was collected 
over a period of 3 hrs while plasma was obtained by spinning 0.8 
ml blood drawn from the carotid artery at 1.5 hrs. The method is 
as follows:
(a) Reagents:
- Picric acid (BDH, Poole, England) 12 gL ^. From this, a
solution of 66.8% Picric acid in H^O was made immediately 
before use.
- NaOH 1.6 M (Fisons,England).was prepared by dissolving 64 g 
NaOH in 1 L H^O.
- Trichloro acetic acid (T.C.A.) (BDH) was prepared by dissolving
19.607 g TCA in 100 mis H^O to yield 1.2 M.
- The diluted picric acid and NaOH 1:1 were mixed just before
use
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- Standard creatinine (Beckman USA) was obtained as 5 mg.dl ^
and was used to plot a calibration curve to check the linearity 
and also to estimate the creatinine concentrations in the 
samples.
(b) Standard curve:
(1) Creatinine 5 mg.dl  ̂was diluted to 0.1, 0.2, 0.3, 0.5, 
1.0, 2.0, 3.0, 4.0, 5.0 mg.dl and at the same time 20 yl urine 
and 100 pi plasma samples were diluted to 500 pi with distilled
HgO.
(2) To both the standards and samples, the following
procedure was applied:
500 pi standard or diluted sample (500 pi H^O for blank)
500 pi TCA
1.00 ml picric acid/NaOH 
Contents were mixed well and incubated for at least 20 minutes at 
25°C, then read at X 490 nm using the Philips spectrophotometer.
(c) Calculation of GFR and other parameters:
GFR was the product of In urine (ng ■ ml~^ x urine output (ml
plasma Cr (ng.ml )
Na^ and were measured using the Corning 450 flame photometer,
while DA using the previously mentioned HPLC-EC with the mobile
phase being acetate-citrate buffer pH 5.2 containing 10% methanol
and 0.5 mM SOSA. The stationary phase was Spherisorb ODS.
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8.2.4 Consistency and reproducibility of DA estimation
The DA concentrations in the urine were calculated from the
—Qpeak height ratios of spiked urine samples. 0.1 ml of DA 10 M
-6and 0.1 ml of DHBA 3 x 10 M were added to the urine samples and 
the peak height ratios of the spiked samples were estimated. The 
reproducibility ofthe FHR of DA/DHBA were taken as a measure for 
the consistency of the method. In the period of the study of this experi­
ment (29th July 1984 to 2nd January 1985), the peak height ratios 
(n = 11)were 0.669 + 0.016 and ranged from 0.61 to 0.77 with only 
2.5% error involved.
8.3 Results
8.3.1 Linearity
The method was linear over the range studied with r = 0.9997 
and y = 0.23 x + 0.006 (P < 0.001) and this was used to calculate 
the GFR in the rest of the samples. This is depicted in Fig. 8.2.
8.3.2 Effect of adrenalectomy on B.P. and heart rate
B.P. was measured every 0.5 hr over the period of the experiment 
as was the heart rate. Using 0.9% saline (Fig. 8.3(a)), mannitol 
(Fig. 8.3(b)), or 1.2% saline (Fig. 8.3(c)), adrenalectomy did 
not result in any significant change in B.P. although there 
was a tendency to do so in all cases.
As seen in Fig. 8.4(a,b) adrenalectomy did not affect HR in 
mannitol or hypertonic saline infused rats.
151
Ec
OO)
0)o
5 0.6
Oco
< y=0. 23X+0.0060.4
r=0 .9997
p<0.0010.2
4.02.0 ao10
Creatinine Gone.(mg.100ml.)
Fig.8.2. Calibration curve for ^he relation between 
creatinine, mg.100 ml and absorbance at 
490 nm. Each symbol represents one observation
152.
( a )
200
O)X
E
E 10 0
OL
CÛ
3.02.0
Time (H o u rs )
0.0
(b)
(c )
200
O)X
E
E 100
0.
CÛ
3.02.0
T im e(H o u rs )
0.0
200
D)X
E
J  100
CL
CO
2.0 3.01.00.0
T im e (H o u rs )
Fig. 8.3. The effect of adrenalectomy on B.P. in rats infused 
with (a) 0.9% saline, (b) mannitol, (c) 1.2% saline 
at a rate of 13.3 ml.hr"^ for 3 hrs. ( •) control,
( □ ) adrenalectomized. No. of experiments are 
at the side of each curve.
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Fig. 8.4. Effect of adrenalectomy on heart rate(H.R.) in rats 
infused with (a) mannitol, (b) 1.2% saline, (•) 
control ( □ ) adrenalectomized. Each point is 
mean + S.E.M. of 5 observations.
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8.3.3 Effect of adrenalectomy on urine volume
For all parameters presented each figure will contain four 
diagrams a, b, c, d. In all cases, (a) are the values obtained in 
rats infused with Krebs, (b) with 0.9% saline, (c) with isotonic 
mannitol 5.07%, while (d) with 1.2% hypertonic saline.
The urine volume was reduced significantly in all four cases. 
Note that in those rats where isotonic saline was infused n = 18, 
for the control and 17 for the adrenalectomized (Fig. 8.5), in 
only 5 cases were the GFR and DA excretion measured. The rest 
of the animals were done before planning for the GFR. If the only 
5 values are considered, there was still a 66.4% reduction in the 
urine volume after adrenalectomy but this was rendered insignifi­
cant because of the large error involved.
8.3.4 Effect on urinary DA excretion
DA excretion fell significantly in urine of adrenalectomized 
rats with the most prominent change in the case of mannitol, where 
the reduction was 87.0% (P < 0.001) (Fig. 8.6).
8.3.5 Effect on GFR
GFR was found to be reduced significantly (P < 0.05) in rats 
infused with Krebs, 0.9% saline, and with mannitol infused 
ones (Fig. 8.7) while no change was seen with hypertonic saline 
infused rats.
155,
( siys |W) indino auijQ
(sjqe’lLU) indino e u u n
(s jqe- | iu )  ind m o  suun
CO
X )0)UX
X:x>•H5
lO lO
T3 .
(D s
m
3 CD bJ
Ch P
C X W
•H
ro + 1
GO
c p c
•H o CO
QJ CM CD
XI E
—1
m 1 CD
-p P P
CO X CO
fn
Nil 1— 1 CDE XW 00 1— 1 3
CD CD
N 00 CD
•H CX
E X 1—1
O cO • O
-P c  •
u CD E  O
CD C 3r—1 •H 1— 1 V
CO 1— 1 o
C CO Ü  ÛH
CD
p
CD
X  *
T3 %% Ü  *
CO CM CO *
CD
T3 1—1
C C
CO O
T3
C
o 3OrH X  CM
O CD O
X
■H CD O
c P
c CO V
1— 1 CO
O E CD a.
P
c  g
CD *
X
c o
0 E
o •H
p
CfH (D
O <y> a
X  IX
X o CD O
3
a CD X  o
X c o
3 •H V
O 1— 1 CD
CO P  CP
CD CD CD ,
C X  %■H E
P X 3
3 — ' z
LX
00
ci
•H
(•sjnE'liu) indino auiin
156,
(•sjqe’6u)*ox3 v a  AJBUUfj
( s jq e * B u ) - 0 X 3  VG AJBUUfl
(SJqe’Bu) 0 x 3  VG AjBUiJfl
T3
<D fcjN•H CO
E
0+1X c
Ü CO
(D CDrH ECOc CDCD PP CO
Tt
CO CO
T3 X
C 1— 1CO 3
1
CO
CD
P
3
CCO
C
E
3 1— I1—4 01— 1 0 00 0
P 0X Xc 0 V0 CO0 CD CL
c•H C0 1
C *X 3
1 0CO X
p CO
X00 CD tH
P 0ci COc 0CO
X Vc C0 CD CL•H
X E•H *
CD P
P CD *0 aX XCD CD
< X
Q 0 CM
>5 CO
0
P p CDCO CD
C X V•H E
P 3 CL
3 z
CO
CO
ci
•i-ibn
( s j ys 'Gu)  0 x 3  VG AjBUjJn
157
CO
d
CJ
d
(LU!LU-|Lu)*yj-o
CO
d
CM
O  O
(UILU' ILU) y  3 0
(U!LU'|LU)'W'3'0
w
CO
+1
s ^(0 o  <u • e o
d) V  pCO a 
3 Co
•H
CO
CO
CDPÛ0
CDP
X .
CO CO P c
c
CD 
CO CD 
C  CO 
CDP3
CO CO
C X
COCH o
I -H
C  X  
•H COE > • P
I— I d)
E  CO 
^  Xoa
fe y
o
00
Ù0
•Ha
( uiiu |IU) y j o
158,
8.3.6 Effect of adrenalectomy on plasma Na^ and urinary Na^ and
Fig. 8.8 illustrates the effect of adrenalectomy on plasma 
Na^. No significnat change is seen with any infusing solution while 
urinary Na^ excretion was reduced by = 70% following the removal 
of the glands (Fig. 8.9). On the other hand excretion was 
not affected by adrenalectomy except in rats infused with 
Krebs, where the reduction was nearly 41.0% and was significant 
(P < 0.05) (Fig. 8.10).
8.4 6-OHDA Introduction
6-OHDA has a unique ability to destroy selectively noradrenergic 
and dopaminergic nerves (Thoenen and Tranzer, 1973). In the rat spine, 
DA- containing neurones were selectively depleted by 6-OHDA and 
desipramine (DM1), while NA containing neurones were destroyed 
by 6-OHDA and benztropine indicating the existence of an independent 
population of spinal dopaminergic axons (Simon and Schramm, 1983).
The fact that 6-OHDA was found, in adult animals, to destroy 
nerve terminals alone leaving the cell body intact provides the 
possibility for subsequent regeneration, whereas in newborn 
animals, the whole neurone is destroyed, making this amine a 
valuable tool for both reversible and permanent sympathectomy 
(Thoenen and Tranzan, 1973). The accumulation of 6-OHDA in the 
nerve terminals appear within a few minutes. Moreover the uptake 
into neurones and not the storage sites is a prerequisite for 
the destructive action of 6-OHDA. Furthermore, twelve hours to 
3 days after administration of large doses of the drug to cats
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and rats, the adrenergic nerve terminals studied were in various 
stages of degeneration while the cholinergic nerve terminals 
were completely intact (Thoenen and Tranzan, 1973).
-1When 6-OHDA was given to rats at doses of 50 mg.kg i.p.
on days 1 and 3 and 75 mg on day 4, the reduction in NA in the
-1rat kidney was 72%, however, if on day 5, 10 mg reserpine.kg 
is administered, i.p., the depletion becomes 90% (Augustin et 
al., 1977 ). Moreover, 6-OHDA was given to dogs ( 2 x 30 mg.kg ^i.v, 
given 24 hrs apart)and animals were killed either 1 or 7 days 
following the second injection (Bell et al., 1978). 1 day after 
the last dose of 6-OHDA, no axonal fluoresence was seen either
in the atrium or the renal cortex and the atrial NA level fell
-1 -1 from 1.95 to 0.04 yg.g ,while from 0.38 to 0.06 yg.g in the
renal cortex . On the other hand, DA was down from 0.11 to 0.025
and from 0.081 to 0.044 yg.g respectively. In animals killed
after 7 days, however, no restoration of axonal fluoresence
was observed in either tissue, but the NA and DA both returned
to at least 50% of normal value (Bell, Lang and Laska, 1978).
It is interesting to note that chemical and immunological 
sympathectomy were found to leave the adrenal medulla unaffected 
and the medulla partially compensated for the destroyed neurones 
(Thoenen and Tranzer, 1973). This compensation is manifested 
in increased synthesis and turnover of CA in the adrenals.
8.4.1 Methodology
Female rats (200 - 225 g) were anaesthetized lightly with 
ether and 6-0HDA(50 mg.kg )̂ was injected into the tail vein.
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The drug was kept in the freezer and the required quantity was 
weighed immediately before use and was dissolved quickly in 1% 
ascorbic acid in saline.
24 Hrs later, rats were anaesthetized as usual and cannulated 
for measuring B.P., heart rate and for blood sampling as 
before. At 1.5 hr (midpoint) 0.8 ml blood was taken for 
measuremnt of GFR and urine was collected over a 3.0 hr period 
following 0.9% saline infusion. Plasma Na^, urinary Ma^ and 
and urinary excretion of DA were estimated as detailed before.
8.4.2 Results
The effect of 6-OHDA on B.P. is seen in Fig. 8.11. Although 
6-OHDA tends to depress the B.P., this was not significant.
The other variables studied are illustrated in Fig. 8.12.
It must be noted that the controls used for this experiment 
were the same as those for the sham adrenalectomized because few 
experiments were carried out using controls (non-sham op.) and 
since results were not different from those with sham op. ones, 
results were pooled.
The only significant variables noticed were the GFR and the 
urine volume(only when n = 18). Although there was a tendency 
for 6-OHDA to reduce DA excretion, by about 20%. this was 
not significantly different from control.There was a tendency 
also to raise Na^ and although not significantly different 
from the control due to the error involved from one rat to another.
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Fig. 8.11. Effect of 6-OHDA mg.kg on B.P.
6-OHDA (V ) was administered into rat tail 
vein and was estimated half hourly, in 4 rats. 
Controls experiments (#) were rats not injected 
with the drug, n = 5.
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8. 5 Discusssion 
8. 5.1 Adrenalectomy
The experiments carried out on adrenalectomized rats were 
designed to study the contribution of the adrenal glands, if 
any, to urinary free DA. DA is well known to be synthesized 
in the adrenal gland and specific storage granules have been 
found (Lackovic and Neff, 1983). The shortest way to study the 
effect of adrenalectomy is to remove the adrenals from a group 
of rats while sham operating another then collect urine either 
acutely by infusing a solution through the animal, or chronically 
by placing the rats individually in metabolism cages and collect 
urine over certain periods of time. Choosing the first method,
I was fully aware of the involvement of the higher centres in 
regulating the mineracorticoids and glucocorticoids of the adrenal 
gland. I however, hoped such a short period of time may not 
be enough to disturb the required responses. Soon, it was obvious 
that the removal of the gland reduced not only the urinary DA 
(Fig. 8.6) but also renal function, the G.F.R. was therefore 
significantly reduced (Fig. 8.7 a-c). The initial design of 
the experiment was to infuse normal saline in control and 
adrenalectomized rats in order to collect urine acutely. When 
the G.F.R. was reduced with saline, other solutions were tried, 
but the use of Krebs solution and an isotonic mannitol solution 
produced the same problem. Peart and Pessina (1975) have found 
that NaCl 0.9% infused into rats reduced G.F.R. significantly 
while the infusion of polyvinylpyrrolidone (PVP) restored the 
G.F.R. in adrenalectomized rats. To distinguish between
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the reduction in being due to adrenalectomy or as a
exc
consequence of reduction in G.F.R., a hypertonic (1.2% saline)
solution was used. As can be seen in Fig. 8.6 (d) and Fig. 8.7(d),
the G.F.R. was maintained while the fell by 44.0%. Our
exc
results are in agreement with those of Imms and Jones (1966) 
who found that within 1 day of the removal of the glands,
exc
was reduced significantly. In another report, Imms and Jones 
(1967) have shown that this effect of adrenalectomy was reversed 
by the administration of corticosterone. Also, in rats with 
demedullated adrenals, the catecholamine levels were within 
normal, indicating that it was the adrenal gland per se that 
altered CA (Imms and Jones, 1967). Recently, Higashihara 
and Kokko (1985), have shown that the infusion of aldosterone
did not affect the G.F.R. in adrenalectomized rat while
significantly (P < 0.02) affecting the response of urinary 
Na^ and to the removal of the gland.
8.5.2 Effect on B.P.
Friedman et al. (1958) studied the acute and chronic effects 
of adrenalectomy and reported a significant reduction in B.P. 
of adrenalectomized rats within 3 hours. This reduction in B.P. 
reached maximum within 24 hrs and was maintained at this 
low pressure until the end of the experiment. On the other hand, 
Peart and Pessina (1975) found eventually no change in B.P. 
within 1 hr of the operation
As can be seen in Fig. 8.3 a,b,c, there was a tendency
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for adrenalectomy to reduce the blood pressure in all groups 
studied, however, none of the changes was significant. The dis­
crepancy between our results and those of Friedman et al. (1958) 
can be explained easily on the understanding that those re­
searchers used bilaterally nephrectomized rats as their control 
and by doing so they have removed an essential regulator of 
B.P. Long term adrenalectomy leads, however, to hypotension 
(Gopse, 1983; Friedman et al. (1984).
8.5.3 Effect on plasma and urinary electrolytes
The only plasma electrolyte measured in our study was Na^ 
which tends not to be different following adrenalectomy (Fig. 
8.8.), in agreement with the results of Friedman et al. (1958), 
who found no change in Na^ or in the first 5 hours after 
adrenalectomy in experimental rats.
As can be seen in Fig. 8.9 and Fig. 8.10, adrenalectomy
reduced U,,, + in all animals except those infused withNa exc.
mannitol (Fig. 8.9c), while no effect on except a
exc.
significant increase in Krebs infused group (Fig. 8.10a).
Although not significantly different, there was a 68% reduction
in in adrenalectomized rats receiving mannitol, but
exc.
it seems that the variation between rats tends to mask its
significance (Fig. 8.9c). The effect on is difficult
exc.
to explain in the light of the fact that adrenalectomy removes 
the source of aldosterone and other mineralocorticoids responsible 
for conservation of Na^. It was expected therefore, that 
would increase dramatically following the removal
exc.
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of these cortisones as seen in the long term effect of the 
operation (Ackpaffiong, 1981; Welch et al., 1983). It seems, 
however, that the acute removal of the adrenal gland varies 
dramatically from the chronic effect, with establishment of 
a new equilibrium which is thought to be due to a neurohypophyseal 
compensatory effect (Friedman et al., 1958).
The most suprising effect was that of mannitol, in both
control and adrenalectomized rats, + and to much lesserNa exc.
extent were reduced when mannitol (5.07%) was infused
exc
at a rate of 13.3 ml.hr for 3 hours. Initially, when choosing
mannitol, it was hoped, being an osmotic diuretic which is
not absorbed, will lead to a reduction in H^O and consequently
Na^ reabsorption from the proximal tubule with a net result
of diuresis and natriuresis (Kleinman and Disney, 1984). It
is not thought that the dose of mannitol should be higher than
the one used. Since mannitol is not absorbable, it will stay
in the tubular lumen and will disrupt the H^O-Na^ concentration
gradient. It may be possible, however, that increasing the
dose will only increase the effect of mannitol on Na^ exc.
Kleinman and Disney (1984 )used 5, 10, 15 and 20 g mannitol/100
ml H^O to infuse the experimental dogs and they reported
a linear relationship between the U of mannitol and thatexc.
of Nâ .
I conclude from my results that as much as 44% of urinary
DA comes from the adrenal gland. Ackpaffiong (1981) found that
in rats adrenalectomized for 14 days, U was reduced by
^ exc.
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80%. He related this reduction, however, to a reduction in 
the concentration of DA in the kidney following adrenalectomy. 
This seems to be highly unlikely, at least in the acute study 
presented here, because the hypertonic saline infusion res­
tored the renal function almost completely while not affecting 
the DA excretion indicating that the reduction in the adrenal 
DA is the prime candidate for the observed reduction in DA 
excretion. The other explanation for the observed reduction 
in the renal DA observed by Ackpaffiong (1981), may be that 
DA in the adrenal travels to the kidneys via "a mini" 
circulation suggested in 1978 by Dempster (See Van Loon and 
Sole, 1980) who reported that the adrenals receive blood supply 
from the subarcuate arteries of the kidneys, and thus the 
reduction in the adrenal DA is reflected by corresponding 
reduction in the renal concentration of the amine.
8.5.4 6-OHDA
6-OHDA is known to accumulate in the adrenergic and dopa­
minergic neurons and result in selective destruction with 
ultimate consequence of reversible functional sympathectomy 
in the adult animal. The effect of depleting CA on B.P. 
is seen in Fig. 8.11. In rats receiving 50 mg.kg  ̂6-OHDA 
and killed 24 hours later, there was a tendency to have low 
B.P. when infused with 0.9% saline over 3.0 hr period. The 
long term effect, however, is certainly hypotension. Recently 
Nicols et al. (1985) found that intravenous injection of 
50 mg.kg  ̂into rats, repeating the dose after 16 and 24 
hrs,killing the animals 16 hrs later, the B.P. was reduced
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by 20%. The difference between our results eind these of 
Nicols et al. (1985) is that either the dose is not sufficient 
or the time lapse is not enough for the effect to be significant 
in our work.
Hoeldke et al. (1974) found that when 50 mg.kg  ̂6-OHDA
was injected i.v. on days 1, 7 and 8 and urine collected
8 days later, i.e. day 16, was reduced by = 18.3%.
exc.
This was not significant, although at this time and dose,
cardiac NA fell below detectable limits indicating efficient
sympathectomy. Moreover, Bell et al. (1978) found that 24
or 72 hrs after 6-OHDA injection i.v. into dogs at 2 x 30 
-1mg.kg separated by 24 hrs, NA and DA in the atrium or the
renal cortex were reduced significantly. The dose, therefore 
seems to be satisfactory. Although surgical denervation by 
applying 10% phenol in alcohol to renal nerves may result in 
different outcome than using 6-OHDA, it has been shown by 
Baines and Chan (1980) to reduce urinary DA by 20%, although 
the renal content of NA was reduced by 96%. As can be
seen in Fig. 8.12a, was reduced by 20% following
_1 exc
50 mg.kg 6-OHDA. This was similar to Hoeldke et al. (1974)
and Baines and Chan,(1980), this was rendered non significant, 
probably due to the standard error involved. Once the number 
of experiments( in the control ) was 18,the value was signi­
ficant (P < 0.05. )It should be noted that in these experiments,
I used the figures from the sham operated rats used in Chapter 
8 because 6 out of 18 controls were ordinary controls but 
since no difference was found between these control and the 
sham operated ones they were pooled. Many experiments
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(Baines and Chan, 1980; Morgunov and Baines, 1981) have
demonstrated that G.F.R. is not correlated to the U_, +Na exc.
in denervated or innervated, animals, and from my discussion
with adrenalectomy, the G.F.R. seems not to be the deterimin-
ant of Na or DA , as seen in Fig. 8.12b.Although exc. exc.
the G.F.R. was reduced significantly, was not.
The conclusion of the work on 6-OHDA is that the dopamin­
ergic neurones contributes not more than 20% to urinary DA.
This work could however be improved by the use of different 
doses of the drug alone or in combination with other depleting 
agents like reserpine, and should be validated against surgically 
denervated animals.
It will be of particular interest to study the effect 
of simultaneous adrenalectomy and sympathectomy on the urine 
free DA production.
Chapter Nine. Effect of different 
concentrations of sodium chloride on urinary 
dopamine and sodium excretion
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9.1 Introduction
The role of DA as a natriuretic substance was discussed earlier, 
however , there seems to be a relationship between and DA.
In the experiments of Ball and Lee (1977) a change from low to high 
Na^ diet increased DA excretion, moreover, Oates and colleagues (1979) 
found that during low Na^ diet, Na^ excretion was reduced with no 
change in DA excretion, but with high Na"*" intake, Na^ and DA excretion 
rose sharply without any change in plasma DA.
Many experiments demonstrated this relation between DA and Na^ 
to be significantly correlated under different conditions such 
as change in posture,(Cuche et al., 1972), Na^ loading (Alexander 
et al., 1974; Faucheux et al., 1977) or DA synthesis inhibition 
(Bail and Lee, 1977), moreover, this correlation was found to be 
specific to Na^ and not related to volume expansion. Faucheux et 
al. (1977) expanded the plasma volume of his experimental dogs 
with either saline or albumin,however, DA excretion responded only 
to saline expartsicuh. Oh the other hand, in work done by Ackpaffiong 
et al. (1980), no correlation was found between DA and Na^ while 
a good correlation was found between DA and Cl excretion. It 
was therefore interesting to study the effect of loading rats with 
NaCl acutely at different tonicities and find out the relationship 
between DA and Na^ and Cl , if any.
Consideration of volume expansion is necessary since all experi­
ments involving urine collection were carried out via volume 
expanded animals. For acute experiments, especially those involving 
urine collection, a solution is usually infused into man or experi­
mental animals, which may consequently increase the plasma volume 
and results in increasing DA excretion (Weinberger et al., 1982).
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It is well established that expanding the ECFV leads to increase 
in Na^ excretion. However, despite intensive investigation, the 
mediators of the volume expansion induced natruiresis are not yet 
well known. Considerable evidence indicates that volume expansion 
causes the release of a high molecular weight natriuretic material 
that causes its effect, at least partially by inhibiting Na^-K^- 
ATPase (Buckalew and Gruber, 1984), other researchers think that 
prostaglandins may be involved as well in the natriuretic effect 
of volume expansion,(Hayler and Lote, 1980)
9.2 Method
Besides those rats previously infused with 0.9% saline and 1.2% 
saline, 2 more groups were prepared as before. In the first, hypo­
tonic saline 0.45% (n=7) in sucrose and in the other, hypertonic 
saline 1.8% n=5 were infused at 13.33 ml.hr for 3 hrs. In each 
group, urine, volume, GFR, DA^^^, plasma Na"̂, urinary Na^ and K^and B.P. were 
measured as explained previously.
9.3 Results
Fig. 9.1 shows histographic presentation of B.P. in the four 
groups. The values obtained with each group was compared to the 
isotonic saline ones. As can be seen, there was no initial effect 
on B.P. Later, however, the 0.45% and 1.8% saline tended to 
depress the B.P. but the difference reached significance only at 
2.5 hrs in the latter group (P < 0.05). In fact, 3 hrs after 
infusing 1.8% saline, half the rats died and out of 13 animals 
studied, only 6 completed the experiment.
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Fig. 9.2(a-f) show the effects of various Na^ concentrations 
on the variables studied compared to the isotonic saline ones. Note 
that with the exception of urinary output, infusing 0.45% saline 
resulted in depression of all responses studied.
Infusing 1.8% hypertonic saline resulted in a reduction of G.F.R.
(P < 0.05)without any other significant effects. On the other hand, 
infusing 1.2% hypertonic saline had no effect on urinary DA excretion, 
urinary output or plasma Na^ concentration but it tended to increase 
Na^ (P < 0.05) and excretion (P < 0.001 )while the G.F.R. was 
reduced significantly (P < 0.05).
9.4 Measurement of Chloride
The Cl ion was measured using an Oricn microprocessor ionalyzer/ 
901 connected to a halide electrode Orion 94-17 filled with an 
Orion solution 90-00-17.
9.4.1 Solutions required
1. 5 M NaNOg served as ion strength adjuster (ISA) and was
prepared by adding 42.5 g reagent grade sodium nitrate (Fisons, 
England) to 100 ml distilled H^O.
2. 0.1 M NaCl (Fisons, England) to serve as standard,
and was prepared by dissolving 5.844 g NaCl in IL of H^O.
9. 4.2 Method
48 urine samples used for measurement of Na'*’ and other variables
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Fig. 9.2. Effect of infusing different tonicities of NaCl 
solution on (a) urinary DA exc. (b) G.F.R. (c)
urine output (d) Plasma Na (e), urinary Na 
excretion (f) urinary K exc. 0.45% - 
n = 7; 0.9% n = 5; 1.2% | | | n = 5;
1.8% % % %  n = 6 were infused at 1.33 ml.hr 
for 3 hrs. Results are mean ± S.E.M.
* P < 0.05 < 0.02 *:fî*P < 0.01
-Jf * P < 0.001
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were used to measure Cl ions as well. They were samples taken from 
control and adrenalectomized rats infused with different solutions 
as explained before. The method for measuring Cl was as follows:
(a) Calibration:
1. 100 ml distilled H^O + 2 ml (ISA) were put in a 250 ml beaker, 
the solution was stirred thoroughly, the electrode was placed 
in, and (CLEAR/READ MV) was pressed.
2. 1 ml of 0.1 M NaCl was pipetted into the solution and stirred 
thoroughly, then ( SET CONCN.) was pressed.
3. 10 ml of 0.1 M NaCl was added, the potential, which is the 
difference between step 3 and 2 was read in millivolts (should 
be 53 - 59 mV at 25°C).
4. The electrode was transferred to a beaker containing 100 ml 
sample + 2 ml (ISA), or 1.0 ml sample and 20 vl(ISA) and 
concentration was read directly.
9.4.3 Results
The aim of measuring Cl ions was to find the correlation of Na^ 
and Cl with DA excretion. This correlation was taken collectively 
from 48 samples used for estimation of Na^ and C1 , any sample 
used for the estimation of one ion but not the other was disqualified. 
The correlation of DA with both ions is tabulated as follows:
Table 9.1.
X y r P
Urinary DA Urinary Cl 0.153 N.S.
Urinary DA Urinary Na^ 0.698 P < 0.001
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9.5 Discussion
9.5.1 Effect of extracellular fluid volume expansion or depletion on
+ and-Na  exc.exc.
Ross et al. (1973) found that the Na^ transport process in the 
kidney is energy dependent and may be the major consuming process in 
the functioning kidney. It was found that Na^ reabsorption requires 
fuel, most of which comes from fatty acids and glucose.
Stein and Reineck (1975) reviewed the effects of alteration in 
extracellular fluid volume (ECFV) on segmental Na^ transport.
The net observation was that Na^ loading increases Na^ excretion 
i.e. reduces Na^ reabsorption in the proximal tubules while ECFV 
depletion increases Na^ reabsorption. This seems to be true in 
all species studied so far, including man, and seems to be 
consistent whether loading or depletion of ECFV was acute or chronic. 
Na^ loading usually takes place either by using intravenous in­
fusions of iso- or hypertonic saline or by increasing dietary Na^ 
intake, on the other hand,Na^ depletion occurs after ECFV depletion 
by the use of diuretics or by low Na"*̂ intake.
Obika and De Schnider (1982) found that keeping rats on a high 
Na^ diet for 7 days, increased Na^ excretion 6 fold while maintaining 
them on low Na^ containing diet reduced Na^ excretion by 99.4%.
The same pattern is seen with our experiments (Fig. 9.2d).. When
+ -1 isotonic saline was infused, urinary Na was 0.5 ± 0.1 mmol.3 hrs ,exc
this value was reduced to 0.025 :: 0.01 mmol.3 hrs when hypotonic
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saline 0.45% was infused, while increased to 2.15± 0.6 mmol.3 hrs ^
when 1.2% saline was infused. As can be seen in Fig.9.2d, increasing
the tonicity to 1.8% resulted in increasing Na^ but to a lesserexc
extent than 1.2% saline. This is probably due to the observation
that animals at 1.8% became weak and prone to functional collapse
and death. Their blood pressure was comparatively lower (Fig. 9.1),
their urine volume, + and U,,+ were reduced as well (whenNa Kexc exc
compared with effects of 1.2% saline). This means that more Na 
is retained with ultimate formation of oedema which was very 
evident in this group.
Brownlee et al. (1983) in a similar protocol to ours, infused 
hypotonic saline (10 mM Na""̂ in 5% glucose) into rats at a 
constant rate of 0.2 ml.min for 3 hours,collecting urine every
20 minutes. Among the observations were that was 2.5 z 0.6
-1 -1y mol.20 min while U^+ was 7.0 ± 1.5 y mol.20 min which
exc.
denotes that hypotonic saline affects U^+ to a greater extent
than U^^+. This seems to be the case because in our experiment,
the infusion of hypotonic saline resulted in and U^+
 ̂ exc exc.
of 24.8 and 36.2 y mol.3 hr respectively. On the other hand,
infusing an isotonic solution reversed this aspect with
_1 exc.
and U^+ being 450 and 145 y mol.3 hrs respectively, 
exc.
The obvious conclusion is that mild volume depletion increased 
Na^ reabsorption. It is worth mentioning that Brownlee et al. (1983) 
infused their hypotonic saline into the tail vein of conscious rat 
which may be a good practice and therefore highly recommended for 
further work since with little skill, it relieves the animal of 
extensive surgery and removes the effect of anaesthesia, operative 
shock and the crude method of collecting urine.
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The same observations have been extended to other experimental
animals like dogs (Faucheux et al., 1977) and also to man. Oates
et al. (1979), found, when human volunteers were given a low
Na^ diet, was reduced so as to bring Na^ balance back
exc.
to equal Na intake. When high Na was given, however,
exc.
was increased significantly (p < 0.001). Moreover, Carey and
Van Loon (1982) found, in normal volunteers given a diet containing
+ -1 -1 150 mmol.Na .day , that was approx. 150 mmol.day as
exc
well. When the volunteers were shifted to a diet containing 10 mmol. 
+ -1Na .day , fell daily until it reached zero on day 10.
exc.
furthermore, in volunteers intravenously administered 0.9% saline
at a rate of 500 ml.hr for 4 hours, U.. + was increased fromNa_1 exc.
5.14 to 10.8 mmol.hr (P < 0.01). On the other hand, volume
depletion with frusemide reduced by 90% (Weinberger
exc.
et al., 1982). All the above mentioned results are in direct
confirmation with our observations and are consistent with the idea
that volume expansion increases while ECFV depletion
exc.
produces a reduction in Na excretion.
It seems that U^+ follows a similar pattern to ,
exc. exc,
and was therefore, reduced by hypotonic saline while being increased
by hypertonic saline infusion. Although there is a general agreement
involving the effect of ECFV expansion or depletion on
exc.
there seems to be less certainty as to the underlying effect on
U^+ . In the above mentioned experiment, Weinberger et al. (1982)
exc.
found that U^+ excretion was not affected by ECFV expansion or 
depletion. The reason for the discrepancy is not obvious; the 
experiment of Weinberger et al. (1982) was carried out on normal 
volunteers receiving i.v. infusion of 0.9% NaCl. In an experiment
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cariried out by Peterson and Wright (1977) , to study the effect 
of Na^ intake on renal excretion, it was found that during 
continued Na^ restriction, Na^, and excretion rates were 
reduced due to enhanced reabsorption of these ions by the collecting 
duct. On the other hand, the administration of large amounts of 
Na^-containing salts produces kaliuresis which was attributed to 
increased fluid delivery to the distal tubule (Gabow and Peterson, 
1980).
9.5.2Effect on plasma Na
DiPette et al. (1982) found, in subtotally nephrectomized rats
maintained on low Na^ diet that plasma Na^ was reduced from
145 1 1.6 to 135 ±0.8 mmol.l  ̂ (P < 0.01). Similar observations
were seen in dogs infused with hypotonic saline(0.45%).When the
-1 -1solution was infused at a rate of 2.0 ml.min .kg for 45 minutes
-1 -1 +followed by 1.0 ml.min .kg. , plasma Na was reduced significantly
(P < 0.01). On the other hand, infusing a hypertonic 1.8% solution 
at 0.5 ml.min ^.kg  ̂ for 45 minutes then at 0.25 ml.min ^.kg  ̂in­
creased plasma Na^ to 146.6 mmol/L (p < 0.02), Cuche et al. (1983).
As can be seen in Fig. 9.2d, following infusion of hypotonic
saline, plasma Na"*̂ was reduced from 125.4 ± 1.6 to 107.0± 3.4
mmol.L  ̂ (P < 0.001) which, compared to the experiment of DiPette
et al. (1982), indicate that the effect is not restricted to
rats with reduced renal mass. Furthermore, infusing hypertonic
saline (1.2%) in our experiment did not affect plasma Na^ cone. whilst
the Na^ concentration was increased to 133.2±3.7 when 1.8% saline was infused,
this, however, was not significant due to the error involved; the
percentage increase was 6.2% while it was 4.6% in the experiments
of Cuche et al. (1983).
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9.5.3 Effect on urinary DA excretion
Weinberger et al. (1982), observed that was 9.4Wg,hr
exc.
in normal subjects and that this value was not altered following
ECFV expansion with 2000 ml saline 0.9%, however, following volume
depletion by .frusemide, it was reduced to 5.4 yg.hr  ̂ (P< 0.01 ).
Similar effect was found in the dog by Cuche et al. (1983) who
infused hypotonic saline and reported that was reduced
_1 exc
from 7.5 ±1.3 to 5.04 ± 0.8 ng.min , while hypertonic saline
infusion did not affect to any extent. This is exactly similar
exc
to the results obtained in Fig. 9.2a where isotonic saline infusion
resulted in of 290 ±16 ng.3 hrs  ̂which was reduced to
exc
168 ± 40(P 0.01) following the infusion of hypotonic saline.
Hypertonic 1.8% or 1.2% saline were without effect.
9.5.4 Relation of DA to urinary Na^ and Cl excretion
In our studies, no attempts were made to study these relationships in
detail, the only trial made was to estimate + and in the
^exc exc
same samples, and to make a simple correlation aiming at finding
which of the two ions fits best with the excretion of dopamine
in the urine. Table 9.1 shows the results obtained in 48 urine
samples.The correlation between U_. and U., + is clear (P < 0.001)DA Na
while no relation at all (r = 0.153) was seen between and U^^-
exc
Many reports have been published in the recent years reviewing 
this point. Thorner (1975 ),therefore,found that the DA-agonist, 
bromocriptine, increased Na^ excretion while in man, Cuche et 
al. (1972) observed a correlation between and Na"*" excretion 
in supine and upright posture. Moreover, Ball and lee (1977) found
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that DA and Na^ excretion were reduced in similar pattern in man 
treated with CD and there was significant correlation between DA 
and Na^ excretion before, during and after the administration of 
the drug. Another assessment of the point came from the work of 
Faucheux et al. (1977). They infused dogs either with saline or 
25% bovine serum albumin to expand the ECFV, and found that
and were increased only in the saline expanded
exc. exc
dogs and concluded that was not a consequence of volume
exc
expansion but specific to Na ion. This experiment was, however, 
disputed recently by the work of Roy et al. (1985), who found 
that 25% human serum albumin infused into dogs increased the 
urinary Na^ excretion. The design of the two experiments were the
same with the exception that the former used bovine serum albumin 
rather than the human serum albumin used by the latter and
-1 -1secondly, the infusion rate used by the former was 0.3 ml.kg .min
while 0.1 ml. kg. ^.min  ̂was used by Roy et al. (1985).
Some experiments have emphasized the importance of Cl ion in
relation to DA. The approach used by Ball et al. (1978), Ackpaffiong
et al. (1980); Ackpaffiong,(1981) and recently by Kurtz and Morris
(1983) was to feed the experimental rats on a diet containing
chloride salts, usually NaCl, KCl, NH^Cl and compare the urinary
effect on DA with non-chloride containing salts, usually NaHCO^ or
sodium ascorbate. The observation by Ball et al. (1978) that NaCl,
KCl and NH^Cl all increased while NaHCO^ reduced it, led
exc.
these authors to conclude that it was probably the Cl ion and 
not the Na^ that is important in relation to DA . In this experiment 
however. Ball et al. (1978) did not carry out any correlation studies, 
but relied on observing the effect of different salts, whereas
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Ackpaffiong (1981 ) estimated DA, Na^ and Cl in the urine of 8
groups of rats and found that DA correlated with Na^ in four groups
while in the same 4 groups plus one other, DA correlated better with
Cl . In the 3 remaining groups, DA correlated with neither. Based
on these observations, we cannot negate the importance of the Na^
ion. Although we can conclude from our results (Table 9.1) that
Na^ is still more important than Cl in relation to urinary DA,
but at the same time we cannot rule out the possibility that Cl 
may also play a significant role. This point clearly needs a
more thorough and more extensive study.
Final Discussion
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The work described in this thesis started with the aim of studying 
some aspects of the renal pharmacology of catecholamines(CA) with 
special emphasis on the relationship between renal CA concentrations 
and hypertension on the one side and salt loading on the other.
Another aim was to concentrate on the relationship between urinary 
DA excretion and that of Na^ and Cl as well as elaborating on the 
source of DA that appears in the urine.
The work logically started by estimating the concentration 
of noradrenaline (NA), adrenaline (ADR) and dopamine (DA) in the 
kidney, and for the completion of the picture, cardiac,adrenal and 
plasma levels of the three amines were studied as well. It was 
found that C.A are found in abundance in the kidney, heart and adrenal 
gland of rat, and much lower concentrations were found in the
plasma. Moreover, it was found that the distribution of CA is
different in different tissues, with NA being the most abundant, 
except in the adrenal gland. In the kidney, DA was found in much 
higher concentrations than ADR, while it was the other way round 
in the heart.
The effect of species, sex and mode of sacrifice were not ref­
lected in changes in CA in the kidney indicating that tissue concen­
trations may not be ideal parameters to be studied probably due 
to continuous turnover of the amines.
Once the basal levels of CA had been estimated, the study was 
extended to estimate the amine concentrations in the normotensive
and spontaneously hypertensive (SHR) rats. It was found that the
renal and plasma concentrations of the amines, and to a lesser
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extent that of the adrenals, were not significantly different in 
both species. Cardiac NA concentration was, however, much lower 
in the SHR which was explained as a combined effect of increasing 
release and a low turnover of the amine in SHR. Moreover, to find 
out if oedema, which often accompanies hypertension, did partici­
pate in the levels of CA in SHR, the concentrations of the three
amines were expressed in relation to protein concentration of the
tissues studied. The concentrations were not altered by this 
method of expression which indicated that concentrations found in 
SHR were not affected by oedema formatinon.
In a study conducted to find out the effect of salt loading 
with 3% NaCl, NaHCO^, or CaCl^ for 3 days on the basal levels of
CA, it was found that this treatment did not affect CA levels in
the kidney, adrenals, or plasma to any appreciable extent while 
the heart was much more prone to the effects of salts, particularly 
CaClg. This was explained on the basis of the well known ionic 
requirement of the cardiac muscle. On the other hand, it seemed 
that the levels of CA in the tissue do not reflect the activity 
of the tissues involved because of a continuous turnover of these 
amines. It was therefore decided to study the turnover of DA 
in the urine, plasma, and different tissues. DA was chosen because 
of the growing interest in its relation to urinary Na^ concentration 
and to renal function in recent years. The turnover studies in­
volved estimating the time-course disappearance of DA from the 
urine, plasma, kidney, heart and adrenal glands of rats injected 
with carbidopa (CD) a DOPA decarboxylase inhibitor.
CD was injected i.p. to anaesthetized rats while urine, plasma 
and tissues were collected 0.5 hourly. It was found that CD reduced
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urinary DA excretion while it did not alter that of Na*; this latter 
was attributed to the huge variation from one rat to another.
On the other hand, CD produced a time-dependent reduction in renal 
and plasma levels of DA. The amine followed, in both, a similar 
pattern of disappearance. In the heart and adrenal gland, DA showed 
a similar profile of change following CD which was distinct from 
the pattern of change followed by the amine in the kidney and plasma. 
It was concluded that either CD is not taken up equally into diff­
erent tissues or that the concentration of DOPA decarboxylase is 
not the same in all tissues. These possibilities were studied 
later using a-monofluoromethyldopa (aMFMD) and was carried out 
using the kidney as a member of the first group, and the adrenal 
gland as a member of the second. Both tissues responded to aMFMD 
induction with a time-course reduction in DA concentration which 
was more evident in the kidney than the adrenals, indicating that 
the CD and aMFMD are taken up into the kidney in higher concen­
trations whereby they affect the amine to a higher degree. Indirectly, 
this observation suggested that renal DA is an important determinant 
of renal function and may be an important source of urinary DA.
At this stage, another experiment was designed to study the source 
of this urinary DA with special emphasis on the adrenal and the 
neuronal elements.This sympatho-adrenal participation was studied 
in adrenalectomized rats and in rats treated with 6-hydroxydopamine 
(6-OHDA).
It was found that adrenalectomy for 3 hours, reduced the renal 
function and the urinary excretion of DA to a similar degree when 
isotonic solutions were infused.This reduction in G.F.R. was 
restored when 1.2% saline was infused while the urinary DA concen­
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tration was still reduced by 44.0%. It was concluded that the 
adrenal gland contributed this high percentage of DA to the urine. 
On the other hand, 50 mg.kg 6-OHDA over 24 hours, reduced urinary 
DA concentration by only 20% which was taken as a measure of the 
participation of the sympathetic neurones to urinary DA excretion.
In another study, the relationship of DA and both Na* and Cl 
was examined. In 48 samples, DA was found to significantly correlate 
with Na* while no significance with Cl was seen. This may 
strengthen the suggestion of DA being a natriuretic substance. A 
further experiment was, therefore designed to elaborate this 
relationship»It was based on infusing different concentrations of 
salt through the rat, followed by assessment of DA and Na* in the 
urine. It was found that hypotonic saline infusion reduced both 
Na* and DA while hypertonic saline infusion enhanced Na* excretion 
with no effect on DA. It was concluded that hypotonic saline in­
fusion increased Na* reabsorption in the proximal tubule while 
hypertonic saline was associated with suppression of aldosterone 
production and probably the release of a natriuretic substance 
which consequently increased the urinary excretion of Na*.
The effects of the adrenal glands on the kidney were studied 
by Marshall and Davis in 1916 by measuring the excretion of 
phenolsulphophthalein, urea and cretainine following complete adren­
alectomy. The result was that the removal of the adrenal glands 
reduced renal function significantly (Guadino and Levitt, 1949).
On the other hand, the interaction of the adrenals with the pituitary 
gland was demonstrated in hypophysectomized rats, where the 
release of aldosterone and deoxycorticosterone from the adrenals 
were significantly (P < 0.001) reduced when compared to control
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rats (Singer and Stark-Dunn, 1955).
From these experiments and from others discussed in the 
following pages, it will become absolutely clear that adrenalectomy 
represents a mixture of withdrawing the adrenal mineralocorticoids 
and stimulating the neurohypophyseal lobe of the pituitary.
Aldosterone acts to increase Na* conservation and K* secretion 
in the renal tubule, large intestine and sweat glands,and its pro­
duction is stimulated by volume contraction and K* loading (Bastl 
et al. 1980). Recently, Horster and Luckoff (1983) found that 
during long term ( 2 - 5  weeks) adrenalectomy, aldosterone (200 yg.kg ^.4hr ^) 
partially restored Na* reabsorption in the rat distal colon. In 
another experiment, in rats adrenalectomized for 7 days, the admini­
stration of aldosterone (120 yg.lOOg  ̂wt.24 hrs ^) partially 
restored the effect of the operation on B.P., plasma Na* and K* 
within 24 hrs (Friedman et al. 1984). On the other hand, Ishikawa 
and Schrier (1982) found that blockade of the ADH by an 
arginine vasopressin antagonist does partially, but not completely, 
restore the ability of adrenalectomzed rats to excrete H^O and 
maximally diluted urine (Welch et al., 1983).
Although from this description, it seems that the neurohypophysis 
intervenes in the face of removing the gland, the extent of this 
intervention is not known, at the present time. My results obtained 
"n adrenalectomized rats, were consistent with the effect on renal 
function, the GFR was therefore reduced, but on the other hand, 
the reduction of Na* excretion in adrenalectomized rats is still 
a bit of a puzzle, and the only hypothesis that I can offer is that
191.
the acute effect of adrenalectomy stimulates the pituitary gland 
with a subsequently reflex mediated increase in Na* conservation.
It seems that, when saline is infused, there is a decrease 
in the fractional reabsorption of Na* in the proximal tubule of 
dogs and rats (Berliner,1968). On the other hand, in rats kept on
Na*-free diet and injected intraperitoneally with furosemide
-1 +15 mg.kg for 2 days, Na excretion was promptly reduced. When
the micropuncture technique was used, it became obvious that the 
reabsorptive capacity of the proximal tubules was greatly enhanced 
and this capacity was thought to be mainly the reason for the reduction 
in Na*exc. rather than a reduction in GFR (Weiner et al., 1971). This 
effect of volume expansion and depletion was recently observed by 
Ely et al. (1985) when rats were given low or high Na* containing diet. 
It was noticed that rats on low Na* diet retained almost all of the 
ingested Na* while rats on high Na* diet excreted very large amounts 
of salts. The interesting observation was that rats on high Na* 
excreted their salt and water within the first 45 minutes of in­
gestion which implied that both groups seem to maintain largely 
equal levels of body fluid volume throughout most of the day.
Brosnihan et al. (1979), found that a 75% reduction in Na* 
intake for 3 weeks plus furosemide treatment produced a 15 fold 
increase in canine plasma renin activity, it was, however the 
volume depletion rather than the furosemide that produced the 
effect, because Stein et al. (1974) found that low Na* intake for
-13 weeks reduced from 0.19 ± 0.02 to 0.04 ± 0.007 yeq.min
exc.
while 5 days furosemide prior to the study resulted in only a small 
additional reduction to 0.03 ± 0.01. In another study, Roy et al.
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(1985) found that in the intact dog kidney, a 43% volume expansion 
using a 25% human serum albumin reduced renin secretion rate by 
85% while in dogs with innervated non-filtering kidney and with de- 
nervated filtering kidney, the reduction with comparable volume 
expansion was 50% indicating that inhibition of renin secretion 
during volume expansion is dependent on both renal tubular mechanisms 
and the integrity of the renal nerves. Despite the denervation, Roy 
et al. (1985) found that fractional excretion of Na* was enhanced 
significantly indicating that it is the volume expansion that produced 
the effect to reduce the renin secretion rather than the suppression 
of the sympathetic system. Further support for this idea came in­
directly from the work of Peterson et al. (1984), who found that 
in the monkey, renal denervation did not affect the magnitude of diuresis 
and natriuresis induced by volume expansion, which implied that the 
renal nerves play no major role in the response to this "hypervolaemic 
intervention", the difference between this experiment and that of 
Roy et al. (1985) was that this latter acutely denervated the kidney 
before the experiments while Peterson et al. (1984) chronically 
dmervated the kidneys at least 2 weeks before the experiment.
The results of above mentioned experiments imply that volume 
expansion and volume depletion alters plasma renin levels with 
ultimate effect on aldosterone secretion which in turn affects 
+ . To what extent is this idea correct?Na exc.
Although the importance of aldosterone is unquestionable,
it seems that this mineralocorticoid is not the most prominent
factor in relation to Na* during Na* expansion at least.exc.
Shrier and Anderson (1980) reported that the onset of Na* retaining 
effect of aldosterone is usually delayed for at least 60 minutes
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while changes in posture - for example - alters Na* excretion 
within a few minutes.
Schrier and Anderson (1980), quoted de Wardner et al. (1961)
who expanded dogs with 0.9% saline and found that Na* wasexc.
enhanced despite dosing the animals with large amounts of mineralo­
corticoids and ADH to offset the inhibitory effect of volume ex­
pansion on aldosterone and ADH production respectively. The net
result was a prompt increase in accompanied by a
exc.
reduction in GFR. These authors concluded that a circulating
substance is released upon volume expansion, and this substance
effectively enhances Na*^^^ .Later, Kaloyanides and Azer, (1971)
found that when an isolated canine kidney was infused with
blood from a donor dog, the in the isolated kidney was
exc.
increased by 150%. They concluded, similar to the first group, 
that such a humoral agent is released upon volume expansion and 
is mediating an increase in excretion.
Since our experiments with volume expansion and volume depletion
produced results similar to all the studies conducted so far,I
conclude that in this type of experiment, infusing hypotonic
saline acutely produces volume contraction and results in enhancement
of the reabsorptive capacity of the proximal tubule with ultimate
results of reducing urinary excretion of Na* and K*. On the
other hand, the expansion of the extracellular fluid volume by
isotonic or hypertonic saline results in an increased Na* whichexc.
seems to be a combination of the inhibition of aldosterone production 
and probably a generation of a natriuretic substance.
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I believe that my work provides a sound ground for further 
studies and that each experiment can be expanded to yield further 
information. The following suggestions are, therefore,forwarded 
for future work.
(1) The study described in Chapter 4, did not find a relationship 
between spontaneous hypertension and renal dopamine. I believe 
this work can be extended to study the relationship of
renal and urinary dopamine in different models of experimental 
hypertension. This work can be carried out acutely in anaesthetized 
rats or in conscious rats infused, in this case, via the tail 
vein. The work can also be extended to rats chronically treated 
with DA agonists and antagonists.
(2) To study further the involvement of neuronal elements in the 
formation of urinary DA. This can be carried out in acute or 
chronically denervated rats, with different doses of 6-OHDA 
and/or other depleting agents. This work can be extended to 
neuronally depleted, adrenalectomized rats with or without 
the use of the prodrug y-glutamyldopa. From this experiment, 
the removal of the neuronal and adrenal elements together 
give a chance to study other factors involved, and the use 
of the prodrug gives a chance to study the activity of the 
kidney to form urinary DA.
(3) The study of carbidopa and aMFMD were carried out using only 
one dose of each inhibitor. I believe it would be a very good 
idea to study the parameters studied in Chapters
6 and 7 using increasing doses of the inhibitors. Also, if
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no interference exists when low doses are used, this may allow 
one to study both the rate of DA disappearance and the rate of 
DOPA accumulation at the same time.
(4) In the light of the information reported in the text that 
demedullation reduced the adrenal DA content by 50%, it 
would be very interesting to repeat experiments carried out 
with adrenalectomized rats in demedullated rats, in adrenal­
ectomized rats receiving substituted therapy of corticosteroids 
and in adrenalectomized rats receiving saline for drinking 
water. The study of different urinary parameters, as well
as tissue levels of DA may provide an opportunity to elaborate
the effect of corticosteroids on urinary, renal and adrenal 
levels of DA.
(5) In control and adrenalectomized rat, mannitol behaved in an 
opposite way to what would have been expected; an experiment 
could be designed utilizing different concentrations of mannitol 
infused at different rates.The construction of a dose response 
curve may lead to an interesting result which may give a clue
as to the cause of the effect of mannitol.
References
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